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 Breast cancer is prevalent among Canadian women, but treatments may cause functional 
impairments among survivors.  Over 22,000 Canadian women join the survivor population 
yearly (Brenner et al., 2020). Despite this substantial number, minimal research has approached 
the challenges faced by this population after primary treatment. Particularly, decreases in 
strength, range of motion and shoulder-related quality of life are widely reported (Harrington, 
Padua, Battaglini, & Michener, 2013; Lee, Kilbreath, Refshauge, Herbert, & Beith, 2008; 
Rietman et al., 2004). These factors, linked with changes in kinematics and muscular activation 
may result in further complications (Brookham, Cudlip, & Dickerson, 2018a, 2018b). Variability 
in previous studies, in both the population sampled and results make it difficult to isolate 
potential mechanism disrupting function. Further, this complicates the determination of key 
deficits to target in the early years of survivorship. Therefore, the purpose of this dissertation was 
to determine which factors affect breast cancer survivors in the first two years following the 
conclusion of treatment, if these factors translate to differences during low load functional tasks, 
and to investigate the feasibility of increasing strength (as a surrogate for function) to help 
mitigate these factors and increase function.  
 Study 1 and 2 shared an in vivo experimental collection, with Study 3 using input from 
the collection in an in-silico approach. Briefly, 35 breast cancer survivors within two years since 
the conclusion of their treatment participated in the experiment. Participants completed a general 
questionnaire about their diagnosis, three shoulder-related quality of life questionnaires, and a 
Godin-Shephard leisure-time physical activity questionnaire, followed by a dual energy x-ray 
absorptiometry (DXA) scan. Eight muscles were monitored on the affected limb (pectoralis 
major (sternal and clavicular), deltoids (anterior, middle and posterior), infraspinatus, 
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supraspinatus, and latissimus dorsi). Six maximal isometric strength trials were completed 
(flexion, extension, abduction, adduction, internal rotation and external rotation). Kinematics of 
the affected limb were collected for the remaining trials. These consisted of 6 maximal range of 
motion trials (flexion, extension, abduction, scapular abduction, internal rotation and external 
rotation), as well as 8 activities of daily living.  
 Study 1 clustered participants into two distinct groups, the low score cluster (LSC) and 
high score cluster (HSC). The variance in treatment, force production, range of motion, body 
composition and shoulder-related quality of life is well documented in literature, however there 
is no distinguishing characteristics that separate survivors who may need rehabilitation following 
treatment. This study determined, through feature reduction, that internal rotation force 
production, active extension range of motion and 3 shoulder related quality of life variables 
(energy/fatigue, social functioning and pain) separated survivors within 2 years of treatment into 
two clusters (LSC and HSC). The LSC participants had higher self-reported disability, role 
limitations (health and emotion), fatigue, and lower self reported physical well-being, along with 
lower abduction, adduction, extension and flexion force production (p<0.001). Several other 
factors differed between groups (p<0.05); the HSC group had more lean mass of the affected 
arm, internal and external force production and active flexion range of motion. These factors 
highlight potentially important factors to address in a rehabilitation program, as survivors finish 
treatment, specifically that lower force production likely corresponds to lower self-reported 
shoulder-related quality of life. 
Study 2 contrasted the muscular activation and kinematics of the LSC and HSC during 
various activities of daily living. The selected low load functional tasks can indicate survivors’ 
ability to complete daily tasks and return to work. The LSC used lower range of angles, and 
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increased muscular activation.  Range of angles differed 6.5-16.1° across elevation angle, axial 
rotation and plane of elevation during the shelf reach, forward reach, pitcher pour and tray 
transfer tasks. Additionally, the LSC had 0.89-12.73% MVC more muscular activation than the 
HSC across all muscles and tasks. At least one muscle differed between groups during each of 
the 8 tasks investigated. 
 Finally, study 3 simulated various treatment scenarios to find a maximal producible force 
and the internal muscle forces required to produce that force in a compromised system with an 
in-silico approach. Beginning with the force from the LSC, and increasing capacity of muscles 
based on given treatment scenarios (permanent damage of a subset of muscles from radiation, or 
overall reduction in capacity due to chemotherapy, or a combination of both), 70-80% of strength 
in adduction and internal rotation is recoverable if retraining of muscles can be achieved. 
Specifically, for adduction rhomboid (major and minor), upper trapezius, subscapularis (lower), 
and triceps (long), latissimus dorsi (upper and lower), pectoralis minor, middle deltoid, middle 
trapezius and biceps (short) increased during the various simulations to increase force output 
compared to the LSC group. During internal rotation, latissimus dorsi, rhomboid (major and 
minor), upper trapezius, posterior deltoid, subscapularis (middle and lower), triceps (long), 
pectoralis minor, middle deltoid, and middle trapezius estimation increased from the LSC group 
levels in each of the simulations. Although no scenario reached reference control population 
force levels, achieving 70-80% of force would be meaningful for enabling daily task 
performance, returning to work and enhancing physical self-efficacy.  
 Taken together, these studies point towards novel strategies and valuable considerations 
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Chapter I - Introduction 
1.1 Motivation  
Breast cancer is prevalent in Canadian women, but treatments often compromise upper 
extremity strength and range of motion. Over 22,000 Canadians join the breast cancer survivor 
population every year, and although this population continues to grow, minimal research focuses 
on the challenges in this population post treatment. Glenohumeral range of motion is decreased 
in 1-67% of survivors (Lee et al., 2008), 9-40% of survivors have weakness in their upper 
extremity (Rietman et al., 2004), survivors have a reduced shoulder-related quality of life 
(Harrington et al., 2013), and muscular activation and glenohumeral motion differ in this 
population from a reference population during daily life tasks (Brookham et al., 2018b, 2018a). 
However, much of the existing data derived from a diverse cross-section of survivors in terms of 
treatment types, and time since the conclusion of treatment. Extensive variability in the survivor 
populations (spanning time since treatment and treatment type) previously evaluated makes it 
difficult to isolate mechanisms of dysfunction in survivors and how these individuals differ from 
a reference population immediately following treatment.  
1.2 Global Objective  
 This dissertation incorporated three linked studies that employ both experimental and 
modelling approaches. The global objective was to determine which factors affect breast cancer 
survivors immediately post treatment, and to investigate the feasibility of increasing strength (as 
a surrogate of function) in breast cancer survivors. The proposed studies delineated factors that 
mitigate differences between cohorts of breast cancer survivors, (Study 1), described differential 
kinematic and muscle activation across these cohorts (Study 2), and explored the muscular 
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implications of various treatments on the potential to increase strength during adduction and 
internal rotation strength trials using an in-silico approach (Study 3).  
1.3 Outline 
The three studies were conceptually linked (Figure 1), with a linear flow that provided 
progressive insight into the breast cancer survivor population. Specific study objectives and 
hypotheses are detailed in subsequent sections of this dissertation. Study 1 clustered participants 
into several different cohorts, and identified the differences in these groups. Study 2 contrasted 
these groups with one another with a specific focus on muscular activation and kinematics during 
activities of daily living. Study 3 focused on replicating various treatment scenarios, determined 
the necessary internal muscle forces required to produce maximum force in a compromised 
system and determined the potential capacity of the system to restore strength (such as with a 





Figure 1: A flowchart outlining each of the three studies contained within this research. Data collected in the experimental protocol is 
used to create cohorts of survivors in study 1, and subsequently used for comparison in study 2. Baseline strength production in study 
3 is based on strength measures collected in the experimental protocol. 
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Chapter II - Literature Review 
2.1 Overview of Breast Cancer  
2.1.1 Prevalence 
 Breast cancer is a common form of cancer among women, with increasingly positive 
outlooks for survival. 1 in 8 Canadian women will be diagnosed with breast cancer in their 
lifetime, representing 25% of new cancer cases in 2018, and 6.1% of all cancer deaths (Brenner 
et al., 2020; Canadian Cancer Society, 2020). Due to improved awareness and detection times, 
80% of cases are diagnosed early (stage I or II), with less than 5% at stage IV. This results in a 5-
year survival rate of 87% (Canadian Cancer Society, 2020). With approximately 27,400 new 
cases reported in Canada each year, there will be 22,880 individuals joining the survivor 
population (Brenner et al., 2020). Although much less common, 1% of all breast cancer 
diagnoses are in men. A total of 240 men will be diagnosed with breast cancer in Canada each 
year (Canadian Cancer Society, 2020). As the survivor population continues to grow, this thesis 
will focus on cisgender women, acknowledging that both men and women experience breast 
cancer diagnoses and potential complications which arise from treatment.  
2.1.2 Disease diagnosis   
 The tissues affected, cell appearance, hormone influence on the tumour and the genetic 
makeup of the tumour specify breast cancer diagnosis. Diagnosis first considers the location 
where the tumour began (Table 1). The tumour often begins in the milk ducts, milk-producing 
lobules, or connective tissues (Figure 2). In addition to the original location, the invasiveness 
(spread) of the tumour is determined and allows for the type to be diagnosed (Table 1). Finally, 
cancerous cells are examined and the difference between healthy cells and cancerous cells are 
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graded from 1-3 (Mayo Clinic, 2019). Generally, a lower grade (grade 1) indicates cancer cells 
that resemble normal cells and are slow growing, grade 2 grow faster than normal and do not 
look like normal cells, and finally grade 3 cancer cells are abnormal, aggressive and spread much 
more quickly than normal healthy cells. 
Table 1: Types of Breast Cancer (Canadian Breast Cancer Network, 2019). 
 
Figure 2: Anatomy of breast tissue (Mayo Clinic, 2019). 
Type Description 
Ductal Carcinoma in 
Situ (DCIS) 
• Abnormal cells within the ducts (Figure 2) 
• Does not spread beyond ducts (non-invasive) 
• Generally early and could spread beyond 
Lobular Carcinoma in 
Situ (LCIS) 
• Abnormal cells in milk-producing glands (lobes) (Figure 2) 
• Usually does not spread beyond lobes  
• Increased risk of invasive re-occurrence 
Invasive Ductal 
Carcinoma 
• Begins in ducts (DCIS) 
• Spreads to surrounding breast tissue 
Invasive Lobular 
Carcinoma 
• Begins in milk glands (LCIS) 
• Spreads to breast tissue  
Metaplastic • Rare (less than 1%) 




• Cancer involves lymph nodes (Figure 2) and surrounding tissues 
• Breast appears red, swollen and tender 
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 Subtype definition considers the hormone sensitivity and genetic makeup of the tumour. 
Various tumours are sensitive to different hormones and are known as estrogen or progesterone 
receptor positive. Thus, they use naturally occurring hormones (estrogen, progesterone) for 
continued growth. If the tumour is insensitive to hormones it is identified as hormone receptor 
negative (Mayo Clinic, 2019). Basal-like and erbB2+ subtypes are both estrogen receptor 
negative tumour types, with laminal subtypes being estrogen receptor-positive (Table 2). ErbB2+ 
subtypes are estrogen receptor negative, but have an over-representation of the HER2 gene, 
which is a growth-promoting protein (Mayo Clinic, 2019).  
Table 2: Subtypes of Cancerous Cells (Perou et al., 2000). 
Along with these characteristics, a stage is assigned during diagnosis. The stage is dependent 
on the rating of the tumour, nodes and metastases (‘TNM’) (Table 3). Each characteristic is 
given a score and from 0-4. Known combinations of the tumour, nodes and metastases dictate the 
severity of the breast cancer diagnosis (Table 4). Stage I tumours are classified as T1N0M0 , and 
stages range to any diagnosis with M1 (indicative of metastases elsewhere in the body) as stage 
IV (Sainsbury, Anderson, & Morgan, 2000). These diagnoses allow for description of the tumour 
and provides insight into the type of treatment available for the specific diagnosis.  
 
Subtype Description 
Basal-Like • Estrogen receptor negative 
• Shortest survival times 
• More likely to relapse  
erbB2+ • Estrogen receptor negative 
• HER-2 overexpression 
• Less favourable clinical outcomes 
Laminal  • Estrogen receptor positive 
• Favourable clinical outcomes 
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Table 3: Description of Stage Characteristics (Edge et al., 2010; Hammer, Fanning, & Crowe, 
2008; Sainsbury et al., 2000) 
Characteristic Description 
Tumour (T) • Tumour size  
• Invasive (spreading beyond the ducts) vs non-invasive (remaining 
with the ducts) 
• Subtype (Table 2) 
Nodes (N)  • Any spreading (micro-metastases or tumours) in the lymph nodes 
Metastases (M) • Any metastases detected elsewhere in the body 
 
Table 4: Criteria for staging of breast cancer diagnoses (TNM). Modified from table 1 of 
(Hammer et al., 2008) 
 Primary Tumour (T) Regional lymph 




Stage 0 Carcinoma in situ No evidence of cancer in 
nearby nodes 
No 
Stage I Tumour ≤ 2cm No evidence of cancer in 
nearby nodes 
No 
Stage IIA No evidence of primary tumour Metastasis to 1-3 nodes No 
Tumour ≤ 2cm Metastasis to 1-3 nodes No 
Tumour  2cm but ≤ 5cm No evidence of cancer in 
nearby nodes 
No 
Stage IIB Tumour  2cm but ≤ 5cm Metastasis to 1-3 nodes No 
Tumour  5cm No evidence of cancer in 
nearby nodes 
No 
Stage IIIA No evidence of primary tumour Metastasis to 4-10 nodes No 
Tumour ≤ 2cm Metastasis to 4-10 nodes No 
Tumour  2cm but ≤ 5cm Metastasis to 4-10 nodes No 
Tumour  5cm Metastasis to 1-3 nodes No 
Tumour  5cm Metastasis to 4-10 nodes No 
Stage IIIB Tumour of any size with direct 
extension to chest wall or skin 
No evidence of cancer in 
nearby nodes 
No 
Tumour of any size with direct 
extension to chest wall or skin 
Metastasis to 1-3 nodes No 
Tumour of any size with direct 
extension to chest wall or skin 
Metastasis to 4-10 nodes No 
Stage IIIC Any tumour designation  Metastasis to 10 nodes No 






2.2 Treatment of Breast Cancer  
Several treatments exist to respond to breast cancer. Surgical treatments are often used as 
an initial intervention to remove the tumour. These procedures include mastectomy, breast 
conserving therapy or axillary lymph node dissection. Following surgery, an adjuvant therapy (or 
several) are often recommended in an attempt to ensure no cancerous cells remain. These 
therapies may include any combination of radiation, chemotherapy and/or hormone therapy.  
2.2.1 Surgical Treatment 
 Three major surgeries are used in breast cancer treatment: mastectomy, breast conserving 
treatment and axillary lymph node dissection. The choice between mastectomy and breast 
conserving treatment depends on the tumour location and size (Sainsbury et al., 2000), available 
technology, and patient choice, while dissection is only used for tumours that have invaded the 
lymph nodes.  In stage I/stage II cancer diagnoses breast conserving treatment is most frequent 
(61% of cases in the United States, vs 34% mastectomy) (American Cancer Society, 2019a). In 
stage III, mastectomy is dominant with 68% of patients receiving this surgery, and only 20% 
receiving breast conserving therapy. Axillary lymph node dissection is the most involved surgery 
and is used when the cancer spreads beyond the breast tissue into the lymphatic system. 
2.2.1.1 Mastectomy 
 Mastectomies are a common surgical treatment used to remove tumours in breast cancer 
patients. Both radical mastectomies and modified radical mastectomies are highly effective. The 
Halsted mastectomy, known as the radical mastectomy, was the original surgery used to remove 
tumours and involved removal of all of the breast tissue, chest wall muscles below the breast 
tissue, and lymph node dissection (Bland, 1981). However, by 1981, less than 3% of surgeries 
were the radical mastectomy (Hammer et al., 2008). As adjuvant therapies were improved and 
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imaging systems advanced, tissues were able to be spared from complete removal. The modified 
radical mastectomy was introduced allowing the pectoral major muscle to remain after surgery 
(Patey & Dyson, 1948). Within the modified radical mastectomy there are skin-sparing, nipple-
sparing and conventional subtypes. However, the pectoral fascia is still traditionally removed to 
ensure no cancerous tissue remains. Some surgeons will spare the pectoral fascia as well, but this 
results in an increased risk of chest wall recurrence (Dalberg, Krawiec, & Sandelin, 2010). 
 With a high survival rate, it is important to consider shoulder-related quality of life and 
function following these surgeries, and how it is influenced by time. Individuals who received 
mastectomy were 6 times more likely to have shoulder restrictions and functional limitations 
compared to breast conserving therapy (Vidt et al., 2020). These limitations led to decreases 
across many domains of shoulder-related quality of life, specifically increased perceived 
disability. However, adjuvant therapy often accompanies surgery and it becomes difficult to 
delineate which effects occur due to surgery, or to additional treatment. Patients with above 
average function (as described through FACT-B questionnaires), were approximately 22 months 
post-surgery, whereas below average function survivors were 8 months post-surgery (Huang & 
Chagpar, 2018b). Beyond functional limitations survivors may experience body image issues 
following mastectomy. As time passes, patients who receive a full mastectomy see 
improvements in body image and function (Huang & Chagpar, 2018a). Body image was below 
average in the first year following treatment, but improved beyond 1 year since surgery.  
2.2.1.2 Breast conserving therapy 
 Breast conserving therapy, also known as lumpectomy, is a surgical intervention used in 
western countries with the intention to preserve more tissue without compromising treatment. 
Breast conserving therapy is more common in western countries due to advances in technology 
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allowing for early diagnosis and therefore smaller, less spread tumours (Newman & Sabel, 
2003). The breast conserving therapy surgery involves removing only the cancerous tissues, and 
sparing as much breast tissue as possible (no more than 25% total reduction) to ensure good 
cosmetic outcomes (Hammer et al., 2008).  
It has been hypothesized that upper limb function and shoulder-related quality of life 
would be improved following breast conserving therapy, versus a mastectomy. By avoiding 
lymph node involvement, there is a reduction in the occurrence of lymphedema, and therefore 
less detrimental on function (Nesvold, Dahl, Løkkevik, Marit Mengshoel, & Fosså, 2008). 
However, studies have found mixed results. A series of studies have found no difference between 
function after each of the surgeries (Kuehn et al., 2000; Lauridsen, Overgaard, Overgaard, 
Hessov, & Cristiansen, 2008), and another set of studies found less impairment in survivors who 
reserved breast conserving therapy compared to mastectomy (Nesvold et al., 2008; Sugden, 
Rezvani, Harrison, & Hughes, 1998). The heterogeneous nature of the populations included in 
each of these studies likely lead to the differences in conclusions, such as differing adjuvant 
therapies, secondary symptoms and stage of diagnosis. A recent study of breast cancer survivors 
in India found overall shoulder-related quality of life 5 years post treatment was relatively 
similar between the two surgery types, with a slight advantage to those receiving breast 
conserving therapy (Bhat, Roshini, & Ramesh, 2019a). Generally, patients who received breast 
conserving therapy felt more complete, and had less difficulty completing everyday activities, 
whereas an equal number of survivors in each group (breast conserving therapy and mastectomy) 
felt they had not regained their full strength (Bhat, Roshini, & Ramesh, 2019b). 
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2.2.1.3 Axillary Lymph Node Dissection 
 Axillary lymph node dissection is the third, and most involved surgical treatment for 
breast cancer. This surgical intervention is used when the cancer has spread beyond breast tissue 
and involves the lymphatic system. Lymph nodes in the axilla are often involved once the 
tumour has reached 5mm, and therefore lymph node dissection is recommended (Silverstein et 
al., 1994). Due to the invasive nature of this surgery, it is more likely that complications may 
arise. As the number of nodes dissected increases, so does the likelihood of developing 
lymphedema (Hack et al., 2010). Patients who receive this surgery have an increased shear 
elastic modulus of the pectoralis major, indicating stiffer muscle post treatment compared to 
breast conserving therapy; however, there was no effect on overall joint integrity (Lipps et al., 
2019). Additionally, 62.9% of survivors reported having mild pain after surgery, with 29.8% 
reporting moderate discomforting pain (Hack, Cohen, Katz, Robson, & Goss, 1999). 17.7% of 
survivors reported weakness, and 63.1% reported numbness following axillary lymph node 
dissection (Hack et al., 1999). Reductions in pain, disability and overall well-being scores are 
often seen in survivors who have exercise interventions (M. Kim et al., 2019). However, the 
format of exercise intervention affects survivors differently. Tools, such as therapeutic exercise 
balls, have been suggested to help ease pain and discomfort early after surgery before 
introducing conventional self-lead stretching programs. Once patients are able to reduce pain 
exercise programs can be introduced to increase function in survivors who received axillary 
lymph node dissection. (M. Kim et al., 2019).  
2.2.2 Radiation Treatment 
 Radiation treatment is often used as a localized treatment after surgical intervention. In 
some instances, radiation follows the conclusion of chemotherapy. 49% of patients in Stage I-II 
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will receive radiation as an adjuvant therapy (American Cancer Society, 2019a). Only 16% of 
patients in stage III opt to receive radiation, as often they undergo full mastectomy (American 
Cancer Society, 2019a). For tumours that are diagnosed early (stage 1-2, or less than 3 lymph 
nodes involved), radiation is effective for increasing survival rates (Shi, Luo, Zhao, Huang, & 
Pang, 2019). The radiation is applied to a localized area in order to damage the DNA of the cells 
directly through the release of free radicals, thereby controlling or killing cancerous cells (Mayo 
Clinic, 2018a). Radiation therapy can be either external (a beam external to the body applies 
radiation treatment) or internal (an implanted device delivers the radiation near the tumour site), 
but in both scenarios one specific region is targeted. Although localization of the treatment 
allows for a specific region to be targeted, often other cells are damaged due to the proximity of 
local healthy cells to the radiation (Courneya, Mackey, & McKenzie, 2002; Lipps, Sachdev, & 
Strauss, 2017; Mayo Clinic, 2018b). The damage to the local cells can cause numerous side 
effects such as fatigue, skin erythema, lymphedema, cardiac and pulmonary toxicities, and 
brachial plexopathy (Truong, Olivotto, Whelan, & Levine, 2004). Specifically, pectoralis major, 
pectoralis minor, latissimus dorsi, and teres major receive enough radiation in most regimens to 
promote future morbidity (Lipps et al., 2017).  Lymphedema is a common side effect of radiation 
and is caused by damage to the lymphatic nodes in the axilla, which then hinders proper drainage 
of the limb (Hack et al., 1999; Truong et al., 2004). Lymphedema is covered more in depth in 
section 2.3.2.  
As the most common adjuvant therapy, radiation is highly effective in treating breast 
cancer. However, combining surgical interventions with radiation often causes scar tissue 
formation. Frequently, adhesions form between the musculature in the radiation zone, effecting 
the glenohumeral joint. This causes joint stiffness, and limits range of motion (Lauridsen et al., 
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2008; Markes, Brockow, & Resch, 2006). Tellingly, up to 2/3 of breast cancer survivors who 
received radiation reported some restriction or pain, and 1/4 reported weakness (Lee et al., 2008). 
2.2.3 Chemotherapy Treatment 
 Chemotherapy is a cancer treatment often chosen to manage micro-metastases in patients. 
In early stages (stage I-II), chemotherapy is less frequently used with 16% of patients receiving 
this treatment, increasing to 56% of stage III patients (American Cancer Society, 2019a). Often 
chemotherapy is delivered intravenously, but can also be taken orally. Treatment is completed in 
durations of cycles (often between 4 and 8) over the course of several months (2-6) (American 
Cancer Society, 2019b). Due to the nature of the drugs, chemotherapy may attack non-cancerous 
cells. The drug is designed to kill cells that are dividing. As cancerous cells divide more rapidly 
than normal cells, these are often the target of the drug. However, normal cells still divide and 
therefore may be targeted and damaged, leading to additional side-effects.  
 Although an effective treatment for cancer, chemotherapy side-effects are well 
documented. Fatigue, nausea, weight gain, decreased strength and range of motion, and overall 
decrease in shoulder-related quality of life are often cited (Markes et al., 2006). In addition, 
chemotherapy patients are less likely to participate in exercise or rehabilitation, perpetuating 
decreases in physical function resulting from treatment (Courneya et al., 2016; Markes et al., 
2006; Tiezzi et al., 2016).  As chemotherapy affects the entire body, secondary symptoms are not 
localized to the affected upper extremity. Klassen et al (2017) investigated strength in the lower 
and upper extremity of breast cancer survivors following chemotherapy treatment. Survivors had 
25% lower extremity strength, and 16% lower upper extremity strength compared to reference 
participants (Klassen et al., 2017). 
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2.2.4 Hormone Therapy 
 Hormone therapy, often surgical or oral treatment, is a targeted treatment used for 
estrogen receptor positive tumours. 83% of breast cancer patients present with a tumour that is 
estrogen receptor positive (American Cancer Society, 2019a) (Table 2, page 6). In these tumours, 
estrogen promotes tumour growth and therefore it is imperative to slow or stop the estrogen 
production to ensure the tumour does not grow (National Cancer Institute, 2017a). Several 
measures can be taken to attempt to limit a second occurrence of the tumour by limiting the 
estrogen production. A double mastectomy, ovary removal, or hormone therapy are all methods 
to decrease likelihood of reoccurrence (National Cancer Institute, 2017b). Surgical interventions 
provide peace of mind to the survivors, however can affect confidence and self-esteem. 
Hormone therapy (also known as endocrine therapy) is an oral medication used to stop 
the production of estrogen. This drug is taken daily for the lifetime of the survivor and may avoid 
extra surgery. However, hormone therapy has several known side effects such as fatigue, weight 
gain and early menopause (Courneya et al., 2002). Cognitive dysfunction has been reported in 
survivors 12-18 months after the start of hormone therapy (Ferreira et al., 2019; Joly, Lange, 
Santos, Vaz-luis, & Meglio, 2019; Shilling, Jenkins, Fallowfield, & Howell, 2003). Additional 
side effects have included self reported pain, musculoskeletal symptoms (including ‘joint 
aches’), insomnia, depression, and decreases in sexual, role and social functioning (Cazzaniga et 
al., 2021; Ferreira et al., 2019; Garreau et al., 2006). Younger patients have been said to suffer 
more with these self reported symptoms (specifically sexual functioning and depression) 
(Cazzaniga et al., 2021). Severe medical side effects such as hypertension, diabetes and 
osteoporosis have also been reported after using hormone therapy (Cazzaniga et al., 2021; 
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Hamood, Hamood, Merhasin, & Keinan-Boker, 2020). With the many side effects that come 
with this treatment, 37-47.5% of patients decide to stop treatment (Garreau et al., 2006).  
2.3 Functional Effects of Treatment  
 Following the conclusion of treatment, survivors often experience difficulties adapting to 
life as a survivor. This includes, but is not limited to adopting the term ‘survivor’, primary care 
concerns, strength, range of motion, shoulder-related quality of life and kinematic and muscular 
adaptations.  
 2.3.1 Survivorship 
Cancer survivorship is complex. There are many different interpretations of survivorship, 
and more importantly there are different challenges within these populations. Patients in active 
treatment are cared for diligently, but following treatment ‘survivorship’ is vague and not well 
understood. Individuals struggle with the term ‘cancer survivor’ as they are unsure if they 
deserve the title, especially with cancers of breast or prostate that have high rates of survival 
(Khan, Harrison, Rose, Ward, & Evans, 2012). The struggle also comes with the reality that their 
disease may reoccur or that their identity does not revolve around their diagnosis (Khan et al., 
2012). However, many accept the term as they have in fact been diagnosed, and completed 
treatment for cancer. A cancer ‘survivor’ in the past was a term held for individuals beyond 5 
years from treatment, but this was a time where the 5-year survivor rate was 50%, and as the 
survivor rate increases, this time frame is not as relevant (Breaden, 1997). This time immediately 
following treatment may also be referred to as ‘transitional cancer survivorship’ which may more 
accurately refer to the season of change a survivor may experience, but still includes the term 
‘survivor’ (Miller, Merry, & Miller, 2008). For the purposes of this dissertation, the term ‘breast 
cancer survivor’ will be used to refer to this population, with acknowledgment that this term is 
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not universally accepted, but clearly encapsulates the time once treatment concludes (excluding 
additional hormone therapy if necessary), and that the individual is designated cancer-free. 
Regardless of the term, the needs of these individuals change once treatment has ended. A 
shortage of oncologists has lead to care being shifted to primary care physicians once the 
individuals move from ‘patient’ to ‘survivor’ (once an individual is deemed cancer free and 
course of treatment has ended), however these physicians may not be well versed in the medical 
complications that may arise due to treatment (ranging from medical side effects, to a loss of 
function, and secondary side effects) (Bodai & Tuso, 2015). 
2.3.2 Primary care  
Breast cancer survivors are often taxed with additional medical side effects post 
treatment. In Korea, where the 5-year survivorship for breast cancer is 93%, individuals who 
have completed treatment are transitioned to primary care (Kang, Park, & Lee, 2019). This is not 
common practice in all countries unless immediately necessary. Two primary care issues that 
may arise are diabetes and osteoporosis (Kang et al., 2019). The increased prevalence for 
diabetes in this population, also coincides with an increase in the reoccurrence of breast cancer 
(Kang et al., 2019). Hormone therapy may cause early menopause and thus accelerate the 
development of osteoporosis – affecting bone resorption, increased bone loss and ultimately 
increasing fractures (Courneya et al., 2002; Poznak, 2015). Bone mineral density decreases exist 
in up to 38.5% of breast cancer survivors (Pillai et al., 2019). Finally, cardiac dysfunction (2%) 
and hypothyroidism (14.47%) are medical morbidities frequently present in this population 
(Pillai et al., 2019). 
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2.3.3 Strength  
Shoulder dysfunction, often referring to decrease in strength or range of motion, is 
variable in the breast cancer survivor population. Decreases in strength have been reported in 9-
40% of survivors (De Groef et al., 2020; Harrington et al., 2011; Hidding, Beurskens, Van Der 
Wees, Van Laarhoven, & Nijhuis-van Der Sanden, 2014; Lauridsen et al., 2008; Lee et al., 2008; 
Pillai et al., 2019; Rietman et al., 2003, 2004). These decreases span grip strength and shoulder 
specific measures of strength. Shoulder specific strength is not commonly measured, as it is 
difficult to obtain in a clinical setting. Decreases in abduction & upward rotation, depression & 
adduction, flexion, external rotation, internal rotation, scaption and horizontal abduction exist 
compared to non-cancer reference groups (Harrington et al., 2011; Ribeiro, Camargo, et al., 
2019). During targeted strength testing infraspinatus, supraspinatus and upper trapezius had 
decreased strength on the affected side (Brookham et al., 2018b). Further, shoulder extensors, 
protractors and retractors were at least 20% weaker on the affected side of breast cancer 
survivors in up to 27.5% of participants (Merchant, Chapman, Kilbreath, Refshauge, & Krupa, 
2008).  
Several techniques have been used to contextualize strength in breast cancer survivors, 
such as grip strength, bench press and chest press tasks. Grip strength is often used in clinical 
settings as it is simple, inexpensive and quick. A clinically significant difference in grip strength 
reduction is represented by 6.5kg or a difference of 19.5% (J. K. Kim, Park, & Shin, 2014). 
When comparing to a non-cancer reference group, De Groef et al (2020), found that grip strength 
in this population was on average 19.1-22.6 kg less. Using the guidelines by Kim et al (2014) 
they determined 12-13% of these participants were impaired compared to a reference population 
(De Groef et al., 2020). Decreases in handgrip strength were larger when the non-dominant limb 
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was the affected limb (Perez et al., 2018). However, grip strength is an imperfect surrogate for 
shoulder strength. One rep maximum (1RM) of bench press is considered a better representation 
of upper limb strength. Rogers et al (2017) investigated the ability of hand grip strength to 
predict 1RM of a bench press in breast cancer survivors. The breast cancer survivors in this study 
had handgrip strength of 23.5kg (range of 9-43kg), and a 1RM of a bench press task of 18.2kg 
(range 2.2-43kg) (Rogers, Brown, Gater, & Schmitz, 2017). It was concluded that each measure 
tests distinct components of strength, and that handgrip over estimates 1RM of bench press by 
4.7kg (Rogers et al., 2017). Finally, Hagstrom et al. quantified the difference in survivors during 
a unilateral chest press exercise prior to an exercise program and the affected limb produced 
150.96N (±27.72N), whereas the unaffected limb produced 161.36N (±29.51N) of force 
(Hagstrom, Shorter, & Marshall, 2019). The complex nature of strength makes it difficult for any 
singular strength measure to be representative of all motion at the shoulder. 
2.3.4 Range of motion  
Range of motion deficits are a variable contribution to shoulder dysfunction in breast 
cancer survivors. Impairments related to range of motion have been reported in 1-67% of breast 
cancer survivors (De Groef et al., 2020; Ernst, Voogd, Balder, Klinkenbijl, & Roukema, 2002; 
Lauridsen et al., 2008; Lee et al., 2008; Nesvold et al., 2008; Pillai et al., 2019; Rietman et al., 
2003, 2004; Tengrup, Tennvall-Nittby, Christiansson, & Laurin, 2000; Voogd et al., 2003). 
However, the definition of impairment is imprecise, and therefore this measure is variable. 
Impairment has been variously defined as a decrease in 15° of range of motion (De Groef et al., 
2020; Tengrup et al., 2000), a decrease of 20° of range of motion (Ernst et al., 2002; Voogd et 
al., 2003), or any significant differences between arms or groups. Further, examining decreases 
between affected and unaffected arms is not a perfect comparison, as individuals often receive 
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chemotherapy, which has full body effects (Klassen et al., 2017). Yet this comparison is often 
used as it is the most accessible. 
Frequently, impairments in flexion, extension, abduction, horizontal abduction and 
external rotation are reported in this population (Bendz & Fagevik Olsén, 2002; De Groef et al., 
2020; Harrington et al., 2011; Ibrahim et al., 2018; Ribeiro, Camargo, et al., 2019). Within two 
weeks of surgery reductions of up to 58° of flexion, 79° of abduction and 24° of external rotation 
were present in breast cancer survivors (Bendz & Fagevik Olsén, 2002).  The decrease in range 
of motion continues to vary by motion after adjuvant treatment concludes. Reported flexion 
decreases range between 10.7-32° (Harrington et al., 2011; Ibrahim et al., 2018), abduction 
decreases from 10.7-41° (Ibrahim et al., 2018; Pillai et al., 2019), external rotation decreases 
between 1-11.4° (Harrington et al., 2011; Ibrahim et al., 2018; Pillai et al., 2019), internal 
rotation and horizontal abduction decreases of 1-8.5° (Ibrahim et al., 2018), and finally extension 
decreases of 6.2° (Harrington et al., 2011). Absolute values of impaired affected limb flexion are 
between 129-141°, and abduction values of 119-124° (De Groef et al., 2020; Tan & Wilson, 
2019). 
Range of motion decreases are associated with several factors and may have implications 
on shoulder-related quality of life and task completion. Survivors are more likely to have a 
decrease in range of motion if they have had an axillary lymph node dissection, have more than 
15 lymph nodes removed, stage II cancer, increased age, or a BMI greater than 25 (Lauridsen et 
al., 2008; Levy et al., 2012). Range of motion explains 12% of self-reported variability in 
shoulder-related quality of life measures, with pain contributing up to 60% (Rietman et al., 
2004). It has been suggested that these impairments may combine to an overall reduction in 
shoulder-related quality of life, and may lead to further rotator cuff diseases (Ebaugh, Spinelli, & 
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Schmitz, 2011). Additionally, individuals who have limitations in their range of motion are 2.5 
times more likely to report a reduction in capacity to complete tasks (Quinlan et al., 2009).  
2.3.5 Shoulder-related quality of life 
 Shoulder-related quality of life provides insight into individual’s daily living and is 
dependent on several factors. For this dissertation, shoulder-related quality of life refers to 
aspects of an individual’s daily living, such as perceived disability, emotional, physical and 
social well-being as well as physical activity, as affected by shoulder function. Primarily, 
increased time since treatment is associated with improvements in shoulder-related quality of 
life, and treatment type, where patients who received breast conserving therapy have better 
shoulder-related quality of life compared to individuals who had more invasive treatment (Arndt, 
Stegmaier, Ziegler, & Brenner, 2008; Chopra & Kamal, 2012; Kaur, Gupta, Sharma, & Jain, 
2018a; Kessler, 2002; Rietman et al., 2006). Although shoulder-related quality of life increases 
as time since treatment passes, their shoulder-related quality of life ratings do not reach that of a 
reference population (Harrington et al., 2011; Kaur, Gupta, Sharma, & Jain, 2018b). However, 
breast cancer survivors report having a greater positive outlook on life compared to a reference 
population (Kessler, 2002). The presence of lymphedema also decreases overall shoulder-related 
quality of life (Kwan et al., 2002), but with intensive treatment targeted to reduce lymphedema 
this can be recovered (De Vrieze et al., 2020a). Younger age at diagnosis has also been 
correlated with decreased shoulder-related quality of life (Andersen et al., 2018; Chopra & 
Kamal, 2012; Howard-Anderson, Ganz, Bower, & Stanton, 2012). Younger breast cancer 
survivors are likely to have increased weight gain, and increased physical inactivity which 
perpetuate further decrease of shoulder-related quality of life (Howard-Anderson et al., 2012). 
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 Dysfunction is largely associated with shoulder-related quality of life decreases. 
Pennsylvania shoulder score (PSS) is used to determine function at the shoulder. Harrington et al 
(2013) correlated these scores with various measures of function. PSS is related to both range of 
motion and strength measures. Specifically, active flexion and external rotation were related to 
PSS, where participants with decreased range of motion also had decreased shoulder-related 
quality of life (Harrington et al., 2013). PSS was also decreased when decreased strength in 
abduction & upwards rotation, adduction & depression, flexion, internal rotation, scaption and 
horizontal adduction were apparent (Harrington et al., 2013). If these factors of dysfunction are 
improved and participants are able to return to work, a larger increase in shoulder-related quality 
of life is seen in breast cancer survivors (Colombino, Sarri, Castro, Paiva, & da Costa Vieira, 
2020). 
2.3.6 Kinematic Changes in Breast Cancer Survivors 
 Aside from range of motion, activities of daily living are often used to investigate 
functional movements and determine which cause difficulty or pain. Activities of daily living 
span tasks such as reaching, washing, putting on a seatbelt and many more. When possible, it is 
recommended to provide a goaled, or functional task, or use props, opposed to simulating a task 
as this provides a more accurate and reliable representation of the individuals abilities (Taylor, 
Kedgley, Humphries, & Shaheen, 2018). These tasks are often variable regardless of whether 
they are simulated or functional, making comparisons difficult. Several studies have used a series 
of activities of daily living to investigate breast cancer survivors. Compared to a non-cancer 
reference group, scapulothoracic and glenohumeral angles were similar during overhead tasks 
(Spinelli, Silfies, Jacobs, & Brooks, 2016). However, there exists a low/moderate relationship 
between increased upward rotation of the scapula during functional tasks and pain in breast 
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cancer survivors (Spinelli et al., 2016). Lang et al (2019) investigated whether breast cancer 
survivors with impingement pain had differences in movement. At extreme postures, survivors 
with impingement pain had decreased humeral abduction and internal rotation, consistent with 
movements at high risk of rotator cuff disease (Lang, Dickerson, Kim, Stobart, & Milosavljevic, 
2019). To avoid pain in general, it has been suggested that breast cancer survivors use less range 
of motion on their affected side, with 6.7° plane of elevation, 2.3° less elevation angle, and 7.1° 
axial rotation used during various reach and rotation tasks, respectively (Brookham et al., 
2018a). In addition to functional tasks, work related tasks are often investigated. Difficulty with 
raising objects and lifting and/or loading a 5kg object are associated with survivors unable to 
return to work (de Souza Cunha et al., 2020).  
2.3.7 Muscular Activation Changes in Breast Cancer Survivors 
 Muscular activation during functional tasks have been compared to a reference 
population. In a comparison of breast cancer survivors to reference participants, survivors 
generally require increased activation for the same tasks (Brookham & Dickerson, 2016; 
Galiano-Castillo et al., 2011; Shamley, Lascurain-Aguirrebeña, Oskrochi, & Srinaganathan, 
2012). During a low load, functional desk work task, the sternocleidomastoid activation of the 
affected side was 31% higher than reference participants. During the same task, the upper 
trapezius muscle was 20% more active on the affected side of breast cancer survivors compared 
with reference participants, and 4% more active on the unaffected side (Galiano-Castillo et al., 
2011). These differences may depend on surgery type. Patients who received mastectomy had 
greater increases in activation compared to patients who received breast conserving therapy 
(Shamley et al., 2012). Brookham et al (2015) completed internal and external rotation tasks and 
found that breast cancer survivors required 3.8-16.9% MVC more during internal rotation tasks, 
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and 4.3-16.3% MVC more during external rotation tasks compared to a non-cancer reference 
group (Brookham & Dickerson, 2016). However, co-activation ratios remained similar between 
breast cancer survivors and reference participants (Brookham & Dickerson, 2014, 2016). The 
increased activation in this population may influence fatigue development and other morbidities.  
 Often, affected side muscle demands are compared to the unaffected side within a 
survivor. Prior to an exercise intervention, Hagstrom et al (2019) investigated EMG during 
strength trials. Before the exercise intervention began both the unaffected and affected side had 
similar activation during maximal strength trials (Hagstrom et al., 2019). During work tasks, 
total muscle effort was 5.1% higher on the affected side compared to the unaffected side in 
survivors (Brookham et al., 2018b). During activities of daily living the posterior deltoid, 
supraspinatus, upper trapezius and serratus anterior required more muscular activation in the 
affected side, while the pectoralis major was lower on the affected side (Brookham et al., 2018b). 
Similarly, although this data was not normalized, breast cancer survivors activated upper 
trapezius and rhomboid less on the affected side during an arm elevation task (Shamley et al., 
2007). Ultimately, these studies provide insight that differences post treatment are not localized 
to the immediate area of treatment, but that muscles outside of this field may also be altered.  
2.4 Secondary Effects of Treatment  
 Breast cancer primary treatments are associated with many additional co-morbidities. 
Surgical and adjuvant therapies often are linked to tissue changes, axillary web syndrome, 
lymphedema, fatigue, depression, numbness and pain. Survivors may not develop any of these 
side-effects, but often will experience one or more.   
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2.4.1 Tissue changes 
 Several types of lesions can form after breast cancer. Changes such as skin thickening, 
rashes, deformity, architectural distortion of muscle and bone, parenchymal scars, and capsular 
contracture are present in these individuals. Within architectural distortion, changes such as 
fibrous stranding in the muscle has been observed, as well as a change in tissue interfaces, and 
disordered trabecular pattern (Sickles & Herzog, 1981). Parenchymal scars are spiculated masses 
(a lump of tissue with spikes or points on the surface) and may be observed following the 
conclusion of treatment. Immediately following treatment 95% of patients displayed skin 
changes, and 83% developed architectural distortion. This percentage reduces to 55% and 35% at 
two years post treatment, respectively. 3 years following treatment 26% of individuals still 
display skin changes, and 16% retain architectural distortion (Sickles & Herzog, 1981). These 
remain even 10 years post treatment. The reduction between 0 and 3 years post treatment 
indicate levels of healing within the first few years after treatment ends (Sickles & Herzog, 
1981). However, individuals who still display these changes 3 years post treatment are not likely 
to experience any more natural healing. These tissue changes may also lead to tightness 
surrounding the joint, limiting range of motion (E. J. Yang et al., 2010). Capsular contracture is a 
side effect that may occur following any type of breast surgery (mastectomy, reconstruction or 
augmentation). However, having a history of breast cancer increases the risk of this 
complication. A capsular contracture is identified as excessive tissue formation and contraction 
of the fibrous capsule, leading to deformation/distortion of the breast, pain or tenderness, and 
hardness (Bachour et al., 2018).  
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2.4.2 Axillary Web Syndrome 
Axillary web syndrome, or cording, may be present in survivors following axillary lymph 
node dissection. A cord (or cords) develops starting at the axillary scar and may extend down the 
arm or into the chest wall and may thicken over time and become visible under the skin. The 
cords often appear within the first month following surgery, and are palpable during abduction 
(Lauridsen, Christiansen, & Hessov, 2005; Moskovitz et al., 2001). In women who had axillary 
lymph node dissection, (35.9-85.4%) develop axillary web syndrome, however it can occur in 
patients with no axillary involvement (Harris, 2018; Koehler et al., 2015; Leidenius, Leppanen, 
Krogerus, & von Smitten, 2003; Yeung, Mcphail, & Kuys, 2015). After 8-12 weeks axillary web 
syndrome was resolved in half of those that developed this symptom (Baggi et al., 2018; Koehler 
et al., 2015). The cording usually resolves within three months, but for those with persistent 
cording, 74% present with severe restriction in range of motion, specifically in abduction (less 
than 90°) , but restrictions in flexion may also occur (Koehler et al., 2015; Tilley, Thomas-
MacLean, & Kwan, 2009; Yeung et al., 2015). Following surgery, 70% of patients who received 
axillary lymph node dissection presented with cording, and 86% had restricted range of motion 
(as determined by their physiotherapist), opposed to 20% presenting with cording and 45% 
having restricted range of motion in the group with no axillary involvement (Leidenius et al., 
2003). Pain was also persistent in those with cording, rating 8.8/10 on a VAS scale (Lacomba et 
al., 2009). Risk factors for developing cording may include extensiveness of surgery, younger 




2.4.3 Lymphedema  
Lymphedema is a common side effect following breast cancer treatments and is defined 
as a retention of fluid in the arm, ultimately causing swelling of the ipsilateral arm. Commonly, 
lymphedema occurs after an axillary lymph node dissection or radiation treatment as damage to 
the lymph nodes located in the axilla has occurred (Shah & Vicini, 2011). However, volume of 
irradiated axilla, older survivor age, larger numbers of dissections, and higher BMI are also 
associated with an increased occurrence of lymphedema (Gross et al., 2017; Hack et al., 2010; 
Sakorafas, Peros, Cataliotti, & Vlastos, 2006).  
Lymphedema presence and onset varies among survivors. Prevalence has been reported 
from 6 to 42% in survivors (Ahmed, Thomas, Yee, & Schmitz, 2006; DiSipio, Rye, Newman, & 
Hayes, 2013; Norman et al., 2009; Petrek, Pressman, & Smith, 2000; Rietman et al., 2003; 
Sakorafas et al., 2006; Schmitz et al., 2010; Sugden et al., 1998; Swedborg & Wallgren, 1981; 
Zou et al., 2018). The variability in this measure can be attributed to measuring techniques, 
reporting rates, and follow up intervals.  Survivors often do not report follow up symptoms as the 
focus is on preventing reoccurrence rather than secondary symptoms and upper limb dysfunction 
(Sakorafas et al., 2006). Importantly, lymphedema may occur up to 20 years post-operative , 
however it often occurs within 3-5 years of treatment (Breast Cancer.org, 2019; Norman et al., 
2009).  
Commonly, lymphedema is measured clinically in one of two ways. In both scenarios, 
the affected arm is compared to the non-affected arm. The first technique requires the clinician or 
researcher to measure the circumference of various parts of the arm, and compare the two arms. 
A difference greater than 2cm is indicative of lymphedema (Ahmed et al., 2006). The second 
method involves measuring the volume of the arm by using displacement of water. An increase 
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in volume greater than 20% indicates the presence of lymphedema (Sakorafas et al., 2006; 
Swedborg & Wallgren, 1981). Dual energy x-ray absorptiometry (DXA) has been identified as a 
superior method to circumference or water displacement (Gjorup, Zerahn, & Hendel, 2010). By 
monitoring individuals from the onset of treatment, an increase in volume of 3-5% (not due to 
weight change – determined by measuring the non-affected limb as well) is indicative of early 
stage lymphedema (International Society of Lymphology, 2016). Not only is DXA a more exact 
way to determine the presence of lymphedema, it can also determine differences in body 
composition that may be a consequence of this secondary symptom (International Society of 
Lymphology, 2016).  
Depending on the severity lymphedema may affect activities of daily living, and reduces 
overall shoulder-related quality of life. Lower shoulder-related quality of life has been reported 
in survivors with clinically diagnosed lymphedema, specifically with scores in mental health and 
overall pain (Lovelace, McDaniel, & Golden, 2019; Pusic et al., 2013; Taghian, Miller, 
Jammallo, Toole, & Skolny, 2014; Velanovich & Szymanski, 1999). The swelling and pain that 
characterizes lymphedema may cause daily tasks to be difficult. Particularly the increased weight 
of the arm causes reduction in range of motion, increased fatigue, and makes it more challenging 
to lift the arm to complete everyday tasks (Lovelace et al., 2019; Pusic et al., 2013). 
Compression sleeves work to counteract this swelling and reduce lymphedema in some 
participants, but more importantly improve shoulder-related quality of life in those that show 
clinically significant lymphedema (Ochalek, Partsch, Gradalski, & Szygula, 2019). However, 
these sleeves may worsen lymphedema symptoms as they are often ill-fitting, and in many 
circumstances may cause the fluid build up to occur in the hand.  
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2.4.4 Fatigue and Depression 
 Fatigue is often reported during, and following cancer treatment. Cancer related fatigue 
presents in 50-75% of cancer patients at diagnosis, 80–96% of patients undergoing 
chemotherapy and 60–93% of patients receiving radiotherapy (Hsieh et al., 2008; Levy et al., 
2012; Mock et al., 2005; Stasi, Abriani, Beccaglia, Terzoli, & Amadori, 2003). Fatigue in breast 
cancer survivors is increased with increased age, increased body fat percentage, fewer years 
since diagnosis, decreased strength and physical activity and more treatments (Winters-Stone et 
al., 2011). It is important to consider fatigue, as it is indicated as a preventative agent for 
completing daily tasks by 91% of cancer survivors. However, although levels of fatigue during 
radiation therapy were at their peak halfway through treatment, they returned to pre-treatment 
levels for most patients 6 months following treatment (Irvine, Vincent, Graydon, & Bubela, 
1998).  
Of survivors who report severe, and persistent fatigue, a correlation has been shown 
relating their fatigue to severe pain and depression (Bower et al., 2000). Depression was most 
strongly correlated with fatigue, where patients who developed depressive symptoms post 
diagnosis reported higher levels of fatigue. The mean value of reported depression was within 
the clinically relevant scores. Further, it is difficult to determine which of these factors causes the 
other. Individuals with depression often report fatigue, and fatigue may cause depression as it 
limits the ability to complete activities of daily living, participate in leisure or return to work 
(Bower et al., 2000). This further relates to a decline in shoulder-related quality of life, and 




2.4.5 Numbness and Pain  
 Numbness appears in breast cancer survivors and is often described as pins and needles, 
burning or a complete loss of sensation. This numbness is often associated with post-mastectomy 
pain syndrome, which is pain in the axilla, chest wall or ipsilateral arm persisting beyond 3 
months from surgery (natural healing times) (E. J. Yang et al., 2010). 65% of survivors report 
numbness, with up to 15% of survivors reporting moderate to severe pain (Bosompra, Ashikaga, 
O’Brien, Nelson, & Skelly, 2002). Pain has been reported in 31-61% of breast cancer survivors, 
with a mean pain score of 4-6/10, indicating that pain is present but generally not debilitating 
(Lauridsen et al., 2008; Levy et al., 2012; Tasmuth, von Smitten, Hietanen, Kataja, & Kalso, 
1995). These symptoms were more often reported with a combination of lymphedema (4% 
reported pain without lymphedema, and 24% with lymphedema; 8% reported numbness without 
lymphedema and 21% had numbness with lymphedema) (Kwan et al., 2002; Lauridsen et al., 
2008; Shamley et al., 2012; Tasmuth et al., 1995). Survivors who do not meet the physical 
activity guidelines, and those that are overweight are more likely to report clinically significant 
pain, than those who are regularly active and at a normal weight (Forsythe et al., 2013). 
Additionally, it has been suggested that the younger patients have greater neural disruption 
which increases pain (Downing & Windsor, 1984). These factors lead to an overall decrease in 
shoulder-related quality of life when persisting past 2 years following surgery, even with mild – 
moderate pain (reported by up to 60% of patients) (Rietman et al., 2004).  
2.5 Biomechanical Modelling  
Biomechanics research uses EMG, kinematics, and kinetics to make inferences about 
underlying mechanisms in the human body. Unfortunately, it is difficult, and sometimes 
impossible to collect comprehensive data sets of all contributing muscles and underlying 
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structures. Moreover, experimentally accessible data are only indirect measures of the system 
and are not direct surrogates of important tissue forces within the body (muscle force, bone on 
bone forces etc). Biomechanical models can help compensate for these issues.  These models 
solve for unknown forces within the system and calculate loads on the body or system 
performance based on modifications to system behaviors. Modelling allows insight into tasks 
and forces that may be difficult to explore in an experimental setting and allows additional 
control of the data input and removes mitigating factors (such as environmental factors). Forces 
internal to the system (inaccessible during experimental techniques) are variously estimated 
using both inverse and forward dynamics (Buchanan, Lloyd, Manal, & Besier, 2004).  
 Two types of models are frequently applied in practice: Digital human modelling and 
computational musculoskeletal models. Digital human models such as Siemens Jack TM 
(Siemens Industry Software Inc., Germany) and Santos Pro TM (SantosHuman Inc., USA) are 
used in both research and ergonomic settings. These software packages allow the user to develop 
environments and tasks completed in practice, and often output joint loads to analyze loads on 
the body (Polášek, Bureš, & Šimon, 2015; Santos, Sarriegi, Serrano, & Torres, 2007). 
Computational musculoskeletal models are typically more customized tools, and are most 
typically used to solve for internal forces within the body (generally muscle forces) (Dickerson, 
Chaffin, & Hughes, 2007). These models include physiological information on muscles (moment 
arms, cross-sectional area, and origin/insertion), subject and task information, and muscle 
geometry. Several assumptions are made (and differ between models) in order to solve for 
unknown forces (Crowninshield & Brand, 1981; Dul, Johnson, Shiavi, & Townsend, 1984). 




2.5.1 Optimization  
 The human body can produce movements through an infinite combination of muscle 
activations making it difficult to determine which muscles contribute to each movement. The 
solution is indeterminate as there are too many unknowns in the system for the available 
equations to solve. Optimization is a mathematical technique that can solve these types of 
problems. It imposes an objective function (goal for the system), to reward an optimal result 
within the range of possible solutions, and thus provides a possible solution to the redundancy 
problem that generates an optimal value for the objective function. These objective functions can 
be a variety of measures including minimizing muscle force, or muscle stress (Crowninshield & 
Brand, 1981; Dul, Johnson, et al., 1984). In many optimization solutions the “best” muscle (the 
muscle with the most advantageous features in terms of the objective function (i.e. moment arm, 
cross sectional area etc.)) is used first, and antagonistic contraction is negated as it is 
counterproductive to the movement at hand (Collins, 1995). Imposing muscle bounds can help 
improve the biofidelity of the output. These bounds are employed to keep muscle stress at levels 
proportional to the cross sectional area of each given muscle (the upper bound is represented by 
σ > Fi/PCSAi ) (Prilutsky & Zatsiorsky, 2002). This ensures the solution for each muscle occurs 
within these bounds and thus forces remain physiologically realistic (Challis, 1997). 
2.5.2 SLAM Model 
 The Shoulder Loading Analysis Modules (SLAM) model is a musculoskeletal model 
used to evaluate tissue and joint demands during movement of the shoulder joints. Input data for 
this model include task specific motion capture and force demands as well as subject specific 
data (height, weight, sex) (Figure 3). The model includes three modules: shoulder geometry 
constructor, external dynamic moment calculator, and the internal muscle force prediction 
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module (Dickerson et al., 2007). The model outputs dynamic joint moment and forces, positions 
and orientations of the defined segments, the line of action and moment arms of each element 
and the muscle forces for each of the 38 muscle elements in the model.  
 
Figure 3: Schematic of SLAM model (Dickerson et al., 2007) 
The musculoskeletal geometry module includes relevant anatomy of the upper extremity and 
torso. The torso, humerus, clavicle, scapula and forearm (ulna and radius) are all modelled in 
SLAM (Dickerson et al., 2007). Each segment is scaled to the participants height based on 
previously published data (Hogfors, Karlsson, & Peterson, 1995; Hogfors, Peterson, Sigholm, & 
Herberts, 1991; Hogfors, Sigholm, & Herberts, 1987; Karlsson & Peterson, 1992; Makhsous, 
Ho, Siemien, & Peterson, 1999). Two contact sites between the scapula and ribcage are 
modelled, located at the superior and inferior angles of the scapula (Makhsous et al., 1999). 
These sites transmit force from the ribcage to the scapula.  Ligaments are also modelled, 
however they do not produce any force in the current state of the model, as ligaments at the 
shoulders generally contribute force only at end range of motion, and muscles are the primary 
contributors to force production (Crowninshield & Brand, 1981; Jinha, Ait-haddou, Binding, & 
Herzog, 2006). All joints of the shoulder (sternoclavicular, acromioclavicular and glenohumeral) 
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are modelled with three degrees of rotational freedom, but no translational movement. The 
shoulder rhythm (interaction between the scapula and the humerus) used in SLAM is adapted 
from previous literature (Karlsson & Peterson, 1992; Makhsous et al., 1999). Once the shoulder 
rhythm is applied constraints are placed to accommodate captured motion data inputted into the 
model. The inferior and superior angles of the scapular are constrained to minimal movement 
from the ribcage. The final element of the geometry module is the muscles. 23 muscles (38 total 
elements) were modelled in SLAM (Dul, 1988). The muscles modelled, and their associated 
elements are levator scapulae (1), omohyoid (1), pectoralis minor (1), rhomboid major (1), 
rhomboid minor (1), sternocleidomastoid (1), stenohyoid (1), subclavius (1), coacobrachialis (1), 
supraspinatus (1), teres major (1), teres minor (1), brachialis (1), brachioradialis (1), latissimus 
dorsi (2 elements), serratus anterior (3), trapezius (4), subscapularis (3), infraspinatus (2), 
pectoralis major (2), deltoid (3), biceps (2), and triceps (3) (Dickerson et al., 2007). The origin 
and insertion of each muscle is modelled, and connected via the muscle elements based on 
previous literature (Van Der Helm, 1994). However, this may model inappropriate lines of 
action, through structures such as bones. Therefore, additional conditional wrapping and 
collision alterations are placed on the elements to ensure proper lines of action (Charlton & 
Johnson, 2001; Van Der Helm, 1994). The geometric proprieties from this module feed into the 
internal muscle force prediction module (Figure 3).  
 The second module is the external dynamic joint moment module. Subject, task and 
motion data are all inputs into this module. Segment properties such as segment mass and 
moment of inertia are calculated based on published proportions and the individual’s sex, height, 
and weight (Zatsiorsky & Seluyanov, 1993).  Joint centres are calculated for glenohumeral, 
elbow and wrist based on published literature from the motion capture data (Nussbaum & Zhang, 
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2000). Data is filtered at 6Hz, and then linear velocity and acceleration of joint centres are 
calculated through differentiation and double differentiation, respectively. Joint coordinate 
systems are calculated based on previously published standards (Hogfors et al., 1987). Angular 
kinematics are determined using joint coordinate system techniques (Nigg & Herzog, 1994). The 
orientation of the upper arm and forearm are defined using equation 1. The hand has a different 
neutral orientation and therefore uses a different rotation sequence [Eq. 2]. The first and second 
derivatives of the Euler angles are then calculated to determine the angular velocity and 
acceleration (Vaughan, Davis, & O’Connor, 1992). The final portion of this module calculates 
net joint forces and torques. The joint load is calculated at the proximal end of the segment, and 
is influenced by the movement and mass of the segments and hand-held weight. The general 
equation used in the model for joint force equilibrium (using reaction forces) is found in equation 
3. Finally, external moments are calculated using the rate of change of segmental angular 
momentum (using segmental moments of inertia and the corresponding segment velocity and 
acceleration). Specifically, the sum of each force crossed to their moment arm is used to 
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}  [Eq. 2] 
                                               ∑ 𝐹 = 𝑚𝑠𝑒𝑔𝑚𝑒𝑛𝑡  ×  𝛼𝐶𝑂𝑀 𝑠𝑒𝑔𝑚𝑒𝑛𝑡                         [Eq. 3] 
The final module of the SLAM model is the internal muscle force prediction module. The 
outputs from the first two modules are used as inputs into the internal muscle force prediction 
module, specifically, shoulder moments and geometric properties. Optimization, as previously 
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described, is used to solve for the infinite combinations of muscle forces possible to complete a 
given task. In the SLAM model, the default objective function is to minimize the sum of cubed 
muscle stresses. This objective function encourages force sharing between muscles instead of 
choosing the most mechanically advantageous muscle (moment arm or cross-sectional area). By 
using muscle stress, it also ensures consideration of both the moment arm and cross-sectional 
area when assigning forces to muscles. Force bounds are placed on each muscle, as well as 19 
mechanical constraints. Muscles forces were bound by zero as minimum, and a maximum that is 
proportional to the physiological cross-sectional area of the muscle. Each individual muscle’s 
physiological cross sectional area was obtained from a cadaver study (Hogfors et al., 1987), and 
the specific tension was set to 88Ncm-2 (Wood, Meek, & Jacobsen, 1989). Eighteen equilibrium 
equations constrain the sternoclavicular, acromioclavicular and glenohumeral joints. Three 
equations define linear equilibrium and 3 equations define angular equilibrium of each of the 3 
aforementioned joints.  The final equilibrium equation constrains the elbow flexion/extension 
moment. Three additional constraints are placed based on directional glenohumeral joint 
dislocation force ratios based on cadaver data (Lippitt & Matsen, 1993). These thresholds were 
placed in 8 equally spaced compass locations on the glenoid (Figure 4).  
 
Figure 4: Directional shear to compressive force tolerance for each of the 8 directions included 
in the SLAM model (Dickerson et al., 2007) 
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Overall, the SLAM model solves for 60 unknown variables. The force output of 38 
muscle elements, 9 joint contact forces, 2 scapulothoracic contact forces, 8 directional 
dislocation force ratio coefficients, and when applicable 3 ligament forces.  
 The SLAM model has been used in several settings to investigate internal shoulder 
exposures, including fundamental science (Chopp-Hurley, Langenderfer, & Dickerson, 2014), 
ergonomic investigations (Fischer, Brenneman, Wells, & Dickerson, 2012; Steele, 
Merryweather, Dickerson, & Bloswick, 2013; Vidt et al., 2019) and clinical studies (Chopp-
Hurley, Brookham, & Dickerson, 2016). 
There are three main limitations to the SLAM model. Although the body parameters are 
scalable by sex, internal muscle capabilities do not account for sex differences. These 
capabilities are based on previous literature that derived from exclusively male participants. 
Secondly, muscle mechanics (length-tension and force-velocity) are not considered in this 
model, which may be important for fast movements or those involving long excursions. Finally, 
antagonistic muscles are largely underestimated in many optimization solutions as objective 
functions are based on mechanical efficiency, and muscles not directly contributing to achieving 
the required net joint moment increase the physiological cost and are therefore not recruited. 
However, the SLAM model partially accounts for antagonist muscles by enforcing activation to 
maintain the stability of the glenohumeral joint. 
2.6 Gaps in Literature 
With a large number of breast cancer patients entering the survivor population every year, 
increased attention should be paid to individuals following treatment. As previously described 
(2.3.1 Survivorship), once survivors’ complete treatment their care may be transitioned and 
primary medical concerns are addressed (2.3.2 Primary care). Functional concerns may not 
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appear immediately and may go unnoticed. Although previous research has identified that these 
issues occur (2.3 Functional Effects of Treatment and 2.4 Secondary effects of treatment), often 
there isn’t an understanding on which survivors may experience specific deficits, and how this 
affects daily tasks. Research has begun to identify rehabilitation programs to mitigate these 
issues, but without specific aim on early deficits this can be difficult. As some survivors 
experience more severe deficits, and some experience none, results can be washed by high 
variability in a diverse cohort, and the true challenges faced by some individuals may be 
misunderstood. The current thesis aims to study survivors immediately after the conclusion of 
treatment (and up to two years post treatment), in order to identify which factors more strongly 
influenced function, and are important to survivors (identified through self-reported shoulder-
related quality of life). Further, how these deficits manifest in the context of low load, daily 
tasks. Finally, the work uses an in-silico approach to determine which muscles should be targeted 
in a rehabilitation program to mitigate these challenges for a subset of survivors, and how much 





Chapter III – Improving evidence-based methods of characterizing 
shoulder-related quality of life for breast cancer survivors   
3.1 Introduction 
Investigation into specific difficulties for breast cancer survivors immediately after 
treatment has been limited. Further, the sparse research features heterogeneous populations, 
complicating direct conclusions on which factors influenced function after treatment. Firstly, no 
time limit is generally enforced in inclusion criteria for time since treatment and therefore extra 
mitigating factors may be introduced during that time. The time since treatment studied ranges 
from less than a year to 19 years past treatment (Brookham et al., 2018b; Kaur et al., 2018b). 
Treatment types also differed drastically between survivors. The type of surgery, and adjuvant 
therapy all differ, as well as the length of treatment and medication taken by patients. Current 
literature spans all treatment types, but minimal research has attempted to define each 
treatment’s individual effects on physical function in breast cancer survivors, as it is difficult to 
find a cohort receiving only one type of treatment. Additionally, and similar to many research 
areas, differing research techniques, foci, and data reduction/interpretation approaches 
complicate comparisons and generalizable conclusions.  Research has presented differences in 
groups with interventions and standard care (De Vrieze et al., 2020b; Kaur et al., 2018b), 
between affected and unaffected limbs (Brookham et al., 2018b; Hagstrom et al., 2019; Merchant 
et al., 2008) and between reference participants and survivors (Brookham & Dickerson, 2016; 
Galiano-Castillo et al., 2011; Kaur et al., 2018b). Foci have included exercise interventions (De 
Vrieze et al., 2020b; Hagstrom et al., 2019; Pillai et al., 2019; Ribeiro, Moreira, et al., 2019), and 
breast cancer reconstruction methods (Browne et al., 2017; Leonardis et al., 2019; Sowa et al., 
2017; Yun, Diaz, & Orman, 2018) despite lacking a thorough understanding of the deficits 
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immediately following treatment.  The greatest difficulty with research on this population is its 
vast inherent variability. True deficits in some individuals are obscured by individuals who have 
no difficulties following treatment. The variability in various datasets shows the range in this 
population. All of these factors make it difficult to accurately represent the population, or 
determine an individual’s potential risk for disability post treatment. Investigating the potential 
for each factor to differentiate survivors, in the context of others, allows a more focused 
overview of function.   
Multivariate analyses are frequently applied to distinguish important factors in large sets 
of data. Particularly, principal component analysis, multivariate regression and cluster analysis 
are common in biomechanics. Regressions assume that a correlation exists between data points, 
and has been used to determine the relationship between range of motion and strength to 
shoulder-related quality of life measures (Harrington et al., 2013). Principal component analysis 
is used to determine a new variable (or component) that sufficiently captures the variation in the 
original variables, whereas cluster analysis searches for natural groupings among variables 
(Chau, 2001). Neither principal component analysis nor cluster analysis assume variables are 
related, and therefore are ideal for characterizing large sets of data. Particularly, cluster analysis 
demonstrated utility in classifying chronic pain subgroups (Almeida, George, Leite, Oliveira, & 
Chaves, 2019), as well as regional peak plantar pressure distributions (Bennetts, Owings, 
Erdemir, Botek, & Cavanagh, 2013). In cluster analysis, data is not forced into assumed 
relationships analogous to regressions analysis. The analysis determines if pieces of data are 
more like one another than data in another group (or cluster). By finding subgroups in each of 
these populations, targeted interventions could be determined. This research aims to use cluster 
analysis to determine cohorts of breast cancer survivors and characterize factors that differentiate 
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them. This enables an in-depth view into which factors most influence the variability in 
dysfunction found in this population.  
3.2 Objective and Hypotheses  
The objective of study 1 was to classify the different function of various groups of breast 
cancer survivors, and to determine factors that differed across groups of survivors.  
The following hypotheses were posed for study 1: 
1. Two clusters of breast cancer survivors will be formed based on physical activity, 
time since treatment ended, internal rotation force production, flexion range of 
motion, and perceived disability. 
2. Between the two groups of survivors one group will have significantly lower 
measures of shoulder-related quality of life, particularly increased perceived disability 
(quantified with the DASH questionnaire) compared to the other group. This group 
will also have decreased physical activity levels (quantified through the GODIN 
questionnaire), increased arm volume differences (indicative of lymphedema), and 
decreased lean muscle mass, strength and range of motion. 
3. Between the two groups there will be a higher percentage of participants with more 
invasive treatments (lymph node dissection surgery and radiation), and more 
advanced diagnosis stage in the group with lower measures of shoulder-related 
quality of life. 
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3.3 Methods  
3.3.1 Participants 
 Thirty-five breast cancer survivors (Stage I – IIIa) participated (Figure 5). All participants 
were women, however we acknowledge that men also experience breast cancer, but at a reduced 
frequency (Canadian Cancer Society, 2020). Survivors must have undergone any form of 
surgical procedure for breast tumour removal, as well as radiation and/or chemotherapy 
treatment. Survivors were within 3 months – 2 years post treatment. Waiting 3 months post 
treatment to enroll in the study allowed time to heal from surgery and recovery of immune 
system function from compromises during adjuvant treatment. The upper cut off was 2 years to 
mitigate external factors (such as seeking physiotherapy to assist with function) and because 
radiation therapy may affect tissues for up to two years following treatment (American Cancer 
Society, 2019c). Delimiting a time window since treatment enabled a more targeted examination 
of effects from treatment. Exclusion criteria included confounders such as prior upper extremity 
injuries, bilateral cancer, metastases elsewhere in the body, a barium swallow within 3 weeks of 




Figure 5: Consort diagram outlining recruitment and retention of participants in the study. The 
data for this thesis was collected in conjunction with an intervention study, but only baseline data 
was included in data analysis. 
 
3.3.2 Motion Capture Instrumentation 
 Kinematic data was collected at 50 Hz using 12 VICON MX20 cameras (VICON, 
Oxford, UK). The collection space was calibrated prior to the participants’ arrival. The global 
origin was set so that all experimental movements occur in the positive quadrant. The 
measurement global coordinate system was transposed into ISB standards (Wu & Cavanagh, 
1995), where +Y was directed up, +X was directed forward, and +Z was to the right of the 
origin, defined by the right-hand rule. Twenty-three reflective markers were placed on the torso 
and both upper extremities over bony landmarks, following ISB standards (Wu et al., 2005) 
(Figure 6). The anatomical landmarks were the suprasternal notch, xiphoid process, cervical 
vertebrae 7, thoracic vertebrae 8, lumbar vertebrae 5, and bilaterally on; anterior and posterior 
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superior iliac spine, acromioclavicular joint, lateral and medial epicondyle of the humerus, ulnar 
and radial styloid processes, and the distal end of the 2nd and 5th metacarpals. Four marker 
clusters (affixed to ridged plates) were placed on segments (bilaterally on the upper arm and 
forearm). A static calibration frame was taken with the participant in anatomical position to 
establish a relationship between anatomical landmarks and each cluster. Clusters were used to 
reduce skin movement artifact, in comparison to anatomical landmarks (Leardini, Chiari, Della 
Croce, & Cappozzo, 2005).  
 
Figure 6: Placement of markers on bony landmarks (pink circles) as well as marker cluster sets 
(pink triangles)  
 
3.3.3 Force Equipment 
 Force data was collected at 1500Hz using a 6 degree of freedom force transducer 
(MC3A, AMTI, Watertown, MA, USA). A cuff was placed on the participant’s upper arm, with 
44 
 
a chain attached to the force cube to direct force application. The force cube was positioned to 
ensure that the chain was pulled tight and force exerted was in the transducer z-axis, while the x 
and y axis forces were minimized (Figure 7).  
 
Figure 7: Axis orientation of the force transducer (AMTI – MC3A) 
3.3.4 Experimental Protocol   
 Individuals were in the lab for approximately a 4-hour collection (Figure 8). Initially, 
participants were given the opportunity to ask questions about the informed consent and all 
activities were outlined. Following informed consent sign-off, participants had a DXA (Dual-
energy x-ray Absorptiometry) scan for body composition. A general health information form 
(documenting diagnosis, treatment, symptoms) was then filled out (Appendix A), followed by 
several questionnaires (Appendix B). Within the general health information form, participants 
were asked to detail diagnosis, treatment types and length, current physical activity levels, co-
morbidities, present medications, and history of upper extremity discomfort prior to diagnosis. 
Experimental set up and collection were completed as outlined below (Figure 8) following 
questionnaire completion. Prior to experimental tasks, participants were outfitted with surface 
electromyography (sEMG) and completed muscle specific MVCs. This data was used in Study 2 
45 
 
and is outlined in section 4.3.3 (page 80). Strength measures were collected first to ensure a 
rested state. Two minutes of rest separated exertions, with extra time upon request. A total of 12 
exertions were completed (6 force directions, on both the affected and unaffected limb – Section 
3.3.4.3). Reflective markers were placed on the participant. Then, 12 active maximal range of 
motion trials were completed (6 fundamental shoulder movements, on both the affected and 
unaffected limb – Section 3.3.4.4). The experimental protocol concluded with activities of daily 
living tasks, which were subsequently analyzed in Study 2 (outlined in Section 4.3.4.1, page 83).  
 
Figure 8: Overview of full lab collection with all components included (EMG and activities of 
daily living outlined in Chapter IV) 
3.3.4.1 Questionnaires 
 A series of questionnaires (Appendix B) provided insight into survivor’s daily lives. Four 
questionnaires were administered, the Functional Assessment of Cancer therapy – Breast Cancer 
(FACT-B) (Brady et al., 1997), Rand-36 Health Survey Short Form (RAND 36) (Hays, 
Sherbourne, & Mazel, 1993), the Disabilities of the Arm, Shoulder and Hand (DASH) (Hudak, 
Amadio, & Bombardier, 1996), and a modified version of the Godin Leisure Time Activity 
questionnaire (Godin & Shephard, 1985). Each questionnaire targeted different facets of return to 
life, and overall shoulder-related quality of life (disability, mental, physical, etc). FACT-B is a 
cancer specific questionnaire, targeting physical well-being of survivors. RAND 36 is a 
questionnaire that includes multiple sections including mental well-being, physical well-being, 
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physical functioning, energy/fatigue and pain. The DASH questionnaire is specific to the upper 
extremity, and its main focus is addressing specific disabilities and hardships due to the 
dysfunction of the hand, arm or shoulder. The Godin questionnaire details physical activity 
levels of survivors and an additional question was added to capture any physical therapy/other 
therapies individuals may have sought out in the past week.   
3.3.4.2 Dual-energy x-ray absorptiometry  
 Dual-energy x-ray absorptiometry (DXA) is a non-invasive whole-body scan used for 
body composition measurements. DXA scans can be used for bone density measures, whole 
body composition and segmental measurements (Mazess, Barden, Bisek, & Hanson, 1990). 
Participants received a full body DXA scan (Hologic Discovery QDR 4500, Hologic, Toronto, 
ON) completed by a Certified Medical Radiation Therapist. In scenarios where the participant 
did not fit within the limits of the scanning table, a second scan was obtained. One full body scan 
emits 1.5mR of radiation in 6.8minutes. Each upper extremity was extracted from the individual 
scan that contained that limb, and all other regions (head, trunk and legs) were averaged across 
the two scans. Scans were segmented by a Certified Medical Radiation Therapist using the 
Hologic software (version 13.2).  
3.3.4.3 Strength  
 Isometric strength trials were collected aligning with several fundamental planes of 
shoulder motion. Maximal isometric force trials were collected for each posture. Each participant 
sat in a chair, against a backrest, and were instructed to remain upright for each isometric force 
trial.  Arm positions were chosen to align with previous research (Hughes, Johnson, O’Driscoll, 
& An, 1999; Stobbe, 1982) (Table 5). A cuff was placed on the upper arm, just above the elbow 
for all force directions, except internal and external rotation. By placing the cuff above the 
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elbow, participants were required to produce force from the shoulder for each motion. The cuff 
was attached to the force cube with a chain, pulled tight to maintain the correct position. The 
chain was aligned to pull force through the z axis of the force cube, and minimize off axis forces 
(Figure 7, page 44). Participants had 5 seconds to reach maximum force and were given 2 
minutes of rest between exertions to minimize fatigue. A recollection took place if the 
researchers witnessed any movement of the upper arm from the initial position, any lean of the 
torso used to produce compensatory or additional force, if a plateau in the force was absent (i.e., 
a definite maximum was not achieved), or if the participant indicated they were unable to 
produce a maximal force. Of the 192 strength trials collected, 9 recollections occurred. Two each 
of the internal rotation, external rotation and abduction trials, and 3 flexion trials were 
recollected due to posture or because there was an indication that maximal force was not 
achieved.  
Table 5: Arm positions for maximal isometric strength forces (Hughes et al., 1999; Stobbe, 
1982) 
Force Direction Position  
Flexion • Humerus abducted 30° in the sagittal plane 
Extension • Humerus abducted 60° in the sagittal plane 
Abduction • Humerus abducted 30° in the coronal plane 
Adduction • Humerus abducted 60° in the coronal plane 
Internal Rotation • Humerus abducted 90° in the coronal plane, elbow flexed 90°, 
forearm neutral  
External Rotation • Humerus abducted 0° in the coronal plane, elbow flexed 90°, 
forearm neutral 
3.3.4.4 Range of Motion 
 Maximal range of motion trials ensued for various movements about the shoulder. Trials 
were completed with both upper limbs. Participants began with their arm by their side, in a 
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neutral position, and moved to their maximal end range for each motion. Five seconds were 
given for the participants to reach end range of motion, and this position was held until the end 
of the trial. The fundamental shoulder movements completed were flexion, extension, abduction, 
scapular abduction, internal rotation and external rotation. A small pole was placed for the 
participant to follow during flexion, abduction and scapular abduction tasks to ensure proper 
movement. Participants were instructed to limit trunk twist during the extension task, and were 
monitored closely. Any movement of the trunk resulted in a recollection of this task.  
3.4 Data Analysis  
 This study involved data analysis of questionnaires, dual-energy x-ray absorptiometry 
(DXA), peak force output and range of motion. The following sections describe how each data 
set was processed prior to statistical analyses. 
3.4.1 Questionnaires 
Each questionnaire was scored as instructed by the creator of the individual 
questionnaire. Each questionnaire (Appendix B) had multiple sections and the ways they are 
scored are outlined below in Tables 6-8. The Godin questionnaire was scored by using the 
following equation: Weekly leisure activity = (9 X strenuous) + ( 5 X moderate) + (3 X light) 




Figure 9: Recoding of RAND 36 responses (Hays et al., 1993) 
Table 6: Scoring for each section of the RAND 36 Questionnaire (Hays et al., 1993) 
  
Physical functioning • Average questions 3-12 after recoding (Figure 9) 
• Higher score indicates higher shoulder-related quality of life  
Role Limitations due 
to physical health 
• Average questions 13-16 after recoding (Figure 9) 
• Higher score indicates higher shoulder-related quality of life 
Role limitations due to 
emotional problems 
• Average questions 17-19 after recoding (Figure 9) 
• Higher score indicates higher shoulder-related quality of life 
Energy/Fatigue  • Average questions 23,27,29,31 after recoding (Figure 9) 
• Higher score indicates higher shoulder-related quality of life 
Emotional well-being • Average questions 24-26,28,30 after recoding (Figure 9) 
• Higher score indicates higher shoulder-related quality of life 
Social Functioning • Average questions 20,32 after recoding (Figure 9) 
• Higher score indicates higher shoulder-related quality of life 
Pain • Average questions 21-22 after recoding (Figure 9) 
• Higher score indicates higher shoulder-related quality of life 
General Health • Average questions 1,33-36 after recoding (Figure 9) 
• Higher score indicates higher shoulder-related quality of life 
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• [(sum of n responses)/n -1] X 25  
• n is the number of completed responses 
• Lower score is optimal 
Work module • [(sum of responses)/4 -1] X 25  
• Lower score is optimal 
Sports/performing 
arts module  
• [(sum of responses)/4 -1] X 25  
• Lower score is optimal 
Table 8: Scoring for each section of the FACT-B Questionnaire, where n is the number of 





• Each score from this section must be subtracted from 4 
• [(Sum revised scores) * 7]/n  
• Score ranges from 0-28 
Social/Family Well-
Being (SWB) 
• [(Sum scores) * 7]/n  
• Score ranges from 0-28 
Emotional Well-Being 
(EWB) 
• Each score from this section must be subtracted from 4, with 
the exception of question GE2  
• [(Sum revised scores) * 6]/n  
• Score ranges from 0-24 
Functional Well-
Being (FWB) 
• [(Sum scores) * 7]/n  
• Score ranges from 0-28 
Breast Cancer 
Subscale (BCS) 
• Each score from this section must be subtracted from 4, with 
the exception of question B4 and B9  
• [(Sum revised scores) * 10]/n  
• Score ranges from 0-40 
FACT-B Trial 
Outcome Index (TOI) 
• PWB score + FWB score + BCS score 
• Score ranges from 0-96 
FACT-B Total score • PWB score + SWB score + EWB score + FWB score + BCS 
score 
• Score ranges from 0-148 
3.4.2 Dual-energy X-ray Absorptiometry  
Body composition measures were extracted from the scan for analysis. Body fat 
percentage, as well as total fat mass and total lean mass were all extracted from the report. 
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Additionally, lean mass, fat mass and percentage fat were exported for the left/right arm, 
left/right leg, trunk and head. The difference between the total mass of the left and right arm was 
used as a basis to identify the presence of lymphedema (≥ 10% volume difference is indicative of 
lymphedema). Therefore, the parameters that were used for analysis were lean and fat mass and 
fat percentage of the unaffected and affected limb, as well as a lymphedema measure -volume 
difference between limbs expressed as a percentage. 
3.4.3 Peak Force Output  
 Peak force data were extracted from each isometric strength trial. Two-point calibration 
was used to convert raw voltage from the system into force data. Raw force data were smoothed 
using a low pass, second order, dual pass Butterworth filter, with a cut-off frequency of 4Hz 
(adjusted to 5Hz (4/0.802) to account for the dual pass filter). This cut-off was chosen to remove 
high frequency noise as human movement occurs between 0-6Hz, and the strength tasks are 
isometric (Winter, 2009), and thus would be at the lower end of that range. Peak force was 
extracted from each trial using a custom MatlabTM R2020a program (Mathworks Inc., USA). 
These outputs represent a measure of isometric strength in each fundamental shoulder motion 
(flexion, extension, abduction, adduction, internal rotation, external rotation).  
Raw force production (in N) was chosen intentionally. Often handheld dynamometers are 
used in clinics, which provide clinicians direct force measures (often in N, but can also be 
expressed in kg or lbs).  Therefore, force production was reported, as opposed to normalized 
strength or shoulder moments, to provide clinical relevance. This enhances translation of the 
study results to rehabilitation settings. Additionally, force in newtons is an input to the model 
used in Study 3, so for consistency this is reported here (Dickerson et al., 2007). Finally, often 
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force is normalized to bodyweight. This is common in lower-limb research as they are weight 
bearing limbs; however, it is less relevant in relation to upper-limb research.  
3.4.4 Kinematic Data - Range of Motion 
 3D markers during range of motion tasks were tracked in VICON Nexus 1.8.5 (Vicon, 
Oxford, UK) and further filtered for use in calculating joint angles. Kinematic markers were 
labelled, and the marker trajectory of missing markers (20 frames or less than 0.4s) were pattern 
filled using present markers in the trial, using the Nexus software. Marker trajectories were 
exported for further processing. Kinematic data was dual pass filtered with a second order, low 
pass Butterworth filter with a cut off frequency of 4Hz (adjust to 5Hz for the dual pass filtering), 
as human movement occurs between 0-6Hz (Winter, 2009).  
Local coordinate systems were calculated from the exported marker trajectories following 
defined recommendations (Wu et al., 2005) (Table 9). In order to calculate the upper arm 
segment, the humeral head (joint centre of the glenohumeral joint) was located. The humeral 
head was located by subtracting 60mm from the acromion marker along the y-axis of the torso 
segment (which connects the centre of SS and C7 and the centre of XP and T8) (Nussbaum & 
Zhang, 2000). The joint centre of the elbow is necessary for the upper arm local coordinate 
system and is defined as the midpoint between the lateral and medial epicondyles. The static 
calibration trial collected was used to develop an anatomical rotation matrix, describing the 
anatomical landmarks of the trunk and upper limb within the cluster coordinate systems to 
decrease skin motion artifact (Leardini et al., 2005; Winter, 2009). Segment rotation matrices 
between the anatomical and cluster axis systems were calculated using the segment cluster 
system relative to the anatomical local coordinate system. This relationship (between the cluster 
and anatomical local coordinate systems) was assumed to remain constant during all tasks. 
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Table 9: Segment coordinate systems, as defined by ISB standards (Wu et al., 2005) 
Axis Torso Upper Arm 
Y-axis  The line created by the centre of C7 
and SS and the centre of T8 and XP, 
pointing upwards  
The line created between the humeral 
head and the joint centre of the elbow, 
pointing upwards  
Temporary 
axis 
Temporary x-axis: line formed 
between SS and C7, pointing forwards 
 
Temporary z-axis: line formed 
between the lateral and medial 
epicondyles, pointing to the right 
Z-axis  Cross multiplication of the temporary 
x-axis and the y axis, pointing to the 
right  
(Formed after x-axis) cross 
multiplication of the x and y axes, 
pointing to the right 
X-axis Crossing the Y and Z axes, pointing 
forwards  
Cross multiplication of the y axis and 
the temporary z axis, pointing 
forwards 
 A direction cosine matrix was calculated for each time point, followed by decomposition 
and extracting appropriate angles. To begin a time varying rotation matrix from the global 
coordinate system to the local cluster system was created by using the position data from the 
cluster on the humerus. The final local coordinate system was found by multiplying the time 
varying rotation matrix by the constant relationship of the anatomical system to the cluster 
system. The direction cosine matrix was calculated by multiplying the transpose of the distal 
segment local coordinate system (humerus) by the proximal local coordinate system (thorax). 
These matrices were decomposed using Euler rotation sequence of Y-X-Y’ (Wu et al., 2005) 
(Eq. 4). The rotations are described in Table 10. For each range of motion trial maximum and 
minimum angles for each rotation were extracted using a custom Matlab TM R2020a program 
(Mathworks Inc., USA). The range of motion was determined by subtracting the minimum angle 
from the maximum angle (Hall, Middlebrook, & Dickerson, 2011) in the relevant rotations (for 
abduction, scapular abduction, flexion, extension elevation angle was used, for internal and 
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Where, γ is plane of humeral elevation, 𝛽 is humeral elevation, and 𝛾2 is humeral internal/external 
rotation. 
Table 10: Humerothoracic rotation descriptions for rotation sequence (Y-X-Y’) (Wu et al., 2005) 
Rotation Description  
e1 () – Plane of 
Elevation 
Glenohumeral plane of elevation (0 is pure abduction, 90 is forward 
flexion)  
e3 (2) – Axial 
Rotation 
Internal rotation (positive); external rotation (negative)  
e2 () – 
Elevation Angle 
Elevation angle (negative), rotation will be expressed as positive for ease of 
understanding 
3.5 Statistical Analysis  
Prior to any statistical analysis a Grubb’s test was completed to identify outliers and these 
data points were removed (Grubbs, 1950). With 47 observations per variable (Table 11) and a 
confidence interval of 95%, a critical z-score was set at 2.87. Means and standard deviations 
were calculated, and a z-score was calculated for each point. Any points beyond the critical z-
score threshold were removed as outliers. Two participants were removed due to missing more 
than 5 data points, and one participant was removed as an outlier (more than 5 data points were 






Table 11: Dependent variables for input in cluster analysis. Variables Marked with * remained 
following the low variance filter. Variables bolded and marked with a + remained following 
backward feature elimination.  
 Dependent Variables  
General Health 






• Physical activity (GODIN) * 
• Physical well-being (FACT-B)  
• Social well-being (FACT-B) * 
• Emotional well-being (FACT-B) 
• Functional well-being (FACT-B) * 
• Trial Outcome Index (TOI) (FACT-B) 
• Full Score (FACT-B) 
• Breast cancer subscale (FACT-B) 
• Disability score (DASH) * 
• Physical functioning (RAND-36) * 
• Role limitation health (RAND-36) * 
• Role limitation emotion (RAND-36) * 
• Energy/Fatigue (RAND-36) * + 
• Emotional well-being (RAND-36) 
• Social functioning (RAND-36) * + 
• Pain (RAND-36) * + 
• General Health (RAND-36) * 
DXA 
• Body fat percentage 
• Total fat mass * 
• Total lean mass  
• Lean mass (affected/unaffected limbs, trunk) 
• Fat mass (affected limb*, unaffected limb, trunk*)  
• Percentage fat (affected/unaffected limbs, trunk) 
• Volume difference (lymphedema score) 
Peak force (affected 
limb) 
• Abduction force * 
• Adduction force * 
• Flexion force * 
• Extension force * 
• Internal rotation force * + 
• External rotation force * 
Active shoulder range of 
motion (affected limb) 
• Abduction range of motion 
• Scapular abduction range of motion 
• Flexion range of motion 
• Extension range of motion * + 
• Internal rotation range of motion * 
• External rotation range of motion * 
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3.5.1 Feature Reduction  
Several important factors must be identified to use cluster analysis: the observations to be 
included, clustering method, similarity measure, and procedure for determining the number of 
clusters (Blashfield, 1980). Observational features for the cluster analysis performed in this work 
were strength measures (6), active range of motion (6), time since treatment (1), body 
composition (13), age (1), height (1), weight (1), physical activity (as determined through the 
GODIN questionnaire) (1), and shoulder-related quality of life (as determined by questionnaire 
results) (17) (Table 11). Prior to completing the cluster analysis, the number of dependent 
variables were reduced. To begin, all data was normalized. For each dependent variable, the 
maximum observed in the study was determined, and each data point was divided by that 
maximum value. Following this a low variance filter was completed. Any variable with variance 
less than 0.03 was removed from inclusion into the cluster analysis. After the low variance filter, 
24 of the original observations remained (Table 11). The observations removed were: age, 
height, weight, BMI, FACT-B (Physical well-being, emotional well-being, TOI, and full score), 
RAND-36 (Emotional well-being), body fat percentage, total lean mass, lean mass (affected and 
unaffected limbs, and trunk), fat mass of the unaffected limb, fat percentage (affected and 
unaffected limbs, and trunk), lymphedema score, and abduction, flexion and scapular abduction 
active range of motion.  
The 24 variables that remained were inputted into backward feature elimination as 
predictors, with the response variable set as role limitation, health. This variable had the greatest 
variance of questionnaire results and allowed for the backward feature elimination to be run. The 
5 dependent variables that were most predictive of the group of data remained for the cluster 
analysis (Table 11). These variables were internal rotation force production, extension range of 
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motion, and three questionnaire variables, all from the RAND-36 questionnaire (energy/fatigue, 
social functioning and pain). 
3.5.2 Cluster Analysis  
  These 5 observations were inputted into a k-means clustering method using a custom 
MatlabTM R2020a program (Mathworks Inc., USA). k-means clustering seeks to reduce the 
distance between each data point and the centroid of its respective cluster, and is commonly 
applied to larger biomechanical data sets (Fraley & Raftery, 1998). Two to nine clusters were 
investigated for this thesis. Nine clusters were the maximum considered as nine possible 
treatment combinations exist (3 surgery types – mastectomy, breast conserving 
therapy/lumpectomy, lymph node dissection, and 3 surgery types – chemotherapy, radiation and 
a combination of the two). The silhouette method was used to determine the appropriate number 
of clusters (Everitt, Landau, Leese, & Stahl, 2011). The average silhouette was calculated for 2-9 
clusters, and the highest average was considered the best fit. Average silhouette represents how 
well a point is clustered. This measure determines how similar a point is to its own cluster, 
compared to other clusters. Values closer to 1 represent points are in the correct cluster, where 
negative values represent data that is likely placed in the incorrect cluster. Average silhouettes 
below 0.2 are considered weak and lack evidence, whereas values above 0.5 are considered 
strong (Kaufman & Rousseeuw, 1990). The average silhouette for two clusters was the largest of 
all scenarios (0.326773), and therefore two clusters were used for analysis for this study (Table 
12). Silhouette values for all data points in the two clusters are depicted in Figure 10. Final 




Table 12: Average silhouette values for 2-9 clusters, where values closer to 1 indicate data is 
accurately clustered. 
Clusters 2 3 4 5 6 7 8 9 
Average 
Silhouette 
0.326773 0.229525 0.245196 0.204399 0.195422 0.193502 0.166886 0.216219 
 
Figure 10: Silhouette scores for each data point in each of the two clusters. Values closer to one 





Figure 11: Cluster Analysis results where red indicates the subject is allocated to cluster one, 
and blue indicates cluster two. The centroid of each cluster is marked within the figure. 
3.5.3 Cluster Comparison  
The similarity between clusters was tested to determine the factors that separate the 
groups, and factors of treatment and diagnosis are listed in a table for comparison (Table 13). 47 
two-tailed t-tests were used to determine the differences of each group based on strength 
measures, range of motion, time since treatment, body composition, age, physical activity (as 
determined through the GODIN questionnaire), and shoulder-related quality of life (as 
determined by questionnaire results) (Table 14). Significance was set at p<0.05. A bonferroni 
correction was implemented to correct for multiple comparisons (/n) and adjusted to p<0.001 
(0.05/47). As this study is exploratory in nature, both levels of significance are discussed to 
provide a clearer picture of important variables. Descriptive statistics (means and standard 
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deviations) were determined and reported for all dependent variables. For variables where means 
and standard deviations were not applicable, counts are reported. All quantitative statistical 
analyses were completed using a custom MatlabTM R2020a program (Mathworks Inc., USA). 
3.6 Results 
 After data reduction techniques, 5 dependent variables were used to complete the cluster 
analysis and 2 clusters of breast cancer survivors emerged. Three participants were removed 
from analysis as outliers, leaving 32 participants. The diagnosis information for participants of 
each cluster, as well as self reported difficulties experienced by survivors in each group (Table 
13). 21 of the 47 variables were significantly different between the 2 clusters with p<0.05, and 
12 were significantly different between the clusters with p<0.001. Individuals in cluster one 
tended towards less fat mass, higher lean muscle mass, higher shoulder-related quality of life, 
lower perceived disability and higher force production and range of motion (Table 14-16). 
Absolute percent difference varied from 0.25% to 110.69% between the two clusters. Cluster one 
will be referred to as ‘High Score Cluster (HSC)’ and cluster two will be referred as ‘Low Score 









Table 13: Counts for each diagnosis variable, and self-reported difficulties in survivors.  




Dominant /Non-Dominant 10/6 8/8 
Surgery (Mastectomy/ Lumpectomy/ 
Lymph Node Removal) 
6/8/2 3/11/2 
Stage (1/2/3) 9/4/3 7/7/2 
Radiation Therapy 13 16 
Chemotherapy 11 8 
Hormone Therapy 10 10 
Shoulder Tightness 6 9 
Shoulder Pain 2 6 
Pain 8 12 
Swelling 5 7 
Self-Reported Decreased ROM 7 12 
Self-Reported Weakness 5 13 
Cording 5 1 
Numbness 7 9 
ADL difficulty 4 13 
Self reported Lymphedema 5 7 
There were no significant differences between the two clusters with respect to age, height 
and weight, as well as months since treatment (Table 14). Eight shoulder-related quality of life 
variables were significantly different (p<0.001) between the two clusters. HSC had 19.5-102.2% 
greater shoulder-related quality of life measures (Figure 12-14) and 110.7% less perceived 
disability than that of participants in the LSC (Figure 14). The HSC also participates in 34% 







Table 14: Comparison of HSC and LSC for general health measures and questionnaire results. 
Higher scores of GODIN, FACT-B and RAND-36, and a lower score for DASH, indicate higher 
shoulder-related quality of life. Variables with p<0.05 are marked with *.  
 HSC (n=16) LSC (n=16) p-value 
Months Since Treatment (months) 11.56 ± 7.81 11.53 ± 6.10 0.99 
Age (years old) 56.88 ± 6.12 56.73 ± 9.00 0.96 
Weight (kg) 72.81 ± 14.48 75.88 ± 14.40 0.56 
Height (cm) 165.85 ± 4.09 164.77 ± 6.12 0.56 
BMI (kg/m2) 26.45 ± 5.10 27.93 ± 5.04 0.42 
Physical activity (GODIN) 45.63 ± 21.69 30.07 ± 18.73 0.04 * 
Physical well-being (FACT-B) 25.26 ± 2.61 19.93 ± 3.26 <0.001 * 
Social well-being (FACT-B) 23.06 ± 6.97 20.53 ± 7.77 0.35 
Emotional well-being (FACT-B) 20.69 ± 3.03 17.73 ± 3.45 0.02 * 
Functional well-being (FACT-B) 23.13 ± 6.93 17.87 ± 3.64 0.01 * 
Breast cancer subscale (FACT-B) 26.13 ± 4.73 21.47 ± 5.76 0.02 * 
Trial Outcome Index (FACT-B) 74.81 ± 8.67 59.27 ± 9.15 <0.001 * 
Full (FACT-B) 118.56 ± 15.98 97.53 ± 15.07 <0.001 * 
Disability score (DASH) 8.18 ± 5.44 28.44 ± 14.53 <0.001 * 
Physical functioning (RAND-36) 89.69 ± 10.87 60.00 ± 17.63 <0.001 * 
Role limitation health (RAND-36) 87.50 ± 22.36 28.33 ± 33.89 <0.001 * 
Role limitation emotion (RAND-36) 97.92 ± 8.33 60.00 ± 33.81 <0.001 * 
Energy/ Fatigue (RAND-36) 75.31 ± 11.47 31.00 ± 16.06 <0.001 * 
Emotional well-being (RAND-36) 74.75 ± 9.32 67.20 ± 10.92 0.05 * 
Social functioning (RAND-36) 91.41 ± 14.94 70.83 ± 19.29 0.002 * 
Pain (RAND-36) 77.34 ± 14.50 57.17 ± 26.51 0.01 * 














Figure 14: Scores for HSC and LSC for the GODIN and DASH surveys. An * represents 
variables with a p<0.05. 
 There were no body composition variables that differed between HSC and LSC at 
p<0.001; however, lean mass of the affected arm was significantly different between the two 
clusters (p<0.05). HSC tended to have less fat mass, and increased lean mass compared to LSC 







Table 15: Comparison of HSC and LSC for body composition results from DXA scan. Variables 
with a p<0.05 are marked with *. 
 HSC (n=16) LSC (n=16) p-value 
Body fat Percentage (%) 38.57 ± 7.20 43.27 ± 8.04 0.10 
Total fat mass (kg) 29.19 ± 11.80 35.60 ± 12.82 0.16 
Total lean mass (kg) 39.66 ± 3.75 39.26 ± 3.80 0.77 
Fat mass trunk (kg) 12.69 ± 5.82 15.27 ± 5.74 0.23 
Lean mass trunk (kg) 20.42 ± 2.66 19.97 ± 2.18 0.61 
Fat percentage trunk (%) 35.94 ± 8.88 41.15 ± 8.18 0.10 
Fat mass affected limb (kg) 1.64 ± 0.59 2.03 ± 0.84 0.14 
Lean mass affected limb (kg) 2.06 ± 0.32 1.84 ± 0.24 0.04 * 
Fat percentage affected limb (%) 41.59 ± 8.87 48.66 ± 10.78 0.06 
Fat mass unaffected limb (kg) 1.70 ± 0.63 2.17 ± 0.86 0.09 
Lean mass unaffected limb (kg) 1.96 ± 0.29 1.89 ± 0.27 0.49 
Fat percentage unaffected limb 
(%) 
43.52 ± 8.19 49.95 ± 12.08 0.09 
Volume Difference 
(Lymphedema measure) (%) 
7.82 ± 5.28 8.64 ± 6.31 0.70 
  
The two clusters differed significantly in all isometric force production measurements, 
and for one of the ranges of motion measurements. HSC participants produced 47.8-57.4% more 
force than participants in the LSC (Table 16). For force directions that were significantly 
different (p<0.001) (abduction, adduction, flexion and extension), absolute difference was largest 
in adduction force (82.6N), and smallest in abduction force (72.2N) (Figure 15). The other two 
isometric force production measures and one range of motion measure were significant at 
p<0.05. External rotation and internal rotation force were 47.8 and 53.4N larger in HSC 
compared to LSC, respectively. Flexion range of motion was 17.8° greater in participants in 





Table 16: Comparison of HSC and LSC for force production and range of motion (ROM) 
results. Variables significant with a p<0.05 are marked with *. 
 HSC (n=16) LSC (n=16) p-value 
Abduction Force (N) 161.87 ± 41.25 89.64 ± 41.32 <0.001 * 
Adduction Force (N) 201.45 ± 44.66 118.89 ± 31.19 <0.001 * 
Extension Force (N) 201.55 ± 50.82 123.80 ± 37.05 <0.001 * 
External Rotation Force (N) 131.73 ± 45.41 83.96 ± 41.14 0.005 * 
Flexion Force (N) 185.55 ± 54.95 105.77 ± 33.31 <0.001 * 
Internal Rotation Force (N) 130.01 ± 56.50 76.62 ± 40.59 0.005 * 
Abduction ROM (°) 160.36 ± 13.09 145.71 ± 31.70 0.10 
Extension ROM (°) 54.24 ± 29.36 50.14 ± 25.60 0.68 
External Rotation ROM (°) 47.66 ± 22.41 45.36 ± 15.82 0.75 
Flexion ROM (°) 162.18 ± 18.01 144.46 ± 25.71 0.03 * 
Internal Rotation ROM (°) 47.36 ± 15.26 40.82 ± 16.15 0.26 
Scapular Abduction ROM (°) 156.35 ± 13.03 147.90 ± 26.28 0.26 
 
 
Figure 15: Isometric force production for HSC and LSC in all 6 positions. An * represents 




Figure 16: Range of motion for HSC and LSC in all 6 motions. An * represents variables with a 
p<0.05. 
3.7 Discussion 
 This study classified breast cancer survivors into two groups (referred to in this study as 
HSC and LSC). The novel classification determined which measures of function (physical 
activity, perceived disability, strength and range of motion) were more predictive of a lower 
shoulder-related quality of life.  
3.7.1 Classification Features 
It was hypothesized that two clusters would be formed, based on physical activity, time 
since treatment ended, internal rotation force production, flexion range of motion, and perceived 
disability. Two groups were formed, however the five variables that remained after feature 
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reduction were internal rotation force production, active extension range of motion, and 3 
variables from the RAND-36 questionnaire (energy/fatigue, social functioning and pain).   
Internal force production was identified as an important factor in this cluster analysis. 
The pectoralis major is an internal rotator (as well an adductor). Therefore, it was expected that 
internal rotation strength would be decreased in breast cancer survivors. The pectoralis major 
may be damaged through both surgery and radiation (Lipps et al., 2017). With the accumulation 
of damage from treatment, pectoralis major may show deficits, including loss of strength. To 
measure this factor, the current study investigated force production. Once the 47 factors were 
reduced, internal rotation force production was left as one of five variables that clustered 
participants into one of two clusters. A reduction in internal rotation force production following 
damage to the pectoralis major is expected due to its function. The HSC had 69.68% greater 
internal force production than the LSC. Literature supports the notion that internal rotation force 
could be reduced in this population  (Harrington et al., 2011; Ribeiro, Camargo, et al., 2019). 
The current study confirmed that internal force production may be an important factor in 
determining whether an individual will have a higher, or lower shoulder-related quality of life. 
Extension range of motion was determined as another predictor variable in this cluster 
analysis. One of the many functions of the pectoralis major is to assist in extension (Brown, 
Wickham, McAndrew, & Huang, 2007). The damage from treatment may cause scar tissue to 
form in the muscle affecting function and resulting in pectoral tightness (Hayes et al., 2012). 
Literature reports modest decreases in extension, between 5 and 10° (Harrington et al., 2011; 
Serra-añó, Inglés, Bou-catalá, Iraola-lliso, & Espí-lópez, 2019). Although this decrease is 
modest, it is indicative of the underlying tightness from the damage (Serra-añó et al., 2019). 
Interestingly, although this variable was identified as an important variable to cluster 
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participants, there was no significant difference in extension between the final clusters in the 
current study.   
Energy/fatigue (from the RAND-36 questionnaire) is the first of three variables that 
emerged from self reported measures. Energy, and more specifically fatigue is often cited 
following cancer treatment. Although most often cited following chemotherapy, fatigue from 
radiation returns to pre treatment levels up to 6 months following treatment (Irvine et al., 1998). 
Energy and fatigue routinely act as an important aspect in survivorship as up to 91% of cancer 
survivors report fatigue as the reason they are unable to complete daily tasks (Irvine et al., 1998). 
With such a large impact on daily life, energy and fatigue is logically a suitable predictor 
variable. Energy and fatigue scores were 142.9% higher in the HSC group (which translates to 
higher shoulder-related quality of life; less effects of fatigue and more energy). 
The second questionnaire variable was pain (from the RAND-36 questionnaire). Pain is a 
commonly indicated symptom in survivors. It is reported in 31-61% of survivors, and although it 
may be rated as mild-moderate, its presence is still persistent and affects daily life of survivors 
(Lauridsen et al., 2008; Levy et al., 2012; Rietman et al., 2004; Tasmuth et al., 1995). Self 
reported pain occurred in 12/16 participants in the LSC (and in 8/16 in the HSC). There was a 
35.3% difference in pain scores in the current study, where the HSC reported higher scores 
(indicating lower pain). As pain is commonly reported in survivors, it is probable that more 
severe pain is an indicator of reduced strength and shoulder-related quality of life, but even mild 
pain persists in over half of survivors that are within two years of treatment. 
The final variable left after feature reduction was social functioning. Social functioning 
was 29.1% higher in the HSC. Social support is an important factor during cancer treatment; 
however, it can become complicated during and even after treatment. The main factors involved 
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in social functioning include abilities to fulfil social roles (spouse, parent, student, employee etc.) 
or “household, family, social and community, self-care and occupational activities” (Bourjolly, 
Kerson, & Nuamah, 1999). Routine follow ups end after five years following the conclusion of 
treatment, and a decline is seen in both self reported social and physical functioning 
(predominantly in younger survivors) as there is a deficit in support (Koch et al., 2013). This 
decline in social functioning persists at 10 years, especially in survivors who received 
chemotherapy or hormone therapy (Ganz et al., 2002). The decline in support, and mounting 
social roles are a continued presence long after treatment ends, and are a defining element of 
survivorship.  
It should also be noted that although these five parameters were the remaining variables, 
this does not mean that other variables may not be important. Rather, due to the low variance 
filter, and backward elimination, variables that would predict similarly are removed. It is 
redundant for these similar variables to be kept for the analysis, so the best predictor remains. 
This does not infer that these variables are unimportant, but that there may be overlapping facets 
of survivorship expressed within another variable.   
3.7.2 Functional differences in survivors  
The second hypothesis was that one group would have lower measures of shoulder-
related quality of life, particularly increased perceived disability (DASH), decreased physical 
activity levels (GODIN), increased arm volume differences (indicative of lymphedema), and 
decreased lean muscle mass, strength and range of motion. Several measures of shoulder-related 
quality of life were indeed significantly lower in the LSC; Physical well-being and the full 
FACT-B scores, physical functioning, role-limitation (health and emotion), and energy/fatigue 
RAND-36 scores, DASH scores, and abduction, adduction, extension and flexion force 
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production. There were minimal significant differences in active range of motion or body 
composition measures (flexion range of motion, and lean mass of the affected limb). 
Force production is an important functional parameter in survivorship. As previously 
stated, force production significantly differed between the two clusters, specifically in abduction, 
adduction, extension and flexion. Range of motion, which is often also cited as an important 
factor in survivor health, did not significantly differ between the clusters. This suggests that 
weakness, or decreased strength had the largest effect on survivors after the conclusion of 
treatment. A difference of strength greater than 63.7N (6.5kg) is deemed a clinically important 
difference (J. K. Kim et al., 2014). Although this is based on grip strength, the exact number is 
not applicable, it provides a guideline for clinically measurable differences in strength. 
Differences between HSC and LSC in abduction, adduction, extension and flexion in the current 
study ranged from 72.23-82.56N, meeting this criterion. Decreases in strength have been 
previously linked to a decrease in shoulder-related quality of life, especially compared to non-
cancer reference populations (Bertoli et al., 2020; Zabit & Iyigun, 2019). These decreases in 
strength may be more evident after a year following treatment (Maciukiewicz, Hussein, 
Mourtzakis, & Dickerson, n.d.). Differences in force production led to difficulties completing 
daily tasks and a return to work in a similar capacity to before treatment.  
The second functional parameter investigated was range of motion. Range of motion 
differences were modest in the current study, below 15° for all planes of motion excluding 
flexion. As 15° is the smallest difference cited as clinically significant (Tengrup et al., 2000), 
there were no other clinically meaningful differences between the two groups. However, flexion 
was significant (p>0.05) and had a difference of 17.7° between the HSC and LSC, which may 
indicate importance of this movement. Decreases in range of motion have been investigated in 
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the workplace, and lead to a loss of productivity (Quinlan et al., 2009). However, like the current 
study range of motion differences are complex in this population. There are clear restrictions in 
the breast cancer survivor population, however it is largely variable. After one year from the end 
of treatment only flexion and scapular abduction experienced a decrease, in comparison to 
individuals within one year from the end of treatment (Maciukiewicz et al., n.d.). Differences 
have also been cited to occur between breast cancer survivors and reference populations 
(Harrington et al., 2011; Lang et al., 2019; Ribeiro, Moreira, et al., 2019), however the current 
study indicates these differences are likely not as imperative to segregate survivors and unlikely 
to correspond to a decrease in shoulder-related quality of life. This is not to say that restrictions 
in range of motion are un-important in this population, but that strength is the more important 
functional parameter in this population.  
Body composition differences were minimal between the HSC and LSC participants. In a 
review article, the impacts of treatment for breast cancer were not definitive (Sheean, Hoskins, & 
Stolley, 2012). There was no consistent weight increase, and any changes in weight did not relate 
to adipose or lean mass changes in participants. However, there was a negative impact on body 
composition with the use of hormone therapy (Sheean et al., 2012). Similar to range of motion, 
there are participants who experience these adverse effects of treatment, but the literature is 
equivocal regarding which participants this may affect. The current study anticipated body 
composition group differences, specifically decreased lean muscle mass in the affected arm of 
the LSC, and a decrease in force production was also hypothesized. Lean mass of the affected 
limb was 2.06 ± 0.32kg in the HSC, and 1.84 ± 0.24kg in the LSC (p=0.04). Overall, with no 
other differences in body composition, the current study supports the notion that breast cancer 
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survivors have no discernible physical changes. As the current study had similar treatments in 
each group, potential treatment-derived differences are indistinguishable.   
3.7.3 Treatment and self-reported deficits  
The third hypothesis stated a higher percentage of participants in the LSC would present 
with a more invasive treatment and more advanced diagnosis stage. The participants in the LSC 
and the HSC had similar counts of treatment type and stage. The majority of both groups 
received a lumpectomy (11 and 8, respectively), and both groups had few participants diagnosed 
as stage 3 (2 and 3, respectively). Most participants (29/32) received radiation treatment while 
50% of the LSC group, and 68.75% of the HSC received chemotherapy. Each group had 10 
individuals receiving hormone therapy. The difference in counts emerged most prominently in 
self reported weakness, shoulder pain and ADL difficulty (Table 13). Literature is inconclusive 
on the effects of each treatment type on self-reported outcomes and the perceived impact of these 
treatments can lead to a great range of issues for survivors.  Weakness is reported by survivors 
who have received chemotherapy and radiation (Lee et al., 2008; Markes et al., 2006). Even in 
the HSC in this study, individuals reported weakness and decreased range of motion although the 
measured data did not corroborate this. This can be attributed to the variety of force production 
for each of these measures, as self reported weakness is not specific to any one plane of motion. 
However, the LSC had larger numbers of self-reported weakness and range of motion and 
increased pain. Participants in the LSC also had worse shoulder-related quality of life, 
specifically in physical functioning (33.1%), role limitation (38.7% emotional, 67.6% health) and 
energy/fatigue (58.8%). They also reported more difficulties with activities of daily living. This 
supports the notion that survivors who perceive weakness or restriction in their affected arm feel 
they cannot complete tasks that affect their ability to fulfill important roles in their lives (work 
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and home life) (Lee et al., 2008; Markes et al., 2006).  A rather low association between 
shoulder-related quality of life and range of motion was identified in literature (Rietman et al., 
2003). Although there were associations between difficulties completing daily tasks and 
morbidity of the upper arm, clinical significance was absent and therefore could not be attributed 
to range of motion. This supports the current finding that range of motion did not differ between 
groups. Although these restrictions are apparent in this population, range of motion is not the 
most important factor that quantitatively relates to overall shoulder-related quality of life. The 
current study results suggest weakness (both measured and self-reported) is more important to 
differentiate shoulder-related quality of life amongst survivors. Previously, strength of the 
shoulder girdle related to decreases in shoulder-related quality of life (Harrington et al., 2011, 
2013). Overall, these associations support that weakness after treatment could be an important 
factor in survivorship.  
3.7.4 Comparison to non-cancer population  
 Aging affects the musculoskeletal system in several ways. The population in the current 
study had an average age of ~ 57 years of age (56.9 and 56.7 for the HSC and LSC, 
respectively). Studies on younger populations often focus on participants under 40, and aging 
population studies on individuals over the age of 65, placing the current study population in 
between. It can be inferred that aging had some affect on our participants, but the loss of strength 
due to aging may not be overwhelming. Median muscle mass loss over the age of 45 is 
approximately 0.37% per year (and accelerates over 75 years) (Mitchell et al., 2012). Strength is 
lost 2-5 times faster than mass in the aging population (Mitchell et al., 2012). A loss in skeletal 
muscle mass and strength is associated with functional impairment and disability, especially in 
women (compared to men) (Avin, Tumuluri, Looft, & Frey-Law, 2015; Janssen, Heymsfield, & 
76 
 
Ross, 2002). The difference in strength in 40 and 60 year old women ranged from 32.8-50.0% 
(Hughes et al., 1999). In the current study the difference between the two clusters ranged from 
47.8-57.4% (Table 16). The participants in the current study ranged in age from 35 to 74 years 
old, but averaged at 57 years old. Unfortunately, due to the COVID-19 pandemic, an age-
matched non-cancer reference population was infeasible to collect. Further research is needed to 
determine whether the HSC in the current study approximates a non-cancer reference population, 
or deficits exist for all survivors following treatment.  
3.8 Limitations 
 Study results should be considered within the context of several limitations. First, the 
study had a relatively small sample size. A larger sample may have decreased the variability and 
increased the difference between the two cohorts. Additionally, variability within each treatment 
(drugs used, doses given, surgeon completing the surgery) may cofound the results of the current 
study. However, the heterogeneity of this population can also be considered a strength to 
determine which factors have a larger influence on survivors’ lives. Further, no repetitions were 
completed for range of motion or strength trials, unless deemed necessary by a researcher 
(deviation in posture, force did not plateau), or participants (maximum was not reached). This 
was controlled to avoid any unnecessary pain, or any fatigue that may mitigate results in this 
population.  
3.9 Conclusions 
 Breast cancer survivors have different experiences after treatment. Wide variance typifies 
treatment types, force production, range of motion, body composition and shoulder-related 
quality of life. However, the relationship between these variables, and more importantly which 
variables might distinguish which survivors may need more rehabilitation remains unclear. The 
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feature reduction in the current study determined that internal rotation force production, active 
extension range of motion, and 3 variables from the RAND-36 questionnaire (energy/fatigue, 
social functioning and pain) successfully distinguished survivors within 2 years of treatment into 
two clusters. Several factors differed between the two clusters or groups. The HSC participants 
had lower self-reported disability, role limitation (health and emotion), fatigue, and higher self 
reported physical well-being, along with increased abduction, adduction, extension and flexion 
force production (p<0.001). Several other factors differed significantly (p<0.05), including lean 
mass of the affected arm, physical activity, internal and external force production and active 
flexion range of motion. This explorative investigation is helpful to clinicians and 
physiotherapists to assist in determining individuals to target rehabilitation efforts. This study 
determined that participants with lower self-reported shoulder-related quality of life likely also 
produce lower maximal force. These associated with more reported difficulties with ADLs, and 
therefore should be factors that are addressed in a rehabilitation program. Little research has 
been completed on these factors and their affect on low load daily tasks in this population, 




Chapter IV - Kinematic and Muscular Activation Differences 
between Breast Cancer Survivors During Activities of Daily Living 
(ADLs) 
4.1 Introduction 
 Functional activities performed by clinical populations are often characterized with 
discrete data points, neglecting additional information that may be contained in considering the 
entire movement. Statistical parameter mapping (SPM) enables multi-dimensional time-series 
biomechanical data analysis as opposed to discrete data. Friston et al (1991) began using this 
technique in image data by comparing pixels of brain scans to one another to determine regional 
differences (Friston, Frith, Liddle, & Frackowiak, 1991). This technique has garnered much 
attention recently in biomechanics as it allows comparison of time-series data. Although it 
appears to have a multiple comparison problem, by using gaussian random field theory SPM 
corrects p-values for the entire volume of the data set (Worsley, Evans, Marrett, & Neelin, 1992). 
Hughes-Oliver et al (2019) used SPM to locate portions of a stop-jump task that differed 
between limbs in a group of participants with anterior cruciate ligament reconstruction. Discrete 
data may often indicate differences, however SPM more specifically identified bilateral 
differences at the ankle during the landing phase of the jump task, where the surgical limb had 
increased peak eversion (44.7%), but decreased peak inversion (67.3%) compared to the non-
surgical limb (Hughes-Oliver, Harrison, Williams, & Queen, 2019). Similarly, during early 
weight acceptance in a stair descent task differences existed during hip flexion/extension and 
abduction/adduction between participants who received reconstruction for ACL injuries vs 
individuals who only received physiotherapy (Sole, Pataky, Tengman, & Häger, 2017). 
79 
 
 Investigations in breast cancer survivors have generally focused on discrete data points 
during various tasks. Recent reports indicate that during various activities of daily living breast 
cancer survivors used less elevation and rotation on their affected side (Brookham et al., 2018a). 
Further, during ADLs, breast cancer survivors experienced higher muscular demand than 
reference participants (Brookham & Dickerson, 2016; Galiano-Castillo et al., 2011; Shamley et 
al., 2012). Differences in total muscular effort vary substantially across ADLs and work tasks. 
Generally, discrete data showed similar muscular effort, but during some tasks differences 
occurred between the affected and unaffected limbs (Brookham et al., 2018b). However, these 
discrete points did not explain the temporality of these differences during the movement, making 
clean comparisons difficult. Lang et al. (2019) reported discrete data points during functional 
tasks comparing breast cancer survivors and reference participants, and accompanied these with 
plots to describe when these differences were occurring. At extreme postures, survivors with 
impingement pain had decreased humeral abduction and internal rotation (Lang et al., 2019). As 
these postures could have serious implications for potential injury mechanisms, it is important to 
consider when these occur during daily tasks to help identify potential risks for survivors. 
4.2 Objective and Hypotheses  
The objective of study 2 was to determine if differences existed in kinematic strategies 
and muscular activation patterns in two a priori defined groups of survivors (by study 1). 
The following hypotheses were posed for study 2: 
1. Differences will exist between the two clusters of breast cancer survivors during 
activities of daily living in elevation angle and plane of elevation specifically that 
the higher functioning score cohort (per study 1) will use more elevation angle 
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and plane of elevation during tasks (particularly during tasks with external 
weights) 
2. Muscular activation will differ for muscles of the affected arm throughout various 
ADL tasks between groups of breast cancer survivors. Specifically: 
a.  The lower functioning cohort (per study 1) will activate pectoralis major 
and latissimus dorsi more to completed the same task, due to damage of 
these muscles (Lipps et al., 2017)  
b. The lower functioning cohort (per 1) will increase activation of muscles 
less likely to be damaged by radiation (deltoids, supraspinatus, 
infraspinatus) during ADL tasks (particularly tasks with external weights)  
4.3 Methods  
4.3.1 Participants 
 Data generated within study 1 (Chapter III, Section 3.3.1, page 40) contributed to study 2. 
The results from study 1 formed the two groups of survivors analyzed in study 2. 
4.3.2 Motion Capture Instrumentation  
 Motion capture instrumentation was identical to that described in study 1 (Chapter III, 
Section 3.3.2, page 41).  
4.3.3 Surface Electromyography Instrumentation 
Eight upper extremity muscles were collected bilaterally (total of 16 muscles) with the 
Noraxon T2000 telemetered system (Noraxon, Arizona, USA). Prior to placement of electrodes, 
the skin overlaying each muscle was shaved and cleansed with alcohol to reduce impedance 
(Cram & Kasman, 1998).  Noraxon bi-polar Ag-AgCl dual surface electrodes with a fixed 2cm 
inter-electrode spacing was placed over the muscle belly of each muscle based on published 
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standards (Table 17). Specifically, anterior, middle and posterior deltoids, pectoralis major 
(clavicular and sternal insertions), infraspinatus, supraspinatus, and latissimus dorsi were 
monitored. A ground electrode was placed over the clavicle. Surface EMG was recorded at 
1500Hz within the VICON Nexus 1.8.5 software (VICON, Oxford, UK). Following electrode 
placement, isometric maximal voluntary contractions (MVCs) for each individual muscle was 
performed. Participants performed specific exertions in postures that elicit the greatest isometric 
activity for each muscle as outlined in Table 17 (Cram & Kasman, 1998; Daniels & 
Worthingham, 1986). Raw EMG signals were band pass filtered from 10-500Hz and 
differentially amplified (common-mode rejection ratio >100 dB at 60Hz, input impedance 
100MΩ) to generate maximum signal amplification. EMG signals were A/D converted at 1500 















Table 17: Electrode placement and MVC postures (Cram & Kasman, 1998; Daniels & 
Worthingham, 1986) 
Muscle Placement MVC Posture 
Anterior 
Deltoid 
4 cm below the clavicle, on the anterior aspect 
of the arm, parallel to the muscle fibers 
Seated, Shoulder flexed forward 
to 90º, elbow fully extended, 
participant pushes upwards 
Middle 
Deltoid 
Lateral aspect of the upper arm, and 
approximately 3 cm below the acromion, 
parallel to the muscle fibers 
Seated, Shoulder abducted to 
90º, elbow fully extended, 
participant pushes upwards 
Posterior 
Deltoid 
2 cm below the lateral border of the spine of 
the scapula and angled on an oblique angle 
toward the arm  
Subject lays prone, shoulder is 
abducted 90º, externally rotated, 





Placed on the chest wall at an oblique angle 
toward the clavicle, approximately 2 cm 
below the clavicle, just medial to the axillary 
fold 
Subject lies supine, elbow and 
shoulder are flexed to 90º, 






Medial to the axillary fold with the arm 
medially rotated, horizontally on the chest 
wall, over the muscle mass 2 cm out from the 
axillary fold 
Subject lies supine, elbow and 
shoulder are flexed to 90º, 
participant exerts upwards and 
inwards 
Infraspinatus 4cm below, and parallel to the spine of the 
scapula, on the lateral aspect of the 
infrascapular fossa  
Elbow bent to 90º; participant 
externally rotates 
Supraspinatus Directly above the spine of the scapula on the 
distal lateral aspect, over the suprascapular 
fossa 
Participant lays on their side, 
elbow fully extend, shoulder 




Approximately 4 cm below the inferior angle 
of the scapula, half the distance between the 
spine and the lateral edge of the torso, 
oriented slightly oblique at approximately 25° 
Seated, shoulder is abducted to 
90º and elbow flexed to 90º, 
participants adducts arm 
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4.3.4 Experimental Protocol   
 The experimental protocol for study 2 was implemented within the collection for study 1. 
Prior to the aforementioned strength trials, electrode placement took place for both the affected 
and unaffected limbs. Participants performed MVCs for each muscle, for a total of 16 exertions 
(Table 17). There was a minimum of two minutes of rest between each exertion to avoid fatigue 
(Chaffin, 1975). Extra time was given between trials at the participant’s request.  
Participants completed the collection protocol by performing ADLs (following all tasks 
for Study 1). These tasks were completed with both the affected and unaffected limb; however, 
some tasks required both limbs. Each trial was completed twice, for a total of 24 trials.  For the 
purposes of this thesis, only the affected limb is analyzed.  
4.3.4.1 Activities of Daily living  
Eight ADL tasks (Table 18) were assessed to provide an overview of function in ADL 
tasks. Where possible, targets and props were used to help decrease variability and increase 
realism in tasks (Taylor et al., 2018). The various tasks spanned both general tasks and those 
more frequently performed by women. More challenging tasks were not targeted to avoid fatigue 
effects in these individuals. Each task began with the participants’ hands placed on a table in 
front of them. The trial ended with the participants’ hands returning to the resting position. Five 
second trials were collected to allow the participant enough time to fully finish the motion and 
return to a resting position. Data was cut to begin and end when the participant is in motion, to 
allow for comparison of the active motion of the trial. Kinematic data was filtered first 
(described below in Section 4.4.1) and then used to crop the time-series joint angles, and EMG 
data. The mean and standard deviation of acceleration of the wrist (the midpoint between the 
ulnar styloid and radial styloid) during static trials was calculated. Three standard deviations 
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from the mean was set as the threshold for movement. Once movement acceleration was greater 
than this threshold, movement had begun, and once the acceleration was less than this, the trial 
had ended. These time points were exported for each trial to use to cut both the kinematic and 
EMG data. 
Table 18: Description of activities of daily living 
Activity Explanation 
Hand to ipsilateral back 
pocket (unilateral task) 
In a resting seated posture, the participant reached and touched the 
ipsilateral back pocket and return to resting 
Reach to shelf at 
shoulder height 
(unilateral task) 
In a seated posture the subject grasped a weighted object, lift it to 
the shelf at shoulder height, release, and then return it to resting 
position. The subject completed this with a weight of 1kg. 
Forward reach 
(unilateral task) 
In a seated posture the subject grasped a weighted object, reached 
to 80% of arm length, released, and then returned to a resting 
position. The subject completed this with a weight of 1kg. 
Lift shopping bag 
(bilateral task) 
From a standing position, subjects reached to the ground to lift a 
weighted (5kg) shopping bag from the floor to a table, then 
returned it the floor. 
Pour from pitcher 
(unilateral task) 
In a seated posture the subject started with the hand resting on the 
table, then reached for the handle of a pitcher, filled a cup, set the 
pitcher down and returned to the resting position. 
Reach with weighted 
tray (bilateral task) 
From a standing position, the subject started at rest, reached out 
and lifted a weighted (2kg) tray from a table, turned a quarter turn 
and placed the tray on a shelf below. The subject lifted the tray 
and returned it to the resting position. 
Bra fasten (bilateral 
task) 
In a seated posture the subject reached with both arms behind the 
torso to touch where the bra fastens in the back, then returned the 
arms to the starting position. 
Put on necklace 
(bilateral task) 
In a seated posture subjects picked up an unfastened necklace, 
reached behind the neck and fastened the necklace then returned 
the arms to the starting position. 
4.4 Data Analysis  
4.4.1 Kinematic Data Processing  
Kinematic data were tracked and filtered for the ADL trials in the same fashion as the 
range of motion trials in Study 1 (outlined in section 3.4.4, page 52). Segment coordinate 
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systems were calculated following ISB recommendations (Wu et al., 2005) (section 3.4.4, Table 
9, page 53). The difference in processing occurred in calculating the joint angles. Once the 
direction cosine matrix was calculated (multiplying the transpose of the distal segment (humerus) 
by the proximal segment (thorax)), the matrices were decomposed using an XZY rotation 
sequence (Eq.5) to avoid common gimbal lock at 0° when using ISB standard YXY’ (Phadke, 
Braman, LaPrade, & Ludewig, 2011; Šenk & Chèze, 2006) (Table 19). This mimics previous 
studies looking at kinematic motion in clinical populations (Lang et al., 2019). Time series joint-
angles for all three rotations were exported for further analysis. Data was cut as described in 
Section 4.3.4.1.  
𝑅 = 𝑅𝑥()𝑅𝑧()𝑅𝑦()     [Eq. 5] 
𝑅 = [
cos  cos (cos  sin cos + sin  sin) (cos  sin sin − sin  cos)
− sin cos cos  cos sin
sin  cos (sin  sin cos  − cos  sin) (sin  sin sin + cos  cos)
] 
Where,  is humeral elevation, 𝛽 is plane of elevation and 𝛾 is axial rotation. 
Table 19: Humerothoracic rotation descriptions for rotation sequence (XZY) (Phadke et al., 
2011; Šenk & Chèze, 2006) 
Rotation Description  
e1 () – Humeral 
Elevation 
Axis fixed to the thorax and coincident with the X-axis of the thorax 
system; elevation (+); depression (-) 
e3 () – Axial 
Rotation 
Axial rotation around Y-axis of the humerus; internal rotation (+); 
external rotation (-) 
e2 () – Plane of 
Elevation 
Common axis perpendicular to e1 and e3 (the rotated Z-axis of the 
humerus; horizontal flexion (+); horizontal extension (-) 
4.4.2 sEMG Processing  
EMG was analyzed in the time domain. Resting bias was removed from the signal of 
each muscle by subtracting the mean of the raw trial from each time point. A high pass, second 
order, dual pass Butterworth filter, with a cut-off frequency of 30Hz was applied to reduce heart 
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rate contamination from all trials (Drake & Callaghan, 2006). The signal was full wave rectified 
and low pass filtered using a second order, single pass Butterworth filter, with a cut-off 
frequency of 2.5Hz (Brookham & Dickerson, 2016). sEMG was normalized to muscle specific 
maximums. Each trial was visually inspected to ensure the signal was clean from any noise, or 
other adverse events. Data was cut with the time points exported as described in Section 4.3.4.1. 
For all ADL tasks, time-series data was exported as %MVC using a custom MatlabTM R2020a 
program (Mathworks Inc., USA) for use in analysis.    
4.5 Statistical Analysis - Statistical Parameter Mapping  
SPM was used to compare the groups determined in study 1 (Section 3.5). SPM one-way 
ANOVAs were used to identify potential differences between groups over the entire duration of 
each trial. Open source code previously used in biomechanical data was used to complete the 
statistical analysis (Pataky, 2012). All 3 thoracohumeral rotations (plane of elevation, elevation 
angle and axial rotation) along with 8 muscles (anterior, middle and posterior deltoids, pectoralis 
major (clavicular and sternal insertions), infraspinatus, supraspinatus, and latissimus dorsi) of the 
affected side were investigated for each ADL. Kinematic and EMG data were time normalized, 
where the start of the trial was set to 0, and the end was set to 1 to avoid bias in the signal due to 
shifts in timing of events. Each time point was divided by the total time to represent the relative 
time for each data point. The p value was set at p<0.05 for each comparison. Z-scores were 
outputted for each time point during each task for comparison. A critical Z-score was determined 
for each trial, where data beyond this score were considered statistically significantly different at 




 Results are presented across all 8 activities of daily living, by ADL.  Kinematic data is 
presented for each of the three planes of thoracohumeral motion. In all trials 0° of plane 
elevation (also referred to as horizontal abduction) indicates pure abduction, and 90° is in front 
of the body (flexion), positive elevation angles indicate elevation, and positive axial rotations 
indicate internal rotation. sEMG data is presented for 8 muscles – pectoralis major-clavicular 
insertion (PEC(C)), pectoralis major-sternal insertion (PEC(S)), anterior deltoid ((A)DEL), 
middle deltoid ((M)DEL), posterior deltoid ((P)DEL), infraspinatus (INFRA), supraspinatus 
(SUPRA), and latissimus dorsi (LATS). 
4.6.1 Pocket 
 Both groups performed similarly when reaching to the ipsilateral back pocket. Plane of 
elevation, elevation angle and axial rotation were statistically the same through the entire task 
(Figure 17). Plane of elevation remained on average between 50 and 70° for both groups. 
Elevation angle ranged from 30 to 65°, and axial rotation ranged from 50 to 60° (Figure 17). As 
participants reached back elevation increased to allow the hand to reach back, and remained in an 
internally rotated posture.  
PEC(C), PEC(S), (M)DEL, and (P)DEL were similarly activated through the entirety of 
the task (Figure 18). All four muscles were, on average, less than 20% MVC while reaching to 
the ipsilateral back pocket. SUPRA and LATS were statistically similar for both the HSC and 
LSC (Figure 18). However, the LSC had a greater amount of variability for these muscles, with 
1SD reaching as high as 40% MVC (Figure 18). In two instances, INFRA was statistically more 
activated in the LSC than the HSC (between 21.5-32.2% of the task, and 69.9-83.8%). During 
these times, the LSC participants required 3.50-5.41% MVC, and 3.19-5.04% MVC more 
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activation than the HSC participants (Figure 18).  Similarly, (A)DEL was statistically different 
from 16.8-25.1% and 28.1-36.4% of task completion (Figure 18). At these times the LSC 




Figure 17: Average affected limb thoracohumeral plane of elevation (left), elevation (middle) and axial rotation (right) angles for the 
HSC (black) and LSC (red) during the reach to back pocket task. Each angle is time normalized to % of task. One standard deviation 
for each group is represented by the shaded area in each corresponding colour. Associated SPM z-scores are reported below, with 
critical z-scores denoted by horizontal solid black lines. Z-scores that exceed the critical value represent significant differences 




Figure 18: Average affected limb sEMG for the eight muscles recorded for the HSC (black) and LSC (red) during the reach to back 
pocket task. Muscular activation is time normalized to % of task. One standard deviation for each group is represented by the shaded 
area in each corresponding colour. Associated SPM z-scores are reported below, with critical z-scores denoted by horizontal solid 




4.6.2 Shelf Reach 
 In plane of elevation and elevation angle, the HSC and LSC groups performed similarly 
(Figure 19). Participants remained within 25-70° (on average) in plane of elevation, and 20-80° 
of elevation angle (Figure 19). Although not significant, the LSC exhibited a reduced range in 
both plane of elevation and elevation angle, compared to the HSC. From 28-37% of task 
completion, there was a difference of 11.5-12.7° in axial rotation between the HSC and LSC 
(Figure 19). Similarly, to plane of elevation, and elevation angle, the LSC used a smaller range 
of axial rotation, compared to the HSC, where the HSC externally rotated closer to a neutral 
position (although both groups remained internally rotated).  
 Muscular activation of 4 muscles were statistically similar across the entirety of the reach 
up to the acromion level shelf (Figure 20). (M)DEL, (P)DEL, INFRA and SUPRA were the same 
in LSC and HSC across the entire task. On average (M)DEL and (P)DEL were below 20% MVC 
for the entire task (Figure 20).  Although not statistically different, the LSC had variability of the 
INFRA and SUPRA muscles, while still remaining less than 20% MVC for the task (Figure 20). 
PEC(C) was statistically more activated in the LSC than the HSC between 57.3-59.7% of the 
task, requiring 4.96-5.46% MVC more activation than the HSC participants (Figure 18).  
Similarly, LATS was statistically different from 96.8-100% of task completion requiring 3.35-
5.43% MVC more from the LSC participants than the HSC (Figure 18). In three instances the 
PEC(S) was more activated in the LSC group (44.4-49.1%, 82.2-83.9%, and 96.2-100% of task 
completion). (Figure 18). During all 3 areas, the LSC required 3.35-4.7% MVC more activation 
than that of the HSC (Figure 18). Finally, (A)DEL differed in four instances (39.5-45.9%, 49.7-
71%, 73.3-76.8% and 80.1-86.7% of task completion). At these times the LSC required 7.87-




Figure 19: Average affected limb thoracohumeral plane of elevation (left), elevation (middle) and axial rotation (right) angles for the 
HSC (black) and LSC (red) during the shelf reach (with 1kg weight) task. Each angle is time normalized to % of task. One standard 
deviation for each group is represented by the shaded area in each corresponding colour. Associated SPM z-scores are reported below, 
with critical z-scores denoted by horizontal solid black lines. Z-scores that exceed the critical value represent significant differences 




Figure 20: Average affected limb sEMG for the eight muscles recorded for the HSC (black) and LSC (red) during the shelf reach 
(with 1kg weight) task. Muscular activation is time normalized to % of task. One standard deviation for each group is represented by 
the shaded area in each corresponding colour. Associated SPM z-scores are reported below, with critical z-scores denoted by 
horizontal solid black lines. Z-scores that exceed the critical value represent significant differences between groups, and are marked 
with an * (p<0.05).
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4.6.3 Forward Reach 
 Plane of elevation, and axial rotation were relatively unchanged throughout the reach 
forward and back with a 1kg weight (Figure 21). As this task was a reach forward and back,  
limited changes were anticipated for these angles. Plane of elevation remained between 60-70° 
for both the HSC and LSC (the bottle was placed to the side of the participant, not directly in 
front) (Figure 21). Axial rotation also remained between 60-70° for both the HSC and LSC, 
indicating participants remained in an internally rotated posture (Figure 21). From 59-90% of 
task completion, the LSC had higher elevation than the HSC (Figure 21). The LSC was 7.5-11.4° 
higher than the HSC (at 26.1-38.7° and 18.4-28.2°, respectively).  
Muscular activation of PEC(C) and PEC(S) were statistically similar during the entire 
forward reach task (Figure 22). Though not statistically different, the LSC had greater activation 
and variability across the entire task for both muscles (Figure 22). (A)DEL was statistically 
different from 43.1-86.3% of task completion, where HSC was activated 3.97-14.98% MVC, 
while the LSC was activated 11.31-23.46%MVC (Figure 22). (M)DEL differed from 54.7-82.3% 
of task completion, with LSC activated 3.11-7.29%MVC more than the HSC (Figure 22).  
(P)DEL differed in two instances, from 0-8.4% and 69.2-75.7% of task completion, where the 
LSC required 0.89-2.38%MVC more muscular activation than the HSC (Figure 22). Similarly, 
the LATS differed from 0.5-6.2% and 58.6-63% of task completion, with 2.97-3.59% more 
activation of the LSC than the HSC (Figure 22). INFRA differed on three instances, 0-9.3%, 
37.8-50% and 54.3-85.7% of task completion, differing 3.11-8.69% MVC between clusters 
(Figure 22). Finally, SUPRA differed on three instances, 1.2-8.1%, 69.5-72.8% and 78-82.5% of 





Figure 21: Average affected limb thoracohumeral plane of elevation (left), elevation (middle) and axial rotation (right) angles for the 
HSC (black) and LSC (red) during the forward reach (with 1kg weight) task. Each angle is time normalized to % of task. One standard 
deviation for each group is represented by the shaded area in each corresponding colour. Associated SPM z-scores are reported below, 
with critical z-scores denoted by horizontal solid black lines. Z-scores that exceed the critical value represent significant differences 





Figure 22: Average affected limb sEMG for the eight muscles recorded for the HSC (black) and LSC (red) during the forward reach 
(with 1kg weight) task. Muscular activation is time normalized to % of task. One standard deviation for each group is represented by 
the shaded area in each corresponding colour. Associated SPM z-scores are reported below, with critical z-scores denoted by 
horizontal solid black lines. Z-scores that exceed the critical value represent significant differences between groups, and are marked 
with an * (p<0.05).
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4.6.4 Lift a Shopping Bag 
 Plane of elevation, elevation angle and axial rotation were all similar for the HSC and 
LSC groups (Figure 23). During the lift of a 5kg bag from the floor to a hip level surface, plane 
of elevation began at 80° for both clusters, and ended at 60°, within one SD participants 
remained between 40-90° (Figure 23). Both the HSC and LSC used minimal elevation angle, 
remaining within 20-40°, although within one SD this ranged from 10-70° (Figure 23). Axial 
rotation for both the HSC and LSC was variable, but stable across the trial, remaining in internal 
rotation for the entire bag lift (50-60°) (Figure 23). 
 Muscular activation of 4 muscles were statistically similar during the bag lift (Figure 24). 
(P)DEL, (M)DEL, PEC(C) and PEC(S) were the same for the LSC and HSC across the task. 
(P)DEL was minimally activated during the task (less than 10% MVC). (M)DEL was activated 
below 20%MVC, however divergence between the two groups began at 75% of task completion 
(Figure 24). PEC(C) and PEC(S) had greater variability in the LSC, and although statistically 
similar, the LSC was higher throughout the whole trial in both muscles, and reaching 25% MVC 
during the task (Figure 24). (A)DEL was statistically different from 8.5-11.6% of task 
completion, where HSC was activated 3.22-3.63% MVC, while the LSC was activated 8.82-
9.77%MVC (Figure 24). SUPRA differed from 0.9-4.5% of task completion, where HSC was 
activated 1.73-2.75% MVC, while the LSC was activated 4.23-5.78%MVC (Figure 24). INFRA 
differed at two instances 1-15.2% and 20.3-26.7% of task completion, where the LSC activated 
1.64-4.41% MVC more than the HSC (Figure 24). Finally, LATS differed at three instances, 5.2-
7.9%, 31.4-34% and 98.9% of task completion, during these times LATS was activated between 
9.48-18.86%MVC in the LSC, where the HSC required 4.80-9.02%MVC for the same task 




Figure 23: Average affected limb thoracohumeral plane of elevation (left), elevation (middle) and axial rotation (right) angles for the 
HSC (black) and LSC (red) during the 5kg bag lift task. Each angle is time normalized to % of task. One standard deviation for each 
group is represented by the shaded area in each corresponding colour. Associated SPM z-scores are reported below, with critical z-
scores denoted by horizontal solid black lines. Z-scores that exceed the critical value represent significant differences between groups, 




Figure 24: Average affected limb sEMG for the eight muscles recorded for the HSC (black) and LSC (red) during the 5kg bag lift 
task. Muscular activation is time normalized to % of task. One standard deviation for each group is represented by the shaded area in 
each corresponding colour. Associated SPM z-scores are reported below, with critical z-scores denoted by horizontal solid black lines. 
Z-scores that exceed the critical value represent significant differences between groups, and are marked with an * (p<0.05).
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4.6.5 Pour from a Pitcher 
 All three angles differed while pouring from a pitcher (Figure 25). Plane of elevation was 
13.0-16.1° higher in the LSC from 29-47% of task completion (Figure 25). Overall, plane of 
elevation was higher in the LSC as this group used a smaller range of plane of elevation during 
this task. Elevation angle was 8.9-9.8° higher in the HSC participants from 31-40% of task 
completion (Figure 25). Again, the HSC used a greater range of elevation angle. Finally, axial 
rotation was 10.0-10.8° different between the clusters, from 33-43% of task completion (Figure 
25). Although the rotation happened later for the LSC, this group, once again used a smaller 
range of motion. 
 All muscles displayed differences while pouring from a pitcher, excluding PEC(C) 
(Figure 26). PEC(S) was 5.18-6.16%MVC higher in the LSC from 88.7-95.7% of task 
completion, at 10.60-11.69% MVC (Figure 26). Although (P)DEL was statistically different, it 
was minimally activated during this task, and thus likely clinically insignificant. At 67.8-100% 
of task completion, the (P)DEL of the HSC was activated 1.64-3.21%MVC, compared to 3.69-
5.74%MVC in the LSC (Figure 26). Similarly, LATS was different from 88.8-93.3% of task 
completion, where a difference between clusters of 3.18-3.47%MVC occurred (Figure 26). Small 
differences were also seen in the (M)DEL, where the clusters differed 3.28-4.63%MVC from 65-
71.2% and 74.4-100% of task completion (Figure 26).  Differences in (A)DEL occurred from 
56.1-70% and 80.9-100% of task completion (Figure 26). During these times the HSC was 
activated 8.10-14.64%MVC, while the LSC was activated 17.69-22.21%MVC (Figure 26). 
INFRA differed from 53.3-73% and 76.7-100% of task completion, with differences ranging 
from 4.4-7.37%MVC (Figure 26). Finally, SUPRA differed from 75.1-81.1% and 97-100% of 




Figure 25: Average affected limb thoracohumeral plane of elevation (left), elevation (middle) and axial rotation (right) angles for the 
HSC (black) and LSC (red) during the pour from the pitcher task. Each angle is time normalized to % of task. One standard deviation 
for each group is represented by the shaded area in each corresponding colour. Associated SPM z-scores are reported below, with 
critical z-scores denoted by horizontal solid black lines. Z-scores that exceed the critical value represent significant differences 




Figure 26: Average affected limb sEMG for the eight muscles recorded for the HSC (black) and LSC (red) during the pour from the 
pitcher task. Muscular activation is time normalized to % of task. One standard deviation for each group is represented by the shaded 
area in each corresponding colour. Associated SPM z-scores are reported below, with critical z-scores denoted by horizontal solid 




4.6.6 Lift a Weighted Tray 
 Plane of elevation and axial rotation differed through the 2kg tray transfer task (Figure 
27). Plane of elevation differed at 66-69% of task completion, with a difference between 6.5-6.8° 
between the HSC and LSC groups (Figure 27). The HSC remained at ~78° plane of elevation, 
where the LSC remained at ~72° during this time. Although statistically different, this minimal 
difference is not clinically significant.  During axial rotation, the two clusters only differed 
between 86-88% of task completion, with a difference of 15.1-15.9° (Figure 27). The HSC 
returned to ~65° of internal rotation, where the LSC was at ~50° of internal rotation. Elevation 
angle was minimally involved in this task, remaining at ~15° in both the HSC and LSC through 
the entire task. 
 Most muscles were statistically similar through the trial, excluding INFRA and LATS 
(Figure 28). During the tray transfer task, the LSC was 1.97-3.79% MVC more activated than the 
HSC from 3.5-23.7%, 25.1-29.7%, 44.9-48.2%, 49.3-52%, 55.9-63.2%, 64.7-73.4% and 84-86% 
of task completion (Figure 28). However, INFRA was minimally activated in this task, at ~2.0 
and 5.5% MVC for the HSC and LSC, respectively (Figure 28). LATS differed from 43.1-47.2% 
of task completion, with the HSC activating 3.44-3.82%MVC and the LSC activating 6.17-
6.75%MVC (Figure 28). PEC(S), (A)DEL, (M)DEL, (P)DEL, and SUPRA were all below 15% 
MVC during the entire trial (Figure 28). Although PEC(C) was statistically similar between the 
two clusters, the LSC had increased variability, reaching 40%MVC within 1 SD (both clusters, 





Figure 27: Average affected limb thoracohumeral plane of elevation (left), elevation (middle) and axial rotation (right) angles for the 
HSC (black) and LSC (red) during the weighted tray transfer task. Each angle is time normalized to % of task. One standard deviation 
for each group is represented by the shaded area in each corresponding colour. Associated SPM z-scores are reported below, with 
critical z-scores denoted by horizontal solid black lines. Z-scores that exceed the critical value represent significant differences 




Figure 28: Average affected limb sEMG for the eight muscles recorded for the HSC (black) and LSC (red) during the weighted tray 
transfer task. Muscular activation is time normalized to % of task. One standard deviation for each group is represented by the shaded 
area in each corresponding colour. Associated SPM z-scores are reported below, with critical z-scores denoted by horizontal solid 




4.6.7 Fasten a Bra 
 All three angles were similar for the HSC and LSC while reaching back to where a bra is 
fastened. For both clusters, plane of elevation remained between 45-65°, however within one SD 
this range increased to 40-80° (Figure 29). Participants used notable elevation to complete this 
task, ranging, on average, from 30-75° (Figure 29). Within one SD elevation angle range 
increases to 15-80°. Axial rotation remained within 40-60° for both the HSC and LSC during the 
bra fasten task (Figure 29).  
 Muscular activation of all muscles were statistically similar during the bra fasten task, 
except (A)DEL (Figure 30). (A)DEL remained below 10%MVC for both groups for the majority 
of the trial (Figure 30). The two clusters differed from 12.9-28.3%, 31.6-36.4%, 41.7-48.4% and 
53.57.9% of task completion (Figure 30). The LSC required approximately twice as much 
muscular activation as the HSC, requiring 3.92-6.56%MVC more activation (Figure 30). 
PEC(C), PEC(S), (P)DEL and INFRA remained similar across the trial, where PEC(C) was 
below 10% MVC, and PEC(S), (P)DEL and INFRA were below 25% MVC (Figure 30). 
(M)DEL, SUPRA and LATS, although statistically similar, the LSC trended towards higher 
activation throughout the trial, and overall had increased variability with a larger range within 




Figure 29: Average affected limb thoracohumeral plane of elevation (left), elevation (middle) and axial rotation (right) angles for the 
HSC (black) and LSC (red) during the bra fasten task. Each angle is time normalized to % of task. One standard deviation for each 
group is represented by the shaded area in each corresponding colour. Associated SPM z-scores are reported below, with critical z-
scores denoted by horizontal solid black lines. Z-scores that exceed the critical value represent significant differences between groups, 




Figure 30: Average affected limb sEMG for the eight muscles recorded for the HSC (black) and LSC (red) during the bra fasten task. 
Muscular activation is time normalized to % of task. One standard deviation for each group is represented by the shaded area in each 
corresponding colour. Associated SPM z-scores are reported below, with critical z-scores denoted by horizontal solid black lines. Z-
scores that exceed the critical value represent significant differences between groups, and are marked with an * (p<0.05).
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4.6.8 Put on a Necklace  
 Plane of elevation, elevation angle and axial rotation were similar for the HSC and LSC 
while putting on a necklace (Figure 31). During this task, plane of elevation and axial rotation 
were stable for both clusters, remaining within 65-75°, and 50-60°, respectively (Figure 31). 
Elevation angle began near 20°, and reached approximately 90° on average (Figure 31). The 
HSC had a higher variability, within one SD reaching 120° of elevation (Figure 31).  
 All muscular activations were statistically similar across this task, except PEC(C) (Figure 
32). PEC(C) differed between the two clusters from 59.8-60.5% and 65.6-68.3% of task 
completion (Figure 32). During these times the LSC required approximately twice as much 
activation at 9.76-11.43% MVC compared to 5.04-5.89% MVC in the HSC (Figure 32). PEC(S), 
(P)DEL, INFRA, SUPRA, and LATS were all below 15%MVC for both the HSC and LSC while 
clasping a necklace (Figure 32). (A)DEL and (M)DEL although statistically similar between the 
two clusters, the LSC trended towards higher muscular activation, and had increased variability 
across the trial (Figure 32). These muscles, on average, remained below 30 and 20%MVC, 




Figure 31: Average affected limb thoracohumeral plane of elevation (left), elevation (middle) and axial rotation (right) angles for the 
HSC (black) and LSC (red) during the put on a necklace task. Each angle is time normalized to % of task. One standard deviation for 
each group is represented by the shaded area in each corresponding colour. Associated SPM z-scores are reported below, with critical 
z-scores denoted by horizontal solid black lines . Z-scores that exceed the critical value represent significant differences between 




Figure 32: Average affected limb sEMG for the eight muscles recorded for the HSC (black) and LSC (red) during the put on a 
necklace task. Muscular activation is time normalized to % of task. One standard deviation for each group is represented by the shaded 
area in each corresponding colour. Associated SPM z-scores are reported below, with critical z-scores denoted by horizontal solid 





Differences in kinematics, muscular activation, or both, existed for all eight activities of 
daily living. Four tasks (shelf reach, forward reach, pour from a pitcher and tray transfer) had 
group differences for at least one plane of motion, and all tasks had group differences in 
muscular activation for at least one muscle. These differences indicate that the performance of 
even low load ADL tasks are sensitive to treatment effects. 
4.7.1 Kinematics during daily tasks 
 The first hypothesis was that the higher functioning cohort (HSC in study 1) would use 
more range of elevation angle and plane of elevation (horizontal abduction) during activities of 
daily living (particularly with external weights- shelf reach, forward reach and the bag lift tasks). 
This hypothesis was partially accepted, as differences occurred for plane of elevation (pour from 
a pitcher and tray transfer) and elevation angle (forward reach, pour from a pitcher). 
Additionally, although no changes were hypothesized, differences emerged in axial rotation 
(shelf reach, pour from a pitcher and tray transfer). Generally, the HSC used a larger range of 
each of the angles. Differences in angles ranged from 6.5-16.1°, 7.5-11.4° and 10.0-15.9° for 
plane of elevation, elevation angle and axial rotation, respectively. Previous research with breast 
cancer survivors reported that breast cancer survivors use narrower ranges than that of a 
reference population (Brookham et al., 2018a). The HSC is likely more similar to a reference 
population with the larger ranges used during ADLs. Simulated tasks (bra fasten task in the 
current study) have increased variability compared to completing tasks with props, or specific 




 Focus is often placed on the ability for individuals to complete daily tasks, however all 
survivors in the current study were able to complete all 8 ADLs with differing kinematics. 
Previous research indicated that breast cancer survivors can complete ADLs, although there are 
likely some compensations that could lead to the pain felt in this population (Spinelli et al., 
2016). In reference populations overheard reach occurred at 72.6° of plane of elevation (closer to 
forward flexion than abduction), and needed a maximum of 121.4° of elevation, and 60.6° of 
axial rotation (Magermans, Chadwick, Veeger, & Van Der Helm, 2005). Breast cancer survivors 
in the current study completed the shelf reach at a similar plane of elevation (30-70°) and axial 
rotation (30-65°), but decreased elevation angle (20-80°), however the shelf reach was not quite 
overhead (the shelf was at acromion height).  During a 4kg bag lift, reference populations use 
63.6° of elevation, and 47.7° of axial rotation, and the task occurred at 79.2° plane of elevation 
(Magermans et al., 2005). The two clusters in the current study demonstrated similar plane of 
elevation (60-80°), and axial rotation (50-60°) but lower elevation (20-40°) than the 
aforementioned reference population. Pouring from a pitcher required on average 8.22-27.2° of 
abduction, -12.32-23.38° of axial rotation, and occurred from 1.52-35.92° of plane of elevation 
in a reference population (Doğan, Koçak, Onursal, Ayvat, & Sütçü, 2019).  Breast cancer 
survivors differed in the current study while pouring from a pitcher, where HSC used a larger 
range in each of the three motions. Overall, the ranges were 30-70° of plane of elevation, 20-55° 
of elevation, and 40-70° of axial rotation. These ranges were similar in the current study (~30° of 
each motion), however these ranges were more indicative of the HSC than the LSC (as their 
ranges were smaller), and plane of elevation angle was closer to forward flexion in the current 
study, whereas the reference population was closer to abduction. Further, to complete the task 
the elevation angle and axial rotation were greater than the reference population. Reaching to a 
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back pocket occurred from -37.85-21.52° plane of elevation (where a negative number refers to 
extension), -21.77-20.97° of axial rotation, and 9.28-22.7° of abduction in a reference population 
(Doğan et al., 2019). Breast cancer survivors in the current study used 55-75° plane of elevation, 
30-60° elevation, and 50-60° of axial rotation. Elevation angle was greater in the current study, 
compared to the reference population, likely to compensate for the reduction in both axial 
rotation and plane of elevation. 
 The current study identified kinematic differences in ADLs between the two clusters of 
breast cancer survivors, and further that these kinematics also differed from a reference 
population. Generally tasks were completed similarly; however, the postures were more 
internally rotated, with lower plane of elevation (horizontal abduction) and with increased 
elevation, compared to reference populations (Doğan et al., 2019; Magermans et al., 2005). The 
kinematics of these tasks are also important in return-to-work scenarios. Nearly half of women 
who receive treatment for breast cancer, regardless of age, reduce their working time, or retire 
from working early (Schmidt, Scherer, Wiskemann, & Steindorf, 2019). Individuals who have 
pain or difficulties raising objects overhead, or lifting objects of 5kg or heavier often are unable 
to return to work, or must return in a limited capacity (de Souza Cunha et al., 2020). Although 
breast cancer survivors are able to complete the tasks, in the long term the differences while 
completing these tasks may provoke long term complications. In functional return to work tasks, 
breast cancer survivors exhibited similar movement patterns to individuals who develop rotator 
cuff disorder (Lang et al., 2019), which is further supported in the current study. The individuals 
in that study, similarly to the current study, used smaller ranges of motion. Lang et al. showed 
decreases in internal rotation, whereas the current study showed decreases in overall range of 
axial rotation in several tasks. The author suggested this may be a compensation to avoid 
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impinging the supraspinatus tendon, and avoid potential impingement pain (Brossmann et al., 
1996; Lang et al., 2019). Additionally, rotator cuff disorders may be perpetuated by the decreases 
in elevation angles and plane of elevation (Ebaugh et al., 2011; Lang et al., 2019). Participants 
may exhibit these movement patterns to avoid pain, or due to tightness or weakness experienced 
after treatment. Therefore, it is important to continue to investigate a wider range of daily tasks 
(and return to work tasks), as even minimal differences to compensate for restriction can lead to 
disorders causing long term pain. 
4.7.2 Muscular Activation during daily tasks 
 The second hypothesis was that muscular activation will differ between the groups of 
breast cancer survivors. Specifically, that lower functioning breast cancer survivors (LSC in 
study 1) would activate muscles that may be damaged by radiation more (Lipps et al., 2017), and 
activate the other muscles more to compensate. Similar to hypothesis 1, this was partially 
accepted, as differences existed in a subset of tasks. In muscles that are likely to be damaged due 
to radiation (pectoralis major (clavicular and sternal insertions) and latissimus dorsi) there were 
some statistical differences between the HSC and LSC clusters during the shelf reach, forward 
reach, bag lift, pitcher pour, and tray transfer tasks. All of these tasks had external weights 
ranging from 1-5kg. Differences between the clusters for PEC(S) ranged from 3.35-6.16%MVC 
during the pour from a pitcher and shelf reach tasks. Similarly, the LSC used 4.96-5.55%MVC 
more activation than the HSC while putting on a necklace and shelf reach tasks. Finally, LATS 
were 2.52-9.85% MVC more activated in the LSC compared to the HSC during the forward and 
shelf reach, tray transfer, bag lift and pour from a pitcher tasks. However, this hypothesis was 
rooted in the thought that the LSC would have a higher percentage of participants receiving 
radiation. This was not the case as 13/16 participants in the HSC received radiation and 16/16 in 
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the LSC. In the current study, activation of pectoralis major (both insertions) and latissimus dorsi 
remained between 5-25% MVC for both the HSC and LSC in ADL tasks. As these tasks were 
low load, daily activities this range is expected. However, previously reports indicated that in 
low load functional and work tasks pectoralis major decreased activation compared to the 
unaffected side (Brookham et al., 2018b; Shamley et al., 2007). This decrease in activation was 
also accompanied by a decrease in size in at least 15.7% of individuals (Gyedu, Kepenekci, Alic, 
& Akyar, 2009; Shamley et al., 2007). It is possible that the decrease in muscle size alters 
function, and may contribute to the decrease in activation. The current study did not compare to a 
reference (either population or unaffected limb), but the overall low activation of pectoralis 
major and latissimus dorsi during these tasks aligns with prior literature. Further research should 
explore whether a decrease in muscle size beyond the affected pectoralis major exists, and 
whether those who experience decrease in muscle size experience increased activation during 
tasks to complete even low load daily tasks, such as seen in the LSC during these ADLs.  
 The partially accepted portion of hypothesis two was infraspinatus, supraspinatus, 
anterior deltoid, middle deltoid, and posterior deltoid would have increased activation in the 
lower functioning cohort (determined to be LSC in study 1) to potentially compensate for the 
less effective damaged pectoralis major and latissimus dorsi. The anterior deltoid required 1.89-
11.99%MVC more activation of the LSC, compared to the HSC in all tasks except the tray 
transfer and put on a necklace tasks. Infraspinatus was also affected in more than half of the 
trials, requiring 1.64-8.69%MVC more activation from the LSC in all tasks except the bra fasten, 
shelf reach and necklace clasp tasks. Modest differences occurred in the supraspinatus, middle 
and posterior deltoid muscles, with the LSC group requiring 0.89-7.29%MVC more activation 
than the HSC. These differences occurred in the forward reach and pour from a pitcher tasks (as 
117 
 
well as the bag lift task for the supraspinatus). Total muscle effort increased by 5.1% on the 
affected side of breast cancer survivors during functional work tasks (Brookham et al., 2018b) in 
an earlier investigation. In functional and daily tasks higher activation of muscles on the affected 
side outside the radiation field occurred compared to the unaffected side (Brookham et al., 
2018b; Hagstrom et al., 2019) and compared to a non-cancer reference population (Brookham & 
Dickerson, 2016; Galiano-Castillo et al., 2011; Shamley et al., 2012). This higher muscular 
activation is accompanied with pain for many survivors (Galiano-Castillo et al., 2011). Lower 
activation of the irradiated muscles is likely due to a diminished capacity of the muscles due to 
treatment, caused by both radiation and chemotherapy (Klassen et al., 2017; Lipps et al., 2017). 
The diminished capacity is evident by the decrease in strength in this population (Brookham et 
al., 2018b; Ebaugh et al., 2011; Maciukiewicz et al., n.d.; Perez et al., 2018). With a 10% 
increase in activation, survivors further from treatment exhibited between 19-42% lower force 
production (Maciukiewicz et al., n.d.). These factors all combine to cause identical tasks to 
require more effort from survivor populations, whether it be a low load functional work or daily 
task, or a full-strength exertion. In study 1, the LSC had lower strength, and in the current study, 
the LSC muscles were consistently more activated than the HSC muscles across all ADLs. This 
supports the concept that after treatment, diminished capacity may exist for some individuals, 
making even low load functional tasks more challenging and increases the possibility to induce 
fatigue through task performance.  
4.8 Limitations  
 Limitations from study 1 also influence the results of the current study. Additionally, 
only one MVC trial was completed for each muscle, to mitigate pain or fatigue that is evident in 
this population. Pain is an important consideration in this population. It is feasible that pain may 
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interfere with participants reaching their true maximum during MVCs. Although there is 
potential that it wasn’t a true maximum, it is that individual’s maximum in their current state – 
and is important to consider. Likely, pain led to the greater variability in the LSC sEMG 
measures. Two repetitions of each ADL tasks were completed, to minimize variability often five 
or more repetitions are recommended, as well as using tools whenever possible (Taylor et al., 
2018). This was generally infeasible given the weakness in the participant population. Additional 
muscles around the shoulder may compensate during these tasks, but were unmonitored. 
Compensation may have been manifested as trunk or neck motions, but were also not 
investigated. Finally, differences were modest, especially in muscular activation. It is difficult to 
determine what the minimum clinically important difference is without specific criteria for each 
scenario (Copay, Subach, Glassman, Polly, & Schuler, 2007). However, tasks that elicit 
activation below 20% MVC are thought to be ideal in early rehabilitation of shoulder related 
function following injury or surgery (Uhl, Muir, & Lawson, 2010). As the ADL tasks studied 
generally remained below this threshold, small changes in activation in these tasks are likely 
more impactful, compared to small changes tasks with higher demands. Time to complete each 
task and cumulative load were not considered in the current investigation, but could also 
contribute greatly to the demands in these individuals.  
4.9 Conclusion   
 Activities of daily living are an important element of survivorship. Although most breast 
cancer survivors can complete these low load daily, functional or work tasks, the manner of 
completion was relatively unknown. The current study investigated 8 daily living tasks, and how 
performance of these tasks differed between two groups of breast cancer survivors. During the, 
upwards reach to a shelf, forward reach, pour from a pitcher and tray transfer tasks breast cancer 
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survivors with lower shoulder-related quality of life and less strength (LSC) used lower ranges of 
angles. In all tasks, at least one muscle displayed significantly increased activation of this same 
group of survivors. These differences ranged from 6.5-16.1° and 0.89-12% MVC. The 
differences between these groups may be due to diminished capacity of the muscles leading to 
increased muscular activation. This, combined with changes in kinematics may predispose these 
individuals for increased injuries, including rotator cuff disorders. This work can be useful in 
determining tasks that may be troublesome for some individuals. Expanding this work to include 
work tasks may assist in appropriate return to work strategies. More importantly, knowing these 
differing strategies exist, physiotherapists may work to correct movement patterns for individuals 
to avoid potential injury.    
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Chapter V – Adaptation of strength production in breast cancer 
survivors: a simulation analysis 
5.1. Introduction 
 Often, physical training protocols are introduced in breast cancer survivors to increase 
shoulder range of motion or overall strength as a means to decrease dysfunction. Training 
programs vary in the types of exercises, the intensity, outcome measures, duration and the timing 
of the start of the program, and the participants who partake (De Groef et al., 2015; McNeely et 
al., 2010; Ribeiro, Moreira, et al., 2019). Commonly, resistance training programs succeed in 
regaining some strength and range of motion in survivors, but often impairments in daily life 
persist. Tissues recover from treatments (specifically chemotherapy and radiation) differently 
and therefore likely respond to these exercise programs differently following disparate damage 
from treatment. It is often infeasible (or untimely) to find a large population of survivors with 
similar deficits who received the same adjuvant therapy to test the efficacy of resistance training 
on those specific deficits due to that form of treatment.   
As previously stated, models are often used to provide insight into problems that are 
difficult or inaccessible with experimental data, such as modelling clinical populations. Clinical 
populations pose a particularly difficult problem as it is often challenging to recruit a substantial 
number of participants to investigate the many questions researchers pose. Although there is over 
22, 000 patients joining the breast cancer survivor population in Canada every year, additional 
barriers may deter them from participating in intervention studies, such as reduced immunity 
from treatment, or the time commitment after already taking time off work for treatment 
(Brenner et al., 2020; Canadian Cancer Society, 2020; Courneya et al., 2016; Markes et al., 
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2006). On the other hand, models are often based on reference populations (although if cadaver 
measurements are used these are often from older adults) (Dickerson et al., 2007; Veeger, Yu, 
An, & Rozendal, 1997). However, adjustments can be made to existing models to account for 
challenges clinical populations face, such as altered kinematics or compensation via differing 
muscular activation (Brookham & Dickerson, 2014; Chopp-Hurley et al., 2016; Lang, Kim, 
Milosavljevic, & Dickerson, 2020). Often a combination of both techniques can help enlighten 
researchers to underlying issues in these populations.  
Two areas that have used biomechanical models to explore clinical populations are 
individuals with rotator cuff pathologies and manual wheelchair users. Models were first adapted 
to the specific population, and then used to investigate research questions (Bolsterlee, Veeger, & 
Chadwick, 2013). Saul et al (2011) used a previously published model to investigate rotator cuff 
pathologies. Postures during rotator cuff surgery can dictate post-operative success, where more 
abducted postures helped during surgery, to ensure closure of larger gaps, but may not lead to 
post-operative success  (Saul, Hayon, Smith, Tuohy, & Mannava, 2011). Dubowsky et al (2008) 
worked with an existing model to create patient specific musculoskeletal wheelchair models. By 
altering the existing model for specific patients, the model was able to better predict 
experimental derived muscle forces (and reducing the error between the model driven results and 
experimental), with a future goal of prescribing the appropriate wheelchair choice (and 
particularly axle placement) to reduce joint forces for manual wheelchair users (Dubowsky, 
Rasmussen, Sisto, & Langrana, 2008). 
 Pectoralis major is often affected by treatment in breast cancer survivors, and therefore 
modifications to its typical capabilities have been modelled in several scenarios. Stegink-Jansen 
et al. (2011) modelled 3 portions of the pectoralis major and the mechanical strain in each 
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portion during a series of exercises aimed to target breast cancer survivor rehabilitation. Single-
axis motions, and motions overhead did not uniformly lengthen all 3 portions of the muscles 
(Stegink-Jansen, Buford, Patterson, & Gould, 2011). Targeting combined movements, 
specifically with extension and external rotation were deemed ideal lengthening exercises for 
pectoralis major, and when tolerated adding abduction should provide the greatest benefits. 
However, it is possible that the muscle may not produce full force and that the tissues may not 
fully recover. Chopp-Hurley et al (2016) modified the previously described SLAM model 
(Dickerson et al., 2007) to investigate the influence of reduced pectoralis major capability on 
muscular strategies for internal and external rotation tasks. By including a pectoralis-specific 
capability constraint, the dysfunction in pectoralis major reflected the population more accurately 
(Chopp-Hurley et al., 2016). Force capability was modelled for 0% (total disability), 25%, 50%, 
75% (partial capabilities) and 100% capability. Muscle force was underestimated compared to 
measured muscle activations during submaximal efforts, however when co-activation and 25% 
pectoralis major capabilities were enforced, these differences were lower than other models of 
levels of pectoralis capability, indicating this population is likely working with a reduced 
capability in at least the pectoralis major (Chopp-Hurley et al., 2016). Additional muscles 
surrounding the shoulder are also commonly affected by treatment, both directly (radiation) or 
indirectly (chemotherapy) and the effects of exercise on these compromised muscles in terms of 
overall function, such as regained strength, should be considered. Simulating the effects of 
surrogate “training” scenarios on specific muscles or muscle groups may provide further 




5.2 Objectives and Hypotheses  
The objectives of study 3 are to: 
1. Alter the muscle capacities within an existing model to replicate the strength outputs of 
the breast cancer survivor population (at a corporate level) 
2. Determine maximum recoverable force outputs from survivors given various scenarios 
for regained muscle function potential (radiation damage, chemotherapy damage, 
combination treatment) and across two maximal isometric strength positions (adduction 
and internal rotation). 
3. Determine the internal muscle forces associated with generating each maximal force 
output (baseline force and maximum recoverable force) and compare these to a non-
cancer reference group with an in-silico approach  
The hypotheses for this study are as follows:  
1. The maximum recoverable force will be less than a reference population for each of the 
fundamental strength measures (adduction and internal rotation) in most scenarios. 
Specifically: 
a. The combined treatment scenario will have the lowest recoverable force output.   
b. Radiation and chemotherapy scenarios will recover similar levels of force, but 
will be less than the scenario with no restrictions 
2. Muscle forces will differ between scenarios across conditions. 
a. The radiation scenario will yield decreased muscle force from internal rotators 
and antagonist muscles to this action, without the contribution of pectoralis major 
and latissimus dorsi  
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i. Although muscle activation may increase in tasks (Brookham & 
Dickerson, 2016; Galiano-Castillo et al., 2011; Shamley et al., 2012), the 
ability to produce force will decrease with reduced capacity (compared to 
reference) 
b. The chemotherapy scenario will result in overall decreases in muscle force to 
achieve maximal force out of these simulations  
5.3 Methods  
5.3.1 Inputs   
The SLAM model was used in this study and required input of both subject and task data. 
Average anthropometrics (body weight and height) for the LSC group of survivors were inputted 
into the SLAM model (Table 20). Due to COVID-19 an age and sex matched non-cancer 
reference groups was not assessed. Previously collected data (Lulic, 2020) was used as a 
surrogate. Participants in this study were young women (Table 20), and multiple maximal force 
trials were completed. Maximal force trials collected in the same position as the current study 
were used for this thesis and filtered as in section 3.4.3 (page 51). Peak force (N) from those 
trials were used as non-cancer reference force (Table 21). Peak force from the LSC (detailed in 
Study 1) was used as the breast cancer survivor force (Table 20).  
The final SLAM input was kinematic (postural) data. A static trial was taken in each of 
the humeral postures for isometric strength trials completed during the experimental collection 
(adduction and internal rotation) (Table 5, page 47). The joint locations from this representative 




Table 20: Population demographics and peak force as inputs for SLAM model  
 Non-Cancer 
Reference Population 
Breast Cancer Survivor 
LSC Group 
Age (years) 22.4 ± 2.3 56.73 ± 9.00 
Height (cm) 164.4 ± 7.7 164.77 ± 6.12 
Weight (kg) 62 ± 4.6 75.88 ± 14.40 
Adduction Force (N) 212.22 ± 55.35 118.89 ± 31.19 
Internal Rotation 
Force (N) 
171.2 ± 44.15 76.62 ± 40.59 
5.3.2 Alterations of the SLAM model 
The first alteration of the model was adjusting the location of force production. 
Historically, the model accepted three-dimensional forces at the grip surface of the hand. For the 
internal rotation trial, this was true and remained unaltered. Adduction forces were exerted above 
the elbow with the cuff, and therefore the model was altered to add the force at this location.  
Several other alterations to the SLAM model preceded simulations in the current study. 
To begin, the average peak force of the reference group was input into SLAM, with no 
alterations. The model was unable to converge on an optimized solution. The SLAM model was 
developed with the use of PSCA from 3 cadavers (ranged from 55-71 years old), a correction 
factor was placed on these values in the original development of the model, however this was 
still insufficient to produce the force of a younger, reference population. To correct for this, the 
correction factor was increased from 2 to 3, where the model was able to sufficiently produce the 
force exerted by the reference population in the current study. The average force of the non-




Figure 33: Flowchart outlining study 3. Force inputs to the model are dictated by strength trials 
collected in the experimental protocol, whereas the cohort of survivors modelled is determined in 
study 2.  
The SLAM model was then altered to produce the force levels of the LSC group of breast 
cancer survivors (Table 20). Capacity of each muscular element was altered, similarly to 
(Chopp-Hurley et al., 2016) until the maximum force output from the model (without failing) 
matched that of the average LSC group breast cancer survivor peak force output collected during 
isometric strength trials in study 1 (Figure 33). A failure was determined when the model was 
unable to successfully converge on an optimal solution that minimized cubed muscle stress while 
satisfying the constraint equations. The capacity of all muscles were altered using equation (6), 
where Fm is the force output from a given muscle, PCSAm is the cross-sectional area from each 
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individual muscle, T is the muscle specific tension (87.9 N/cm2), and C is the capability of the 
muscle (0, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9 and 1.0).  
Fm=PCSAm*T*C               [Eq. (6)] 
The capability of all muscles were altered together, as a simplification of the overall 
capacity for breast cancer survivors. Altering muscles individually was considered, but many 
combinations of muscle capacity could lead to the decreased force in the LSC group of breast 
cancer survivors, and uncertainty would persist for any selected strategy. Therefore, it was 
decided to decrease the capacity as a whole, to mimic atrophy and a ‘worst case scenario’.  
After each alteration, simulations were run to determine whether the modifications 
matched the breast cancer survivor group (until the maximum force capable equalled that of the 
breast cancer survivor group). To ensure no over, or under correction was completed when the 
model failed, the capability was increased by 0.01 until the model converged on an optimal result 
for the given force. When this was achieved, these modifications became the baseline for a 
compromised system (Figure 33, Table 22). This was completed for both isometric strength trial 
posture. 
5.3.3 Scenario Simulations  
Following the acceptance of altered muscle capacity, various training scenarios were used 
to determine the maximum force output that could be achieved through retraining certain muscle 
groups to a priori defined states of capability. Each scenario is outlined in Table 21. The 
capability of all muscles were altered to the maximum that could be trained based on each given 
scenario. All muscles were ‘fully trained’ based on each scenario, and the final capabilities were 
established (Table 22). Maximal force output for each scenario was determined at the maximum 
capabilities for each muscle, for each scenario. Force was input starting at the LSC breast cancer 
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survivor level, and increased by 10% for each iteration until the model was unable to produce 
force at the given level with the current muscle capacities modelled. It was proposed that if the 
configuration was able to produce the force of the reference population, the minimum 
capabilities to produce that force would be determined. However, in all scenarios, the muscles 
trained maximally were unable to reach the reference population force. Each scenario was 
completed for both of the aforementioned isometric strength trials ((reference population + 
baseline +3 scenarios) X 2 strength trials = 10 total).  
Table 21: Training scenarios used to govern increases in force capabilities (each treatment 






• All muscles are able to be trained, however muscles can only regain 
25% of reference capability from the reduced level to represent the 
inability for PCSA to increase similarly to normal muscle after 
damage from chemotherapy (Christensen et al., 2014)  
Scenario B 
“Radiation” 
• All muscles damaged by radiation are unable to be trained-
pectoralis major, pectoralis minor, teres major, latissimus dorsi 
(Lipps et al., 2017) 
Scenario C 
“Combination” 
• All muscles damaged by radiation (pectoralis major, pectoralis 
minor, teres major, and latissimus dorsi) are unable to be trained 













Table 22: Capacity of all muscles through each training scenario  
Muscle Elements Adduction Internal Rotation 












Latissimus Dorsi Upper 1 0.53 0.78 0.53 0.53 0.41 0.66 0.41 0.41 
Latissimus Dorsi Lower 2     0.53 0.78 0.53 0.53 0.41 0.66 0.41 0.41 
Levator Scapulae 3 0.53 0.78 1 0.78 0.41 0.66 1 0.66 
Omohypoid 4 0.53 0.78 1 0.78 0.41 0.66 1 0.66 
Pectoralis Major Sternal 5 0.53 0.78 0.53 0.53 0.41 0.66 0.41 0.41 
Pectoralis Major Clavicular 
6 
0.53 0.78 0.53 0.53 0.41 0.66 0.41 0.41 
Pectoralis Minor 7 0.53 0.78 0.53 0.53 0.41 0.66 0.41 0.41 
Rhomboid Major 8 0.53 0.78 1 0.78 0.41 0.66 1 0.66 
Rhomboid Minor 9 0.53 0.78 1 0.78 0.41 0.66 1 0.66 
Serratus Anterior Upper 10 0.53 0.78 1 0.78 0.41 0.66 1 0.66 
Serratus Anterior Middle 
11 
0.53 0.78 1 0.78 0.41 0.66 1 0.66 
Serratus Anterior Lower 12 0.53 0.78 1 0.78 0.41 0.66 1 0.66 
Sternocleidomastoid 13 0.53 0.78 1 0.78 0.41 0.66 1 0.66 
Sternohyoid 14 0.53 0.78 1 0.78 0.41 0.66 1 0.66 
Subclavius 15 0.53 0.78 1 0.78 0.41 0.66 1 0.66 
Trapezius Middle 16 0.53 0.78 1 0.78 0.41 0.66 1 0.66 
Trapezius Lower 17 0.53 0.78 1 0.78 0.41 0.66 1 0.66 
Trapezius Upper 18 0.53 0.78 1 0.78 0.41 0.66 1 0.66 
Trapezius Clavicular 19 0.53 0.78 1 0.78 0.41 0.66 1 0.66 
Deltoid Middle 20 0.53 0.78 1 0.78 0.41 0.66 1 0.66 
Deltoid Posterior 21 0.53 0.78 1 0.78 0.41 0.66 1 0.66 
Deltoid Anterior 22 0.53 0.78 1 0.78 0.41 0.66 1 0.66 
Coracobrachialis 23 0.53 0.78 1 0.78 0.41 0.66 1 0.66 
Infraspinatus Upper 24 0.53 0.78 1 0.78 0.41 0.66 1 0.66 
Infraspinatus Lower 25 0.53 0.78 1 0.78 0.41 0.66 1 0.66 
Subscapularis Upper 26 0.53 0.78 1 0.78 0.41 0.66 1 0.66 
Subscapularis Middle 27 0.53 0.78 1 0.78 0.41 0.66 1 0.66 
Subscapularis Lower 28 0.53 0.78 1 0.78 0.41 0.66 1 0.66 
Supraspinatus 29 0.53 0.78 1 0.78 0.41 0.66 1 0.66 
Teres Major 30 0.53 0.78 0.53 0.53 0.41 0.66 0.41 0.41 
Teres Minor 31 0.53 0.78 1 0.78 0.41 0.66 1 0.66 
Biceps Long 32 0.53 0.78 1 0.78 0.41 0.66 1 0.66 
Biceps Short 33 0.53 0.78 1 0.78 0.41 0.66 1 0.66 
Triceps Long 34 0.53 0.78 1 0.78 0.41 0.66 1 0.66 
Triceps Medial 35 0.53 0.78 1 0.78 0.41 0.66 1 0.66 
Triceps Lateral 36 0.53 0.78 1 0.78 0.41 0.66 1 0.66 
Brachialis 37 0.53 0.78 1 0.78 0.41 0.66 1 0.66 
Brachioradialis 38             0.53 0.78 1 0.78 0.41 0.66 1 0.66 
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5.4 Data Analysis   
 A total of 10 training scenarios were simulated (3 training scenarios (and baseline and 
reference) by 2 isometric strength trials). Maximum force is reported for each scenario. 
Additionally, resultant shoulder torque was extracted for each scenario. In addition, percentage 
of maximal force (%MVF) was extracted for each muscle element at the baseline and maximal 
force output for each training scenario.  The muscle elements are as follows: levator scapulae (1), 
omohyoid (1), pectoralis minor (1), rhomboid major (1), rhomboid minor (1), 
sternocleidomastoid (1), sternohyoid (1), subclavius (1), coacobrachialis (1), supraspinatus (1), 
teres major (1), teres minor (1), brachialis (1), brachioradialis (1), latissimus dorsi (2), serratus 
anterior (3), trapezius (4), subscapularis (3), infraspinatus (2), pectoralis major (2), deltoid (3), 
biceps (2), and the triceps (3). %MVF is expressed as a percent of the reference population 
capability to allow comparisons between scenarios.  
 To examine the agreement of the model with EMG data, the results were compared to 
empirically measures EMG measures of the LSC breast cancer survivor group. For this 
comparison %MVF was also exported as a percent of the given scenario’s maximal capacity for 
the 8 muscle elements in which %MVC can be reported. These muscles are the pectoralis major 
(sternal and clavicular insertions), latissimus dorsi (lower), deltoid (anterior, middle, posterior), 
infraspinatus (lower), and supraspinatus. sEMG was filtered and analyzed as in section 4.4.2 
sEMG Processing (page 85). Unlike Study 2, peak sEMG was extracted from strength trials for 
comparison. The differences between the maximum for each scenario were calculated and 
reported (Chopp-Hurley et al., 2016; Lang et al., 2020). 
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5.5 Statistical Analysis    
 Descriptive outputs were created for all scenarios. Forty variables were thus extracted for 
10 simulations run (2 known force levels (baseline and reference) and 3 training scenarios 
(radiation damage, chemotherapy damage, combination treatment damage) for 2 isometric 
strength trials (adduction and internal rotation).  The 40 variables that are reported are peak 
force, peak shoulder torque, and %MVF (as a percentage of reference force capacity) for each 
muscle element (latissimus dorsi (2), serratus anterior (3), trapezius (4), subscapularis (3), 
infraspinatus (2), pectoralis major (2), deltoid (3), biceps (2), triceps (3), levator scapulae, 
omohyoid, pectoralis minor, rhomboid major, rhomboid minor, sternocleidomastoid, 
sternohyoid, subclavius, coacobrachialis, supraspinatus, teres major, teres minor, brachialis, 
brachioradialis). Each variable is reported within strength trials, to allow for visual comparison 
across the scenarios.  
Additionally, %MVF, expressed as a percent of reduced capacity, was exported for all 10 
simulations for comparison to experimentally derived %MVC for the LSC group of breast cancer 
survivors. Only 8 muscle elements were compared, as those were the only muscles 
experimentally collected (latissimus dorsi, pectoralis major (sternal and clavicular), deltoid 
(anterior, middle and posterior), infraspinatus and supraspinatus).  
5.6 Results 
 The two force exertions investigated were adduction and internal rotation. Maximal force 
outputs for each scenario (reference population, LSC breast cancer survivor, chemotherapy 
simulation, radiation simulation, and combination of chemotherapy and radiation simulation) as 
well as percentage of full capacity muscle force are reported for both force directions. A 




Figure 34: Isometric positions for adduction (left) and internal rotation (right). These model 
outputs are representative simulations, but the posture remained across all scenarios. 
5.6.1 Adduction 
 With full training of all available muscles, the LSC group of breast cancer survivors were 
unable to reach the full force output of the non-cancer reference population (Table 23, Figure 
35). To begin, the LSC had 55.6% of the maximal force producible of the reference group 
(Figure 35). The maximal force producible for the chemotherapy and radiation simulations were 
77.9 and 80.1% of the reference group (Figure 35). Finally, the maximal recoverable force for 
the combination simulation was 69.5% of the reference population (Figure 35). As determined in 
Study 1, the HSC produced an average of 201.45N, in contrast to the 212.22N of the reference 
population (Table 16, page 64). Similarly, the LSC group had shoulder moment values that were 
52.5% of the reference population (Table 23, Figure 35). The three scenarios fell between with 
chemotherapy and radiation groups 75.1 and 78% of the reference population (Figure 35). The 
combination treatment scenario had the lowest shoulder moment of the scenarios, at 19.94Nm, or 




Figure 35: Peak force (input) (N) and peak moment (Nm) during each of the 5 adduction 
simulations run: baseline (LSC from Study 1), reference (non-cancer reference population), and 
the 3 scenarios (chemotherapy, radiation and the combination of both chemotherapy and 
radiation) 
 The muscles with the biggest differences were scapular stabilizers, adductors and some 
antagonist abductors (Table 23, Figure 36). Generally, a lower percentage of maximal force 
production was used in scenario simulations compared to the reference population simulation. 
%MVF is representative of a full capacity muscle (normalized to reference population capacity 
for comparison), and therefore these values are necessarily below that of the reference 
population, as the input force is less and the capacity of the muscle is decreased. The LSC group 
estimated 10.9-47.1% MVF less than the reference group for the latissimus dorsi (upper and 
lower), levator scapulae, omohyoid, rhomboid (major and minor), trapezius (upper), deltoid 
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(middle), subscapularis (lower), teres major, biceps (long) and triceps (long) (Table 23, Figure 
36). The chemotherapy simulation predicted 16.9-25.6% MVF less than the reference group for 
the latissimus dorsi (upper and lower), levator scapulae, omohyoid, rhomboid (major and minor), 
trapezius (upper), deltoid (middle), subscapularis (lower), biceps (long) and triceps (long (Table 
23, Figure 36)). The radiation simulation estimated 16.96-70.64% MVF more for the pectoralis 
minor, sternocleidomastoid, trapezius (middle), teres major and biceps (short), compared to the 
reference simulation (Table 23, Figure 36). Additionally, this simulation predicted 17.8-45.9% 
MVF less of the latissimus dorsi (upper and lower), deltoid (middle), subscapularis (lower), and 
biceps (long), compared to the reference group (Table 23, Figure 36). Finally, the combination 
simulation estimated 16.7-48.6% MVF more for the pectoralis minor, sternocleidomastoid, 
trapezius (middle), and biceps (short) compared to the reference (Table 23, Figure 36). This 
simulation also estimated 19.9-45.9%MVF less compared to the reference for the latissimus 
dorsi (upper and lower), levator scapulae, rhomboid (major and minor), trapezius (upper), deltoid 




Figure 36: Predictions of each muscular elements with %MVF that differed during each of the 5 adduction simulations run (baseline 
(LSC from Study 1), reference (non-cancer reference population), and the 3 scenarios (chemotherapy, radiation and the combination 
of both chemotherapy and radiation). %MVF represents percentage of maximal force of the capacity of muscles in the reference trials. 
136 
 
Table 23: Model outputs for peak force and muscle elements (%MVF is percentage of each 
muscles full capacity as dictated by reference population) for adduction scenarios 
 Baseline 
(LSC) 






Peak force (input) (N) 118.02 212.22 165.22 171.12 147.52 
Peak shoulder moment (Nm) 15.67 30.01 22.54 23.41 19.94 
Latissimus Dorsi Upper (%MVF) 51.63 98.73 73.94 53.00 53.00 
Latissimus Dorsi Lower (%MVF) 52.56 98.92 73.87 53.00 53.00 
Levator Scapulae (%MVF) 53.00 99.82 77.91 99.23 77.52 
Omohypoid (%MVF) 39.53 70.18 46.35 82.84 68.59 
Pectoralis Major Sternal (%MVF) 7.76 15.48 11.08 6.69 6.12 
Pectoralis Major Clavicular (%MVF) 0.00 0.00 0.00 0.00 0.00 
Pectoralis Minor (%MVF) 0.00 0.00 0.00 51.83 43.30 
Rhomboid Major (%MVF) 53.00 100.00 78.00 99.43 77.87 
Rhomboid Minor (%MVF) 53.00 100.00 78.00 99.19 77.61 
Serratus Anterior Upper (%MVF) 0.16 0.16 0.16 0.16 0.16 
Serratus Anterior Middle (%MVF) 0.16 0.16 0.16 0.16 0.16 
Serratus Anterior Lower (%MVF) 0.16 0.16 0.16 0.16 0.16 
Sternocleidomastoid (%MVF) 0.00 0.00 0.00 25.00 16.74 
Sternohyoid (%MVF) 0.00 0.00 0.00 2.58 2.10 
Subclavius (%MVF) 1.41 1.33 0.00 15.25 12.19 
Trapezius Middle (%MVF) 0.00 0.00 0.00 62.33 21.71 
Trapezius Lower (%MVF) 0.00 0.00 0.00 0.00 0.00 
Trapezius Upper (%MVF) 51.82 97.33 71.72 92.82 74.03 
Trapezius Clavicular (%MVF) 0.05 0.05 0.00 0.00 0.00 
Deltoid Middle (%MVF) 52.68 97.97 74.45 64.14 57.64 
Deltoid Posterior (%MVF) 0.46 0.00 0.00 0.00 0.00 
Deltoid Anterior (%MVF) 0.00 0.00 0.00 0.00 0.00 
Coracobrachialis (%MVF) 0.00 0.00 0.00 0.00 0.00 
Infraspinatus Upper (%MVF) 0.00 0.00 0.00 0.00 0.00 
Infraspinatus Lower (%MVF) 0.00 0.00 0.00 0.00 0.00 
Subscapularis Upper (%MVF) 0.00 0.00 0.00 0.00 0.00 
Subscapularis Middle (%MVF) 0.01 0.11 0.51 0.00 0.13 
Subscapularis Lower (%MVF) 47.16 85.86 66.06 68.09 58.74 
Supraspinatus (%MVF) 0.00 0.00 0.00 0.00 0.00 
Teres Major (%MVF) 11.00 21.91 17.43 38.87 26.76 
Teres Minor (%MVF) 0.00 0.00 0.00 0.00 0.00 
Biceps Long (%MVF) 34.45 65.55 46.23 42.43 27.42 
Biceps Short (%MVF) 1.23 2.91 8.79 73.68 51.53 
Triceps Long (%MVF) 36.76 69.64 52.69 64.08 49.78 
Triceps Medial (%MVF) 0.00 0.00 0.00 3.00 0.00 
Triceps Lateral (%MVF) 0.00 0.00 0.00 0.00 0.00 
Brachialis (%MVF) 0.00 0.00 0.00 0.00 0.00 




Muscle force production varied greatly from experimentally collected muscle activation. 
Pectoralis major (clavicular activation), infraspinatus, supraspinatus, and the anterior and 
posterior deltoid were not activated in the simulation (0% MVF) (Table 24). Pectoralis major 
(clavicular insertion) however, was largely activated in the experiment, averaging 45.3%MVC 
(Table 24). The supraspinatus and posterior deltoid were relatively inactive experimentally (less 
than 10%MVC) and therefore well represented in the simulation (Table 24). The infraspinatus 
and anterior deltoid were moderately active experimentally (16.6 and 15.9% MVC, respectively), 
and were therefore underestimated in the model (Table 24). The middle deltoid was the furthest 
from accurate with activation predicted at 56.3-91.6% MVF larger than that of the 7.8%MVC 
experimentally measured (Table 24). The latissimus dorsi was relied on heavily in the 
simulation, and overestimated the activation by 63.8-69.1% MVF compared to the 30.89%MVC 
of the LSC (Table 24). Of the muscles that were activated in the model (and experimentally 
monitored), the pectoralis major (sternal insertion) had the closest agreement. The model 
underestimated this muscle by 27.1-31.1%MVF (at 11.6-15.5% MVF) compared to the 
experimentally derived 42.6%MVC of the LSC group of breast cancer survivors (Table 24).  
Table 24: Comparison of muscle elements and experimental sEMG for each scenario during 
adduction strength simulations. %MVF in this table represents percent of reduced capacity 




















Latissimus Dorsi Lower  99.17 98.92 94.71 100.00 100.00 30.89 ± 10.92 19.65 ±14.07 
Pectoralis Major 
Sternal  
14.65 15.48 14.21 12.63 11.55 42.60 ± 13.02 35.84 ± 14.72 
Pectoralis Major 
Clavicular  
0.00 0.00 0.00 0.00 0.00 45.30 ± 8.89 37.25 ± 14.44 
Deltoid Middle  99.39 97.97 95.45 64.14 73.90 7.82 ± 4.91 6.65 ± 3.67 
Deltoid Posterior  0.87 0.00 0.00 0.00 0.00 6.97 ± 5.93 4.49 ± 2.27 
Deltoid Anterior  0.00 0.00 0.00 0.00 0.00 16.57 ± 5.93 14.48 ± 10.71 
Infraspinatus Lower  0.00 0.00 0.00 0.00 0.00 15.87 ± 9.02 13.05 ± 6.45 
Supraspinatus  0.00 0.00 0.00 0.00 0.00 8.73 ± 6.55 6.54 ± 4.46 
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5.6.2 Internal Rotation  
 In all training scenarios, the LSC group of breast cancer survivors did not reach the full 
force output of the non-cancer reference population (Table 25, Figure 37). The LSC produced 
44.5% of the force of reference group, and 40.2% of the shoulder torque, at 76.14N of force, and 
26.04Nm of torque (Table 25, Figure 37). As a comparison, the HSC produced 130.01N of 
internal rotation force (Table 16, page 67). When all muscles were fully trained, the 
chemotherapy and radiation simulations were able to reach 68.9 and 75.5% of the reference 
group’s force, and 65.9 and 72.9% of shoulder moment, respectively (Table 25, Figure 37). 
Finally, the maximal recoverable force for the combination treatment simulation was 60.0% of 
the reference population, and 56.6% of the reference population shoulder moment (Table 25, 





Figure 37: Peak force (input) (N) and peak moment (Nm) during each of the 5 internal rotation 
simulations run: baseline (LSC from Study 1), reference (non-cancer reference population), and 
the 3 scenarios (chemotherapy, radiation and the combination of both chemotherapy and 
radiation). 
 Internal rotators and scapular stabilizers were affected by the training simulations (Table 
25, Figure 38). Generally, maximal voluntary force in the simulations was lower than the 
comparison reference group (Table 25, Figure 38). In the radiation, and combination simulations 
some muscles predicted increased %MVF compared to the reference group (Table 25, Figure 
38). The baseline group (based on LSC force production) used 16.0-53.0% MVF less than the 
reference group for the latissimus dorsi (upper and lower), levator scapulae, omohyoid, 
rhomboid (major and minor), trapezius (upper), deltoid (middle and posterior), subscapularis 
(middle and lower), biceps (long and short) and triceps (long) (Table 25, Figure 38). In the 
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chemotherapy simulation, a prediction of 13.0-30.4% MVF less of the latissimus dorsi (upper 
and lower), levator scapulae, omohyoid, rhomboid (major and minor), trapezius (upper), deltoid 
(middle and posterior), subscapularis (middle and lower), biceps (long) and triceps (long) were 
estimated, compared to the reference simulation (Table 25, Figure 38). During the radiation 
simulation, 10.3-46.1% MVF more of pectoralis minor, sternocleidomastoid, trapezius (middle), 
teres major and biceps (short) (Table 25, Figure 38). Additionally, this simulation predicted 7.8-
47.3% MVF less of the latissimus dorsi (upper and lower), trapezius (middle), deltoid (middle), 
subscapularis (middle and lower), biceps (long) and triceps (long) (Table 25, Figure 38). Finally, 
the combination treatment simulation predicted 11.1-15.8%MVF more from pectoralis minor and 
trapezius (middle) (Table 25, Figure 38). This simulation also estimated 12.6-47.3%MVF less of 
the latissimus dorsi (upper and lower), levator scapulae, omohyoid, rhomboid (major and minor), 
trapezius (upper), deltoid (middle and posterior), subscapularis (middle and lower), biceps (long) 




Figure 38: Predictions of each muscular elements with %MVF that differed during each of the 5 internal rotation simulations run 
(baseline, reference, and the 3 scenarios (chemotherapy, radiation and the combination of both chemotherapy and radiation). %MVF 
represents percentage of maximal force of the capacity of muscles in the reference trials. 
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Table 25: Model outputs for peak force and muscle elements (%MVF is percentage of each 
muscles full capacity as dictated by reference population) for internal rotation scenarios 
 Baseline 
(LSC) 






Peak force (input) (N) 76.14 171.20 117.94 129.34 102.74 
Peak shoulder moment (Nm) 26.04 64.72 42.67 47.21 36.62 
Latissimus Dorsi Upper (%MVF) 32.24 82.05 53.52 41.00 40.24 
Latissimus Dorsi Lower (%MVF) 35.27 88.27 57.86 41.00 40.92 
Levator Scapulae (%MVF) 34.97 86.15 57.03 78.26 53.66 
Omohypoid (%MVF) 16.28 41.93 27.66 34.48 26.88 
Pectoralis Major Sternal (%MVF) 0.37 3.82 1.70 0.69 0.78 
Pectoralis Major Clavicular (%MVF) 0.00 0.00 0.00 0.00 0.00 
Pectoralis Minor (%MVF) 1.64 5.32 3.28 33.14 16.45 
Rhomboid Major (%MVF) 36.32 89.06 58.91 82.20 55.50 
Rhomboid Minor (%MVF) 31.90 78.74 52.19 73.44 49.78 
Serratus Anterior Upper (%MVF) 1.59 5.33 3.11 0.24 1.20 
Serratus Anterior Middle (%MVF) 0.24 0.24 0.24 0.24 0.24 
Serratus Anterior Lower (%MVF) 0.24 0.24 0.24 0.24 0.24 
Sternocleidomastoid (%MVF) 0.27 1.06 0.65 11.38 5.21 
Sternohyoid (%MVF) 0.04 0.09 0.05 0.52 0.55 
Subclavius (%MVF) 0.29 2.29 1.71 4.80 3.96 
Trapezius Middle (%MVF) 0.00 0.51 0.27 46.58 16.28 
Trapezius Lower (%MVF) 0.00 0.00 0.00 0.00 0.00 
Trapezius Upper (%MVF) 23.88 58.54 38.82 30.40 33.44 
Trapezius Clavicular (%MVF) 0.00 0.05 0.04 0.00 0.00 
Deltoid Middle (%MVF) 19.21 43.28 29.42 16.66 19.18 
Deltoid Posterior (%MVF) 15.44 40.92 26.75 40.09 28.36 
Deltoid Anterior (%MVF) 0.00 0.00 0.00 0.00 0.00 
Coracobrachialis (%MVF) 0.00 0.00 0.00 0.00 0.00 
Infraspinatus Upper (%MVF) 0.00 0.00 0.00 0.00 0.00 
Infraspinatus Lower (%MVF) 0.00 0.00 0.00 0.00 0.00 
Subscapularis Upper (%MVF) 2.46 2.87 2.60 0.29 1.92 
Subscapularis Middle (%MVF) 18.26 42.12 29.09 27.54 23.77 
Subscapularis Lower (%MVF) 27.72 65.74 44.20 57.93 41.89 
Supraspinatus (%MVF) 0.00 0.00 0.00 0.00 0.00 
Teres Major (%MVF) 0.02 1.52 0.48 11.91 3.47 
Teres Minor (%MVF) 0.00 0.00 0.00 0.00 0.00 
Biceps Long (%MVF) 15.60 38.89 25.49 29.67 22.09 
Biceps Short (%MVF) 8.36 24.33 15.47 45.58 24.83 
Triceps Long (%MVF) 20.90 52.47 34.52 41.99 31.36 
Triceps Medial (%MVF) 0.06 0.00 0.00 2.22 0.64 
Triceps Lateral (%MVF) 0.00 0.00 0.00 0.00 0.00 
Brachialis (%MVF) 0.00 0.00 0.00 0.00 0.00 




Muscle force production varied from the experimentally derived muscle activation in 
many cases. In the simulations, pectoralis major (clavicular insertion), anterior deltoid, 
infraspinatus and supraspinatus were not activated (all were 0% MVF) (Table 26). Both the 
infraspinatus and supraspinatus were activated at 10%MVC or less in the experiment, however 
the pectoralis major (clavicular insertion) and anterior deltoid were both activated above 20% 
MVC (Table 26). The sternal insertion of pectoralis major was underestimated in the simulation 
(0.9-3.8% MVF) compared to 32.8% MVC in the experiment (Table 26). The latissimus dorsi 
was overestimated by 69.0-83.0%MVF compared to 17.0%MVC collected for the LSC group. 
The middle deltoid of the radiation simulation was the most accurate, only overestimated by 
7.5% MVF, compared to19.9-37.6% MVF during the other simulations.  
Table 26: Comparison of muscle elements and experimental sEMG for each scenario during 
internal rotation strength simulations. %MVF in this table represents percent of reduced capacity 






















86.0 88.27 87.67 100.00 99.81 16.99 ± 6.91 9.76 ± 5.19 
Pectoralis Major 
Sternal  
0.9 3.82 2.58 1.68 1.89 32.78 ± 14.22 28.31 ± 10.46 
Pectoralis Major 
Clavicular  
0.00 0.00 0.00 0.00 0.00 38.07 ± 15.46 28.54 ± 12.16 
Deltoid Middle  46.84 43.28 44.58 16.66 29.06 9.21 ± 6.17 7.42 ± 3.74 
Deltoid Posterior  37.66 40.92 40.54 40.09 42.97 7.08 ± 7.40 4.36 ± 2.60 
Deltoid Anterior  0.00 0.00 0.00 0.00 0.00 20.05 ± 10.19 14.85 ± 8.82 
Infraspinatus Lower  0.00 0.00 0.00 0.00 0.00 7.24 ± 4.21 6.34 ± 3.02 
Supraspinatus  0.00 0.00 0.00 0.00 0.00 10.01 ± 4.76 8.56 ± 8.12 
5.7 Discussion  
 The results of the simulations indicate that the focus in training for regaining strength 
following breast cancer treatment should not be placed solely on the agonist movers, but also 
glenohumeral stabilizers. The simulations represented common treatment scenarios, and included 
known reduced force capability effects on several muscles. Although multiple configurations of 
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muscle forces are capable of producing a given external force, a representative, and conservative, 
approach was taken to model the average force of each given group. The purpose of this study 
was to determine the maximal recoverable force outputs for 3 treatment scenarios, while also 
investigating the internal muscle force patterns associated with producing those forces as 
estimated by a modified shoulder biomechanical model. It was hypothesized that the 
combination treatment scenario would have had the lowest recoverable force in both force 
directions, and that muscle forces would decrease in all muscles represented as having reduced 
capacity. The combination treatment simulation did produce the least force, however in the 
radiation and combination simulations several muscles were predicted to require increased 
muscle force, translating to increased demand, and thereby more rapid fatigue likelihood. Most 
muscles, however, were estimated to contribute less muscle force than the reference population 
to produce maximal forces (which is less than the reference force). 
5.7.1 Rehabilitation Implications  
 Simulating training with the damage expected from treatment, can help to infer important 
rehabilitation considerations and refine or complement contemporary practice. The current study 
demonstrated the importance of considering muscles outside the radiation field (if radiation was 
used), and glenohumeral and scapular stabilizing muscles during adduction and internal rotation 
when improving strength. Reaching 70-80% of reference group strength (in all scenarios except 
the combination scenario in internal rotation), would allow survivors to sufficiently return to 
many daily tasks (de Souza Cunha et al., 2020). During adduction simulation, 16.95-48.62% 
MVF less muscle force was estimated from levator scapulae, omohyoid, rhomboid (major and 
minor), upper trapezius, subscapularis (lower), and triceps (long) compared to the reference, for 
all three simulations (Figure 36). During the chemotherapy simulation latissimus dorsi (upper 
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and lower) was also relied on. In the radiation and combination simulations pectoralis minor, 
middle trapezius and biceps (short) were more heavily relied on compared to the LSC group. The 
middle deltoid was also predicted as contributing more force during the chemotherapy and 
radiation only simulations compared to the LSC group. Similarly, during internal rotation, 
muscle force was predicted to be 7.80-47.34% MVF less from latissimus dorsi, levator scapulae, 
omohyoid, rhomboid (major and minor), upper trapezius, posterior deltoid, subscapularis (middle 
and lower) and triceps (long) compared to the reference, for all three simulations (Figure 38). 
Pectoralis minor and middle trapezius were also recruited during radiation and combination 
simulations. The middle deltoid was predicted as producing more force in the chemotherapy 
simulation compared to the LSC group, and less in the radiation group. With the results of this 
simulation, to increase adduction force it is recommended to focus on both strengthening 
muscles that historically are thought to contribute to adduction (latissimus dorsi, triceps, teres 
major and pectoralis major), as well as muscles that work to stabilize the scapula (rhomboid 
major and minor), and stabilize the glenohumeral joint as antagonist muscles to adduction 
motion (upper trapezius and middle deltoid) (Moore, Dalley, & Agur, 2010). In internal rotation 
focus should be placed on increasing strength of subscapularis, latissimus dorsi, anterior deltoid 
and pectoralis major, as well as muscles that work to stabilize the scapula during rotation 
(posterior deltoid, middle trapezius and rhomboids). Due to the nature of optimization models 
(discussed further in section 5.7.4 Model Comparison to experimental data) antagonist muscle 
predictions often do not include all probable or possible muscles, but rather larger antagonist 
muscles are recruited due to the chosen cost function (cubed muscle stress) (Dul, Johnson, et al., 
1984). The importance of these muscles to maintain stability of the joint is still apparent with 
increased force production during all simulations, compared to the LSC group.  
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 In traditional exercise programs, focus is placed on targeting primary movers (agonists) 
of particular actions. As observed in study 1 of this dissertation, strength is a more informative 
measure than range of motion (in terms of functional measurements) and therefore it is important 
to consider this measurement to address shoulder-related quality of life in breast cancer 
survivors. Several review studies have concluded that resistance training programs often 
combine several simple upper body and lower body exercises (bicep curl, rowing, chest press, 
lateral raises, squats, calf raises) as well as active stretching (De Groef et al., 2015; Lopez et al., 
2020; Ribeiro, Moreira, et al., 2019). Although the majority of these studies showed 
effectiveness in increasing strength, there is no specific focus on stabilizing the entire 
glenohumeral joint, instead focus is on the major muscle groups of all joints throughout the 
body. Stan et al (2016) investigated the use of yoga vs traditional resistance training in breast 
cancer survivors. Yoga combines both active stretching and can strengthen individuals, while 
using only body-weight (making implementation simpler). However, the goal of this program 
was to reduce cancer-related fatigue and strength changes were not considered (Stan et al., 
2016). Schmitz et al (2019) focused on lymphedema mediation in breast cancer survivors by 
implementing a full year intervention focusing on facets of resistance training and weight loss. 
Weight loss intervention, alone or in combined with a resistance training program did not 
improve lymphedema for either group (Schmitz et al., 2019). Each exercise program aimed to 
target an adverse symptom experienced by breast cancer survivors. Although resistance training 
increases the strength of those muscles, more focus should be placed on ensuring that not only 
the primary movers are targeted, but also on increasing the strength of stabilizing muscles to 
improve function of breast cancer survivors following treatment to improve both function and 
shoulder-related quality of life.      
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5.7.2 Complexities of treatment  
 The effects of treatment, however, are not uniform for individuals who undergo these 
treatments. Immediately, participants in the HSC and LSC received similar treatment types, yet 
their maximum force production levels differed greatly (Table 16, page 67). In fact, the HSC 
force production was closer to that of the reference group in adduction, and the radiation 
simulation during internal rotation (Tables 23 and 25). Currently, it is difficult to prospectively 
predict whether survivors will be more similar to the LSC or HSC. The current simulation study 
modelled the ‘worst case scenario’ beginning with the force production of the LSC and assuming 
that muscles cannot be trained if damaged from radiation, and that chemotherapy will result in a 
finite capacity increase if properly trained. It is clear with the ability of the HSC group of breast 
cancer survivors that individuals who receive treatment can regain or maintain strength. In the 
development of the scenarios, the effects of treatment were considered. Mainly, that several 
muscles (latissimus dorsi, pectoralis major/minor and teres major) had received greater radiation 
during treatment, and were thus damaged during the process (Lipps et al., 2017). The effect of 
radiation lingers in the muscle, and scar tissue may form; though it may not be permanent. In this 
study a conservative approach was taken and the assumption was made that the damage was 
permanent and these muscles cannot be trained to produce more force (Lauridsen et al., 2008; 
Markes et al., 2006). Chemotherapy results in a reduced strength capacity in all muscles, as this 
is not a targeted treatment (Klassen et al., 2017). In this study, muscles were able to be trained to 
increase force capacity by only 25% to mimic the inability for capacity to continue to increase 
similarly to a normal muscle  (Christensen et al., 2014). Again, this was a conservative approach 
to mimic a worst-case scenario. The combination scenario yielded the lowest recoverable force 
output for both adduction and internal rotation (Tables 23 and 25). With this logic, 17 of the 32 
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participants in study 1 would belong in the LSC, and have force less than 147.52N and 102.74N 
in adduction and internal rotation, respectively. However, this is not the case as there are 8 
survivors in the LSC and 9 in the HSC who received both chemotherapy and radiation.  
The force production of each group may be modulated by several factors such as age, 
surgery, reconstruction, side of diagnosis, strength before treatment, rehabilitation after 
treatment, and the differing regimens of each treatment (length of radiation, type of 
chemotherapy drug). The effect of age on strength are discussed in the following section (5.7.3 
Aging Effects on Strength). As previously discussed, mastectomy, breast conserving therapy and 
axillary lymph node dissections are the three main surgeries used for treatment. Mastectomy and 
axillary lymph node dissection patients are 6 times more likely to have shoulder restrictions or 
functional limitations (which includes both range of motion and strength deficits), compared to 
breast conserving therapy (Vidt et al., 2020). Due to the removal of tissue in mastectomies force 
imbalances may occur between the affected and unaffected limbs (Crosbie et al., 2010). Higher 
invasiveness of surgery may exacerbate residual impairments, as well as additionally surgeries as 
is necessary in reconstruction. No participants in the current study had undergone reconstruction 
at the time of participation and therefore considering the additional consequences of these 
procedures is beyond the scope of this thesis, but it is important to consider that the various 
reconstructive surgeries may also modulate the ability of survivors to regain their full-strength 
following treatment. Further, a more pronounced difference occurs when the affected side is the 
non-dominant limb (Perez et al., 2018). Right-handed individuals have significantly greater grip-
strength on their dominant side and therefore dominance should be considered (Incel, Ceceli, 
Durukan, Erdem, & Yorgancioglu, 2002). The simulations completed in this in-silico study were 
completed as the right limb, and all participants in study 1 and the reference population were 
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right hand-dominant. There was a mix of left and right affected limbs in the LSC, so it is not 
likely this had an effect on the force production of this group. However, the laterality of 
diagnosis may have an affect for individual survivors and if the non-dominant side is the affected 
side may lead to a lower capacity to begin with, and therefore more difficulty achieving a given 
strength level.  From pre-surgery to 1-5 years post surgery, strength is decreased, specifically 
13.6-38.7% of survivors experienced continued loss in internal rotation strength, of an average of 
1.39kg, coupled with an increase in arm volume (Belmonte, Messaggi-Sartor, Ferrer, Pont, & 
Escalada, 2018). Individuals who are active prior to surgery are 85% more likely to report 
limited disability 3 weeks following surgery (A. Yang, Sokolof, & Gulati, 2018), suggesting 
potential benefits of ‘prehabilitation’. Similarly, as discussed in the previous section, 
rehabilitation and exercise programs completed will have differential outcomes for individuals. 
Finally, differences in the regimens of each treatment (length of radiation, type of chemotherapy 
drug) will also affect the musculature and each individual differently. No research has been 
completed on the biomechanical repercussions of individual treatment regimens, but it is likely 
that more intense chemotherapy drugs, and longer radiation regimens would lead to more 
damage and a reduced capacity to regain strength. Combined, all of these factors make it 
complex to assume that the scenarios simulated in this study capture all of the areas that would 
prevent muscle capacity gains. Rather, this study illuminated that even in the worst-case 
scenario, emphasis should not be placed on just the primary movers, or the muscles most often 
damaged by radiation, but also muscles responsible for stabilization of the scapula and 
glenohumeral joint.    
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5.7.3 Aging Effects on Strength 
 As previously discussed in section 3.7.4 Comparison to non-cancer population (page 75), 
aging affects the musculoskeletal system. As stated, over the age of 45, muscle mass is lost at a 
rate of 0.37%, and strength is lost 2-5 times faster than mass (and these effects accelerate over 
the age of 75 (Mitchell et al., 2012). The reference population in the current study was 22.4 years 
old, while the LSC breast cancer groups was 56.7 years old. If the strength loss begins at 45, and 
conservatively we assume its 5 times faster than mass loss, a 22.2% strength loss may occur by 
the age of 57 (Mitchell et al., 2012). In similar postures to those evaluated in the current study 
strength loss is 4.8% in adduction between 20-29-year old’s and 50-59-year old’s, but 46.2-
52.6% in internal rotation for the same age groups (Hughes et al., 1999). The difference between 
the reference population and LSC breast cancer group in this study was 56.4 % in adduction and 
76.3% in internal rotation. Even conservatively, these differences exceed age-related effects, and 
therefore can at least partially be attributed to treatment or the disease itself. Ideally, an age-
matched reference population would serve as an additional comparison group in this study, but 
COVID-19 resulted in the suspension and ultimate termination of collections before this data 
could be acquired. The HSC breast cancer group had similar strength to the reference population 
in adduction (201.45N and 212.22N, respectively). This is comparable to the 5% loss due to 
aging previously cited (Hughes et al., 1999). The difference between the reference population in 
the current study and internal rotation strength of the HSC is larger (27.3%), but again can be 
considered plausible within aging effects (Hughes et al., 1999; Mitchell et al., 2012). In 
adduction, therefore, the addition of an age-matched reference group would have had minimal 
difference, and would likely have fallen between the radiation treatment maximal recoverable 
force (171.1N) and the reference group (212.2N).  In internal rotation, the effects of aging are 
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less predictable. The HSC breast cancer group force output was 130.0N, which was comparable 
to the radiation treatment maximal recoverable force (129.3N). Given the effects of aging and 
strength previously described, it would be expected that the HSC breast cancer group was within 
the range of strength expected of an aged-matched reference population (Hughes et al., 1999; 
Mitchell et al., 2012). With this comparison, strength may be recoverable up to 90.7 and 99.5% 
in the chemotherapy and radiation treatment scenarios, respectively. The combination treatment 
scenario would reach 79.0% of the age-matched control force output. With these results, and 
comparisons to age-matched reference values, it may be realistic to assume that strength may be 
recoverable to 70-80% even with a combination of treatments, and accompanying worst-case 
damage. These simulations, however, did not account for damage from surgery or secondary 
symptoms (such as lymphedema or chording), and these should be taken into consideration for 
future studies as they would potentially increase dysfunction. 
5.7.4 Model Comparison to experimental data  
 The SLAM model has been used in the breast cancer survivor population in several 
situations, however not with maximal exertions. The model was initially designed to assess a 
reference, non-clinical population, and although there was difficulty predicting magnitude of 
antagonistic muscles during static holds (a common outcome with optimization models), the 
correct muscles were recruited during targeted reaching tasks (Dickerson, Hughes, & Chaffin, 
2008). Previously, breast cancer survivor population was simulated with the SLAM model 
during submaximal internal and external rotation tasks, with hand forces at 19.6N and 40N 
(Chopp-Hurley et al., 2016), and under 10N during functional tasks (Lang et al., 2020). In both 
of these studies predicted muscle forces underestimated empirically collected values (13.4-30.4% 
and 7.3-31.6%, respectively) (Chopp-Hurley et al., 2016; Lang et al., 2020).  
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The larger discrepancies in the current study (6.10-91.57% in adduction, and 7.24-
83.01% in internal rotation) likely emerge due to several factors. Firstly, co-contraction is not 
well represented in optimization models, although the inclusion of a stability constraint increases 
the recruitment of some glenohumeral antagonist stabilizers, it is not a perfect solution 
(Dickerson et al., 2007, 2008). The sum of the cubed muscle stress (the cost function of SLAM) 
leads to load sharing between muscles, but still preferentially recruits larger muscles to limit 
stress (Dul, Townsend, Shiavi, & Johnson, 1984). Beyond this, the model is a single average 
musculoskeletal geometry. Both the input of height and weight to scale the model are an average 
of the group, and the shoulder rhythm included represents a population average (Dickerson et al., 
2007). Segments and coordinate systems are based on published proportions (Hogfors et al., 
1987; Makhsous et al., 1999). These proportions are guided by height (as described), and an 
input of experimentally collected bony landmarks from one representative individual. The 
shoulder rhythm included in the study is again, a representation modified from previously 
reported rhythms (Hogfors et al., 1991; Karlsson & Peterson, 1992; Makhsous et al., 1999). 
However, in SLAM these are modified to support the bony landmarks experimentally collected 
(Dickerson et al., 2007). The combination of these factors, and average muscle attachment sites 
leads to a model that represents one particular geometry, and not the breadth of individuals 
included in our average values.  
Secondly, experimentally measured data has inherent, well known limitations. MVCs 
may not be accurate, and represent population averages. MVCs completed in different postures 
may lead to inaccurate muscle activation representation (Maciukiewicz, Lulic, MacKay, 
Meszaros, & Dickerson, 2019). In addition to potentially inaccurate representation, EMG 
measures come with variability in collection and output (De Luca, 1997; Maciukiewicz et al., 
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2019; Winter, 1991). If we consider the variability in EMG to account for these differences, most 
of the model predictions are within two standard deviations of experimental data (Table 24, 25). 
Beyond inherent issues with EMG, it is challenging to ensure accurate MVCs with a clinical 
population, due to physical limitations, and pain avoidance (Lindstroem, Graven-Nielsen, & 
Falla, 2012). If a true maximal effort is not achieved, muscle activation may be overestimated 
when normalized to this maximum. In the current study %MVF is calculated based on both full 
capacity (of the reference population) to allow comparison between simulations (Tables 23 and 
25), and for the capacity of each given scenario to allow comparison to measured %MVC 
(Tables 24 and 26). However, %MVC is not a perfect representation of %MVF. Muscle 
activation and muscle force magnitudes are qualitatively and conceptually similar, but they are 
not linearly related. %MVC does not necessarily correspond to the exact proportion of %MVF, 
but it is the closest approximation currently available (Disselhorst-klug, Schmitz-rode, & Rau, 
2009). Validity, as a concept, involves checking all aspects of the model, and is a continual 
process (Lewandowski, 1981). SLAM has been tested in various scenarios and tasks and has 
relatively good agreement in predicting inactivity of muscles that are not recruited, as well as for 
primary movers in given tasks (Chopp-Hurley et al., 2016; Dickerson et al., 2008; Lang et al., 
2020). Although it has not been investigated in maximal tasks, the results from the current study 
align with the prediction of primary movers. An important part of construct validity or 
appropriateness is interpreting the results (Lewandowski, 1981), where the utility of using the 
model is not for prediction of exact %MVF of each muscle, but the patterns of muscles used 




The final component, load sharing between muscles, combines model and physiological 
factors. The ability for SLAM to accurately load share can be influenced by several factors, 
mainly co-activation, moment arm and size of the muscle. Physiologically, we do not activate 
one muscle at a time, rather several muscles to complete the same task and to maintain 
glenohumeral and scapular stability. Previously, a co-activation constraint was investigated 
during internal and external rotation tasks (Chopp-Hurley et al., 2016). By enforcing known co-
activation relationships the fidelity of the model improved, and lowered the differences between 
the predicted forces and experimentally collected data by an average of 6% (Chopp-Hurley et al., 
2016). As the co-activation ratio was specific to the posture and task, it was not used in the 
current study, however this could improve future estimates. Further, with the use of the cubed 
muscle stress cost function larger muscles with larger moment arms are preferentially recruited 
(Dul, Johnson, et al., 1984). The internal rotation and adduction positions used in the current 
study created an ideal situation for latissimus dorsi (a large muscle) to be effective in both 
internal rotation and adduction, respectively and therefore attractive to the mathematical 
minimization routine. Rhomboid major was also largely recruited as a scapular stabilizer, with 
the largest moment arm and PCSA. The pectoralis major with its small size and moment arm was 
too costly to activate and therefore not required or desired to contribute in the simulation. Further 
research should include extra partitions of this muscle, as well as co-activation constraints to 
better represent the pectoralis major and further understand the effects of treatment on this 
muscle. 
5.8 Limitations 
 There are several limitations that delimit this work. Although the cubed muscle stress is a 
common and established cost function, it is difficult to predict exactly which cost function best 
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represents an individuals neuromuscular task completion approach (Dul, Johnson, et al., 1984). It 
is possible that after undergoing treatment, a different cost function, such as pain avoidance via 
limiting muscle excursion or lengthening, or drastically avoiding specific muscle use, may better 
represent this population. However, this likely differs between all participants and cannot be 
easily quantified (such as a reduction of pain). Beyond the limitations of modeling and more 
specifically SLAM, the scenarios are worst-case representations, and therefore the experiences of 
individual breast cancer survivors could vary greatly from the proposed scenarios. Along these 
lines, the training of muscles was not based on a specifically defined rehabilitation program, but 
rather on the ability to train all muscles to a similar extent and increasing the capacity of the 
muscles uniformly in a stepwise manner. There is no direct evidence to suggest this is possible.  
5.9 Conclusions 
 Muscle capacity is affected by breast cancer treatment. The current study determined that 
even with the challenges posed by given treatment scenarios (permanent damage of a subset of 
muscles from radiation, or overall reduction in capacity due to chemotherapy, or a combination 
of both), 70-80% of strength is recoverable if retraining of muscles can be achieved. The 
simulations showed that proper attention should be taken to strengthen not only the primary 
movers, but also provide stabilizing muscles of the scapula and glenohumeral joint. Specifically, 
for adduction rhomboid (major and minor), upper trapezius, subscapularis (lower), and triceps 
(long), latissimus dorsi (upper and lower), pectoralis minor, middle deltoid, middle trapezius and 
biceps (short) were recruited during the various simulations to increase force output compared to 
the LSC group of breast cancer survivors. During internal rotation, latissimus dorsi, rhomboid 
(major and minor), upper trapezius, posterior deltoid, subscapularis (middle and lower), triceps 
(long), pectoralis minor, middle deltoid, and middle trapezius recruitment increased from the 
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LSC group levels in each of the simulations. Although no scenario reached the levels of the 
reference group, the increase in achieved forces produced would be meaningful for enabling 
daily task performance and enhancing physical self-efficacy if achieved. It is important to 
increase the force output of breast cancer survivors, as having adequate strength capability is an 
important element in enhancing shoulder-related quality of life. The current study will be helpful 
to inform potential strategies for rehabilitation, and to set reasonable goals with known limitation 
of musculature. Ideally, this work will also be considered when considering treatment and 




Chapter VI - Research Outcomes and Future Directions 
6.1 Summary of Research 
 This thesis has contributed novel findings to the current state of breast cancer research, 
and specifically in the area of arm function in survivors. In Study 1, a cluster analysis identified 
two distinct groups of breast cancer survivors within two years of the conclusion of treatment, 
where one group had less overall function (parameterized by strength and range of motion) and 
shoulder-related quality of life. The five features identified to split the two groups were internal 
rotation force production, active extension range of motion, and 3 variables from the RAND-36 
questionnaire (energy/fatigue, social functioning and pain). The two groups differed significantly 
in self-reported disability, role limitation (health and emotion), fatigue, and physical well-being, 
physical activity, lean mass of the affected arm, active flexion range of motion, as well as 
abduction, adduction, extension, flexion, internal and external force production.  
Study 2 examined the effect of these differences on daily living tasks, and whether there 
were discernible differences in kinematics or muscular activation between the groups. In 8 daily 
living tasks (reach to back pocket, pour from a pitcher, forward reach, shelf reach, bra fasten, put 
on a necklace, tray transfer and bag lift), all 8 muscles monitored experienced differences 
between the two groups, where the group with more self-reported disability and lower function 
required greater muscular activation to complete the same tasks. Additionally, this group used 
less range of motion for all three planes of motion for half of the tasks.  
Study 3 focused on determining how much force, and which muscles are predicted to 
contribute to that force when damage from treatment is modelled. To recover 70-80% of force, 
strengthening programs should focus on not only primary movers, but also stabilizing muscles of 
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the scapula and glenohumeral joints during movement. The three studies combined to determine 
that strength is an important facet of survivorship, and can influence performance of even low 
load tasks. Strength deficits can be recovered up to 70-80% which may help mitigate reduced 
shoulder-related quality of life, but depends on the level of damage to important tissues. 
6.2 Clinical Implications of Research 
This dissertation made several principal contributions to the research on breast cancer 
survivors, with clinical relevance. 
1) Determination of factors that define breast cancer survivor function following 
treatment  
In study 1, 5 factors were determined to separate the group of high and low scoring breast 
cancer survivors. These factors (internal rotation force production, active extension range of 
motion, and self-reported energy/fatigue, social functioning and pain) defined which group a 
breast cancer survivor belonged to. These groups differed in many self-reported shoulder-related 
quality of life factors, as well as all force production measures. By identifying the most 
important factors to determine which group a survivor belongs in, monitoring can be more 
targeted. Further, focus on encouraging rehabilitation in the lower scoring individuals may help 
rectify functional deficits and improve shoulder-related quality of life. 
2) Identification of muscle and movement patterns in breast cancer survivors during 
low load daily tasks 
In study 2, different muscular and kinematic strategies existed between the HSC and LSC 
groups of breast cancer survivors. Particularly, the LSC group more highly activated muscles 
(and displayed increased variability) when completing all the low load daily tasks. Further, this 
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group also used a smaller range of motion in all planes, during a subset of tasks. This is an 
important finding, recovering full strength or range of motion is a common clinical target, but 
patterns adopted by individuals, possibly for compensation, may be equally as important to 
consider. With this information, attention should be paid to regain maximal function (which may 
mitigate these differences), but also on how daily tasks are completed. These compensations may 
increase fatigue, or lead to rotator cuff disorders (such as impingement of the supraspinatus 
tendon) and further hinder function in these individuals.  
3) Strength recovery of up to 70-80% was possible when accounting for damage to 
certain muscles from treatment.  
Study 3 investigated the feasibility of increasing strength with several damage scenarios 
faced by breast cancer survivors. By modelling a reduction in capacity of all muscles 
(chemotherapy) or a subset of muscles (radiation), 70-80% of strength was recoverable, and that 
both the primary movers for an action and accessory muscles that stabilize the scapula and 
glenohumeral joint have importance. Clinically, this study paves the way for targeting 
rehabilitation driven by specific muscles and acknowledging the limitations that muscles may 
face from treatment. Combining the knowledge from study 1 and 2, this targeted approach could 
lead to improved shoulder-related quality of life, and in turn influence daily tasks completion.  
6.3 Future Directions 
This thesis lays a foundation to better understand treatment effects in breast cancer survivors 
immediately following treatment, but further work can extend this initial progress and potentially 
yield more benefits for the breast cancer survivor population. Collection of an aged matched 
reference population would help determine which changes relate variously to aging and 
treatment type and status. An expansion of the activities of daily living tasks (including more 
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challenging tasks, and more work specific tasks) would also extend the current research. These 
could identify tasks that may be challenging for a subset of survivors, and tasks that may put 
survivors with lower function at risk for injury. It is well documented that pectoralis major is 
damaged during treatment. To better quantify the effect of treatment on pectoralis major, 
additional partitions of the muscle should be modelled to increase the fidelity of SLAM. 
Following this investigation, an intervention study should be completed to determine the 
effectiveness of targeting specific muscles driven by an in-silico approach. Finally, 
reconstruction is another facet of survivorship. The effect of the various reconstruction surgeries 
on the factors discussed in this thesis are not fully understood. Study 3 identified latissimus dorsi 
as an important muscle in adduction and internal rotation strength recovery, even if damaged 
with radiation treatment. However, a popular reconstruction technique involves altering the 
latissimus dorsi, which in turn modifies the function and strength of this muscle (Leonardis et al., 
2019). By adding in another factor, a more complete understanding of life after treatment can be 
explored. Many of these research extensions could instigate improved arm function in numerous 
survivors, and extend independence following breast cancer treatment. 
6.4 Overall Conclusion  
No two individuals experience the effects of breast cancer treatment equally. This 
dissertation determined that several factors can help differentiate survivors, and guide which 
individuals may experience challenges following treatment. More so, that these differences do 
not exist solely through maximums and functional tasks, but also daily living tasks. Survivors 
with decreased strength and shoulder-related quality of life also completed tasks in a manner 
which may predispose them to rotator cuff disorders, furthering any existing issues from 
treatment related effects. Although it may not be possible to fully recover the damage in tissues 
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from treatment (specifically chemotherapy and radiation), 70-80% of strength is achievable when 
accounting for these tissue changes, as well as aging effects. Recovering strength may mitigate 
the need for kinematic compensations, increased muscular activation and improve shoulder-
related quality of life. Completing an intervention study with focused rehabilitation to increase 
strength of primary movers, and shoulder/glenohumeral stabilizers may provide insight into the 
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Appendix A: Information Consent and Participant Information  
Title of Project: Longitudinal evaluation of upper limb functional capacity and body 
composition in breast cancer survivors 
Investigators:  
Marina Mourtzakis and Clark Dickerson, PhD  
Department of Kinesiology, University of Waterloo 
(519) 888-4567 Exts. 38549 and 37844 
 
Student-Investigator:  
Jackie Maciukiewicz, MSc., PhD Student, Department of Kinesiology 
Research Assistant: 
Alicia Nadon, MSc., Department of Kinesiology 
Purposes of this Study: 
While 5-year breast cancer survivorship is 88% in Canada, up to 72% of breast cancer survivors 
(BCS) have upper limb impairments that remain following treatment. This can severely diminish 
shoulder-related quality of life, reducing the ability to complete activities of daily living (ADL) 
and successfully return to work. It is currently unknown which ADL tasks and arm postures pose 
the biggest problem for BCS, as prior studies have focused on coarse clinical measures. A 
refined definition of these deficits will provide critical information to aid in the development of 
targeted survivorship programs. In this project, we will assess functional impairment by 
measuring body composition, shoulder-related quality of life, and shoulder strength, range of 
motion, joint movement and muscular demands during ADL. This is one of the first studies that 
objectively looks at and quantitates shoulder function in breast cancer survivors. Understanding 
upper limb impairment in BCS will allow development of more specific and effective strategies 
to improve short- and long-term outcomes for BCS. These evidence-based strategies will be 
incorporated into existing survivorship guidelines for breast cancer patients and clinical decision 
makers. The purpose of this study is: 
• to describe the upper limb impairment of breast cancer survivors in terms of body 
composition, kinematics, muscle activation and strength, and to relate these physical 
measures with objective and subjective measures of function and shoulder-related 
quality of life during ADL and work 
• finger prick to determine HbA1c (glycated haemoglobin) will allow for investigation 
into changes in average blood sugar levels over a period of 3 months. 
• Compare the body composition, kinematics, muscle activation and strength of breast 





Who Can Participate:  
Two groups of participants will be recruited into this study.  
Group 1: Breast Cancer Survivors 
Participants in this study should be more then 3 months, but less than two years post-treatment. 
They may have had Stage I to IIIa cancer, received any form of radiation therapy or 
chemotherapy, have undergone any form of surgical procedure for breast cancer removal, and 
have had any form of breast cancer pathology. Participants cannot have had bilateral cancer, 
metastases, barium swallow within previous 3 weeks of participation, women who are or suspect 
they are pregnant, or have had upper arm dysfunction prior to cancer treatments. Please note, 
only the female gender are being recruited for this study, as breast cancer is very rare among men 
(~1% prevalence) and the potential impairments we are describing have different characteristics 
across genders.  
Group 2: Age-Matched Control Group 
Participants in the control group should not have had any upper arm dysfunction in the past 2 
years. Additionally, women will be excluded if they are, or suspect they are pregnant.  
Procedures Involved in this Study: 
The total in-lab time commitment for the participants in the breast cancer survivor group will 
amount to approximately 6-8 hours; two 3-4 hour collections are required, with a 16 week 
duration between each.   
The total in-lab time commitment for the participants in the control group will be 3-4 hours, with 
only one lab visit required.  
Intervention period 
During the 16 week duration, participants in the breast cancer survivor group will participate in 
regular exercise classes (performed in junction with the Stay Fit classes in the UW WellFit 
program). A volunteer will monitor exercises and record weights, reps and heart rate during all 
sessions. All fees related to the exercise program, including parking, will be covered as part of 
the research study. 
Exercise classes will take place at the Toby Jenkins building: 
CCCARE  
University of Waterloo 
Toby Jenkins Applied Health Research Building 
340 Hagey Blvd.,Waterloo, Ontario N2L 6R6 
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Each lab session (regardless of group) will be identical and include all of the following 
procedures. 
Participant Information and Body Composition 
✓ Medical History: cancer type, treatment (surgery, chemotherapy, radiation and hormonal 
therapy), chronic conditions, medications, and any musculoskeletal injury that may limit 
performance 
✓ Anthropometric Measures (10 minutes): Measurements of standing height, weight and waist 
circumference will be taken. 
✓ FACT-B quality-of-life survey (10 minutes): This survey asks you to respond to questions 
using a rating scale for such things as your physical well-being (e.g., I have a lack of energy, I 
have nausea, I have pain).   You may, at any time, choose not to answer some or all of the 
questions by leaving them blank.   
✓ RAND 36-Item Health Survey Questionnaire (10 minutes) : This survey asks you to respond 
to questions using a rating scale for such things as your physical well-being and your physical 
functioning (e.g., During the past 4 weeks, have you had any of the following problems with 
your work or other regular daily activities as a result of your physical health?) 
✓ DASH Questionnaire (10 minutes): This questionnaire asks you to respond to questions about 
symptoms related to your arm, shoulder, and hand as well as your ability to perform certain 
activities in the past week. (e.g. During the past week, were you limited in your work or other 
regular daily activities as a result of your arm, shoulder, or hand problem?) 
✓ DXA- Dual-Energy X-Ray Absorptiometry (20 minutes):  The DXA will be used to precisely 
measure lean tissue mass as well as body fat for the whole body and for specific regions of 
the body. There is a very low dose of radiation emitted, which is 200 times less than the limit 
for exposure to the general public (i.e. the radiation emitted from the scanner is 0.012 
mSV/DXA scan, where the maximal trivial dose is 5mSV/year for the general public. This is 
a very low dose of radiation emitted which is 200 times less than the limit for trivial exposure 
(and less than the amount of radiation you would be exposed to on a transatlantic flight).  This 
test requires that you put on a hospital gown, remove all jewellery and lie on an X-ray bed.  A 
certified Medical X-Ray Technologist (MRT) will conduct the scan. If you have had barium 
swallow in the past 3 weeks, you will not be eligible for the DXA scan.  You will be asked if 
you are taking oral contraceptives and if you are pregnant or if you suspect that you are 
pregnant.  The potential risks associated with radiation exposure to an unborn fetus are 
unknown. Thus, if you are pregnant, you will not be eligible for this assessment or study. 
✓ Bioelectrical Impedance Analysis (BIA) (5 minutes): To measure your body composition, you 
will be asked to void your bladder before the assessment. Two disposable adhesive electrodes 
will be placed on your foot (one above the middle toe and one on the ankle) and 2 on your 
hand (one on the middle finger and one on the wrist).  The skin will be cleaned with rubbing 
alcohol before placing the disposable electrodes. If you are allergic to rubbing alcohol, please 
indicate this to the researcher and the skin will be cleaned with water instead. The 4 electrodes 
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will be connected to the cables where the signal is sent and received. If you have a pacemaker; 
this test will not be performed.  Otherwise, there are no risks involved in this assessment. 
✓ HbA1c Finger Prick (3 minutes): To measure your average blood glucose levels over the 
previous few months, we will do a finger prick analysis for glycolated haemoglobin using the 
HbA1c test. A trained phlebotomist (wearing disposable nitrile/vinyl gloves) will perform the 
test, in which you will provide one finger to prick. The finger will be wiped with rubbing 
alcohol, and pricked with a small device containing a lancet. If you are uncomfortable the 
procedure and/or allergic to alcohol wipes, you do not have to participate. In some cases, 
bruising or discomfort can result from the finger prick.   
Physical Activity and Rehabilitation Frequency Assessment 
✓ Godin Leisure Time Activity Questionnaire (5 minutes): In addition to each lab collection, 
you will receive (via preferred method – email or phone) this questionnaire once per month, 
which asks you to describe your level of physical activity in the 7 days prior. Four additional 
questions will evaluate the frequency of your rehabilitation visits. 
Biomechanical Shoulder Assessment 
✓ Biomechanical Shoulder Assessment (120 minutes): In order to systematically evaluate your 
shoulder function to describe upper limb capacities and dysfunctions in breast cancer 
survivors, we will perform a biomechanical assessment of your upper arm. This assessment 
includes arm motion, muscle coordination, and strength during activities of daily life and work 
activities. The preparation and testing protocol that will be done in the laboratory is outlined 
below. 
Participant Preparation 
It is recommended that participants are dressed in comfortable athletic or workout attire. A 
sleeveless shirt is required for the biomechanical shoulder assessment. Participants should avoid 
wearing clothing that has any metal or reflective pieces on it.  
EMG Preparation 
EMG preparation will be performed by a female graduate student with 3 years of experience 
with surface EMG. She has had both apprenticeship training from her supervisor as well as 
formal course training in a UW graduate program.  
Prior to electrode placement, any hair in the placement area is shaved. The removal of hair 
enhances the signal and makes the removal of the electrode easier. A new disposable razor is 
used for each participant. Over 1000 participants have undergone this procedure in the 
Kinesiology department, and to date no participants have been cut. All shaving and electrode 
placements will be done by females.  The skin areas for electrode placement are wiped with 
isopropyl alcohol and then the electrodes are placed on the skin. 
Eight surface adhesive bipolar electrodes will be placed on the skin over 8 muscles on each arm 
(therefore 16 muscles total).  One additional electrode will be placed on the sternum as a ground 
electrode. On occasion the electrodes can leave a mark after removal. Usually, these marks 
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disappear within hours or within two days. Should the irritation/redness last longer than 3 days, 
please contact your physician. 
You will then be asked to perform 14 maximal exertions that require full muscular effort for a 
total of five seconds each. Two rounds of each of these maximal voluntary muscle exertions will 
be performed for each muscle group. There will be 2 minutes rest in between each MVC in order 
to prevent fatigue. You will then be asked to lie down on a bench while remaining as relaxed and 
still as possible. This resting EMG trial will be used to remove bias in the signal. On completion 
of the session the electrodes are removed and the skin is rubbed with isopropyl alcohol to remove 
any residual gel or adhesive material left behind from the electrodes. 
Motion capture preparation  
Three-dimensional kinematics will be recorded using an 8-camera (2 MP) optoelectronic Vicon 
MX20+ motion tracking system (sampling rate 50 Hz) (Vicon, Oxford, UK). Thirty-nine 
reflective markers will be placed on the skin (adhesive backing) over the upper limbs, scapulae, 
thorax, head, and pelvis. The cameras will track these reflective markers, and these will be used 
to calculate joint angle. Some participants may experience mild skin irritation/redness from the 
tape used to attach the instrumentation to the skin. This is similar to the irritation that may be 
caused by a bandage and typically fades within 1-3 days. Should the irritation/redness last longer 




We will then measure isometric joint moment positions of the shoulder. Maximal voluntary force 
will be assessed at the hand using a 6 degree of freedom force transducer (FS6-500, AMTI); 
three 5 second trials will be performed for a total of 24 per participant. You will be pushing 
against a force transducer that will record how hard you push with your arm in four different 
positions. We will repeat the trials for both arms. At least two minutes rest will be given between 
trials to avoid fatigue. 
 
Shoulder Range of Motion (ROM) 
You will then be asked to move through a selection of active shoulder ROM positions. 
Movement (abduction, flexion, extension, and rotation of the shoulder) in each anatomical plane 
will be recorded using motion capture cameras.   
 
Performance of Activities of Daily Living 
You will then be asked to perform a series of activity of daily living (ADL) tasks (12 in total). 
Examples of these are bra fasten, pour water from pitcher, push/pull, and forward reach. You 
will perform each task twice with both arms, however some require both hands and will only 
need two trials. You will be given at least two minutes rest between trials to avoid fatigue. A 




Rating of Perceived Exertion 
Following the completion of each ADL task, you will be asked to rate your perceived exertion 
(RPE) on a calibrated, modified continuous Borg CR-10 scale for the neck, as well as each 
shoulder, elbow, wrist, and hand.  
At any point during the study, participants should advise the researcher if any of the movements 
or activities are causing discomfort or pain.  
Incidental Findings 
DXA: In addition to providing us with a measure of fat mass and lean mass, the DXA scan also 
estimates whole body and regional bone mineral content. The procedure for the DXA scan that we 
perform is not meant to accurately assess bone mineral density, however, the bone mineral density 
results that we collect from the DXA scan may provide a crude indication of potential measures of 
bone mineral density (i.e. whether one may have lower bone mineral density than for someone 
their age). It is your decision if you would like to be notified if we find that your bone mineral 
density if below what is considered normal. After receiving notification of your bone mineral 
density, we encourage you to share this information with your physician to discuss whether you 
should undergo a bone scan to more accurately measure your bone mineral density. 
Do you wish to be notified if we find your bone mineral density to be below what is considered 
normal? 
 I do wish to be notified if my bone mineral density is below what is considered normal. 
 I do not wish to be notified if my bone mineral density is below what is considered normal. 
Confidentiality and Security of Your Information and Data: 
To ensure the confidentiality of your data, you will be identified by a participant identification 
code known only to members of the research team. Your information will be stored in a locked 
office at the Lyle Hallman building (0603) and Burt Matthews Hall (1404 and 1044) at the 
University of Waterloo. The information will be stored for a minimum of 25 years. Data will also 
be encrypted and stored on a password-protected computer and server.  
The data may need to be inspected from time to time for quality assurance (to make sure the 
information being used in the study is accurate) and for data analysis (to do statistical analysis that 
will not identify you).  The following organizations may do this inspection: the University of 
Waterloo Research Ethics Committee and other members of the research team (including monitors 
or auditors) as required, ensuring the safety of participants and the quality of data. 
Photographs and video recordings will be taken during the study, if you give consent to do so. 
These photographs or video recordings will be focused on the upper body and arm, but will not 
be focused on facial features. These photos and recordings are useful to verify the movement 
information recorded by the researchers, and may be helpful in teaching purposes such as when 
presenting the study results in a scientific presentation or publication. Any facial features or 
other distinguishing features that are visible in photos or recordings used for these above 




Questions and Ethics Clearance: If you have any further questions or want any other information 
about this study, please feel free to contact:  
Marina Mourtzakis, PhD, Department of Kinesiology 888-4567 Ext.38459 
Clark Dickerson, PhD, Department of Kinesiology 888-4567 Ext. 37844 
This project has been reviewed by, and received ethics clearance through, a University of 
Waterloo Research Ethics Committee (ORE # 21124). If you have any questions, you may 
contact the Chief Ethics Officer, Office of Research Ethics, at 519-888-4567 ext. 36005 or ore-
ceo@uwaterloo.ca.   
Remuneration: 
Breast cancer survivor participants will be provided with a $50 gift card in appreciation for their 
participation in this study. Participants in the control group only attend one lab session and 
therefore will be remunerated $25.The amount received is taxable. It is your responsibility to report 
this amount for income tax purposes.  
Changing Your Mind about Participation 
Participation is voluntary. You may withdraw from the study at any time without penalty. To do 
so, indicate this to a member of the team by saying, “I no longer wish to participate”. You may 
choose to have your data destroyed, or with your permission, your data will be used for the study. 
Please note, if you choose to withdraw at any time during the first session or before the start of the 
second session, you will receive a $25 gift card as part of remuneration.  
The StayFit program is available for individuals outside this research study. Therefore, if 
participants chose to withdraw from the study they are able to continue exercising in the program. 
Please note, if you chose to withdraw from the study and want to continue exercising in the StayFit 
program, you would be expected to pay for the remainder of the session. 
Consent to Participate By signing this consent form, you are not waiving your legal rights or 
releasing the investigators (Professor Marina Mourtzakis and Professor Clark Dickerson) or 
involved institution (University of Waterloo) from their legal and professional responsibilities. 
 I agree to take part in a research study being conducted by Professor Marina Mourtzakis and 
Professor Clark Dickerson of the Department of Kinesiology, University of Waterloo. 
 
 I consent to the finger prick (HbA1c) test  
 
I have made this decision based on the information I have read in the Information letter. All the 
procedures, any risks and benefits have been explained to me. I have had the opportunity to ask 
any questions and to receive any additional details I wanted about the study. If I have questions 
later about the study, I can ask one of the researchers (Professor Marina Mourtzakis, 519-888-
4567 Ext. 38549; Professor Dickerson, 519-888-4567 Ext. 37844). 




This project has been reviewed by, and received ethics clearance through, a University of 
Waterloo Research Ethics Committee (ORE # 21124). If you have any questions, you may 
contact the Chief Ethics Officer, Office of Research Ethics, at 519-888-4567 ext. 36005 or ore-
ceo@uwaterloo.ca.   
_____________________________    __________________________    
 Printed Name of Participant   Signature of Participant 
_____________________________   ___________________________ 
 Dated at Waterloo, Ontario    Witnessed 
Consent to Use Video and/or Photographs 
Sometimes a certain photograph and/or part of a video recording clearly shows a particular 
feature or detail that would be helpful in teaching or when presenting the study results in a 
scientific presentation or publication. If you grant permission for photographs or video recording 
in which you appear to be used in this manner, please complete the following section. Please 
note that any facial features will be blotted out so that you will not be identifiable. 
I agree to allow video and/or photographs to be used in teaching or scientific presentations, or 
published in scientific journals or professional publications of this work without identifying me 
by name. I understand that I retain the right to withdraw my consent to be video recorded or 
photographed at any time, and that existing video or photos may be destroyed at my request. 
There will be no penalty to me if I choose to refuse this consent. 
__________________________ _______________________________  
Printed Name of Participant   Signature of Participant 
_________________________ _______________________________  
Dated at Waterloo, Ontario   Witnessed 
UW WellFit Participants Only: Consent to Use Previous Data (ORE 18987) 
Some of the questionnaires (specifically those related to shoulder-related quality of life and arm 
function) used in this study replicate those in ORE 18987. For participants who have completed 
those in the last two weeks, if you grant permission, those results can be shared with the 
researchers of the current study to reduce replication. 
I agree to allow the researchers to view my results from ORE 18987. I understand that I retain 
the right to withdraw my consent at any time. There will be no penalty to me if I choose to refuse 
this consent. 
__________________________ _______________________________  
Printed Name of Participant   Signature of Participant 
 
_________________________ _______________________________  
Dated at Waterloo, Ontario   Witnessed  
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Participant Information Form 
 
Participant ID:               
DIAGNOSIS INFORMATION 
Date of Diagnosis: ______________________________________________________ 
Type of Breast Cancer: __________________________________________________ 
Stage of Breast Cancer: __________________________________________________ 
 
TREATMENT INFORMATION      
            
Radiation Therapy: 
a. Start date: _________________________________      
b. Frequency (i.e. everyday, every other day etc):  _____________________________ 
c. Duration of therapy: _____________________  
d. Date of last radiation dose: _______________        
 
Surgery:  
a. Date of surgery(ies):____________________   
b. Type of surgery (lumpectomy vs mastectomy vs other): _____________________  
c. Side (R, L or both): ___________________________  
 
Chemotherapy: 
a. Start date:       
b. Total cycles:     
d. Date of treatments (e.g. Every Wednesday for 6 weeks): 
______________________________________________________________________________
__________________________________________________________________ 
e. Chemotherapy Drugs (if known):         
            ______ 
f. Did you have a PICC or port-a-cath? ______________________________________________ 
g. If yes, when was it removed? ___________________________________________________ 
h. Did you experience any pain or discomfort with it? 
______________________________________________________________________________ 
 




PHYSICAL ACTIVITY  
Are you currently physically active? (meet Canada’s P.A. Guidelines)     Yes   No 
Current Physical Activity 
i.e. lifting weights, cardiovascular activity, recreational or other unstructured physical activities 
that are part of  daily life/job?  
•   





Previous Physical Activity 





Physiotherapy and Exercise Prescription 
Have you ever been to a physiotherapy or other allied health professional for treatment regarding 
your arm or shoulder? ___________________________________________ 
 
If yes, how long did you receive treatment? __________________________________ 
What did the treatment involve? __________________________________________ 
 
Have you ever received an exercise program specifically for your arm or shoulder? _____ 
If yes, how long did you do the program for? ___________________________________ 
Are you still currently doing the program? _____________________________________ 
 
Do you have any difficulty in completing daily tasks? Yes / No 
a. If yes, what tasks di you have trouble doing (e.g., reach overhead, lifting)?: 
______________________________________________________________________________ 
Do you often feel tightness in the chest or shoulder of your affected arm? Yes / No 
If yes: 
Does this occur at a certain time of day or after a certain activity (i.e., morning, night, after 
exercise)? 
_______________________________________________________________ 
Does anything help ease the tightness (i.e., certain exercises, medications)? 
_______________________________________________________________ 
Do you experience the following in the chest/shoulder/arm of affected side? 
1. Pain________ 
2. Swelling________ 




7. Other? Please describe. 
 












CHECKLIST FOR SIGNS AND SYMPTOMS OF DISEASE 
 
Condition Yes No Comments 
Cardiovascular 
Hypertension    
Hypercholesterolemia    
Heart Condition    
Fainting/dizziness    
Chest pain    
Pulmonary 
Asthma    
Bronchitis    
Emphysema    
METABOLIC 
Diabetes    
Excess weight changes    
Thyroid disease    
MUSCULOSKELETAL 
Osteoporosis    
Arthritis     
Low back pain    
Swollen joints    
Orthopedic pain    
Artificial joints    
 
OTHER 
    
    
    
    
    
 
PRESENT MEDICATIONS (name, dose, frequency: i.e. Aspirin/325 mg/ 1 daily)  
Name Dose Frequency Comments 
    
    
    
    
    





Appendix B: Questionnaires 
FACT –B 
Below is a list of statements that other people with your illness have said are important. Please circle or mark one 
number per line to indicate your response as it applies to the past 7 days. 
  Not at all A little-bit Somewhat Quite a bit Very much 
 Physical Well-Being 
     
GP1 I have a lack of energy 
0 1 2 3 4 
GP2 I have nausea 
0 1 2 3 4 
GP3 Because of my physical 
condition, I have trouble 
meeting the needs of my 
family 
0 1 2 3 4 
GP4 I have pain 
0 1 2 3 4 
GP5 I am bothered by side effects 
of treatment 
0 1 2 3 4 
GP6 I feel ill 
0 1 2 3 4 
GP7 I am forced to spend time in 
bed 
0 1 2 3 4 
 Social/Family Well-Being 
     
GS1 I feel close to my friends 
0 1 2 3 4 
GS2 I get emotional support from 
my family 
0 1 2 3 4 
GS3 I get support from my friends 
0 1 2 3 4 
GS4 My family has accepted my 
illness 
0 1 2 3 4 
GS5 I am satisfied with family 
communication about my 
illness 
0 1 2 3 4 
GS6 I feel close to my partner (or 
my main support) 
0 1 2 3 4 
GS7 I am satisfied with my sex life 
(if you prefer not to answer, 
skip this question) 
0 1 2 3 4 
 Emotional Well-Being 
     
GE1 I feel sad 
0 1 2 3 4 
GE2 I am satisfied with how I am 
coping with my illness 
0 1 2 3 4 
GE3 I am losing hope in the fight 
against my illness 




Not at all A little-bit Somewhat Quite a bit Very much 
GE4 I feel nervous 
0 1 2 3 4 
GE5 I worry about dying 
0 1 2 3 4 
GE6 I worry that my condition will 
get worse 
0 1 2 3 4 
 Functional Well-Being 
     
GF1 I am able to work (include 
work at home) 
0 1 2 3 4 
GF2 My work (include work at 
home) is fulfilling) 
0 1 2 3 4 
GF3 I am able to enjoy my life 
0 1 2 3 4 
GF4 I have accepted my illness 
0 1 2 3 4 
GF5 I am sleeping well 
0 1 2 3 4 
GF6 I am enjoying the things I 
usually do for fun 
0 1 2 3 4 
GF7 I am content with the quality 
of my life right now 
0 1 2 3 4 
 Additional Concerns 
     
B1 I have been short of breath 
0 1 2 3 4 
B2 I am self-conscious about the 
way I dress 
0 1 2 3 4 
B3 One/both of my arms are 
swollen or tender 
0 1 2 3 4 
B4 I feel sexually attractive 
0 1 2 3 4 
B5 I am bothered by hair loss 
0 1 2 3 4 
B6 I worry that other members of 
my family might someday get 
the same illness I have 
0 1 2 3 4 
B7 I worry about the effect of 
stress on my illness 
0 1 2 3 4 
B8 I am bothered by a change in 
weight 
0 1 2 3 4 
B9 I am able to feel like a woman 
0 1 2 3 4 
P2 I have certain parts of my 
body where I experience pain 






Godin Leisure-Time Exercise Questionnaire 
1. During the past 7 days (week), how many times on the average do you do the following kinds 
of exercise for more than 15 minutes during your free time (write appropriate number on each 
line).  
 
                                                                                              Times per Week                    
a) STRENUOUS EXERCISE                                                ____________                                
 (HEART BEATS  RAPIDLY)  
 (e.g., running, jogging, hockey, football, soccer, squash, basketball, cross country skiing, judo, 
roller skating, vigorous swimming, vigorous long distance bicycling)  
b) MODERATE 
EXERCISE                                                                             ____________                                   
(NOT EXHAUSTING)                         
 (e.g., fast walking, baseball, tennis, easy bicycling, volleyball, badminton, easy swimming, 
alpine skiing, popular and folk dancing) 
 c)  MILD 
EXERCISE                                                                             ____________                                    
(MINIMAL EFFORT)  
(e.g., yoga, archery, fishing from river bank, bowling, horseshoes, golf, snowmobiling, easy 
walking) 
2. During the past 7 days (week), in your leisure time, how often do you engage in any regular 
activity long enough to work up a sweat (heart beats rapidly)?  Please check one. 
 
 1.  Often _______          2. Sometimes  ______  3. Rarely/Never _______ 
 
Rehabilitation Assessment 
1. Do you have an additional health practitioner or rehabilitation specialist (chiropractor, 
physical therapist, naturopath, other)? 
    __________________________________________________________________________ 
2. If yes, how often did you visit a health practitioner or rehabilitation specialist in the past 7 
days (week)? 
__________________________________________________________________________ 
3. Do you continue to do exercises prescribed by a specialist in your own home? 
    __________________________________________________________________________ 





The Rand SF 36 Quality of Daily Living Questionnaire  
 
The following questionnaire asks questions to gain insight into a picture of your daily health. For 
each question, please circle one number that most appropriately describes your situation.  
 
1. In general, would you say your health is : 
Excellent                  1    Very Good              2       Good                  3 
Fair                          4     Poor                         5 
 
2. Compared to one year ago, how would you rate your health in general, now: 
Much better now than one year ago   1 
Somewhat better now than one year ago   2 
About the same      3 
Somewhat worse than one year ago   4 
Much worse now than one year ago   5 
 
The following items are about activities you might do during a typical day. Does your health 







limited at All 
3. Vigorous activities, such as running, lifting heavy 
objects, participating in strenuous sports 
[1] [2] [3] 
4. Moderate activities, such as moving a table, pushing a 
vacuum cleaner, bowling, or playing golf 
[1] [2] [3] 
5. Lifting or carrying groceries [1] [2] [3] 
6. Climbing several flights of stairs [1] [2] [3] 
7. Climbing one flight of stairs [1] [2] [3] 
8. Bending, kneeling, or stooping [1] [2] [3] 
9. Walking more than a mile [1] [2] [3] 
10. Walking several blocks [1] [2] [3] 
11. Walking one block [1] [2] [3] 




During the past 4 weeks, have you had any of the following problems with your work or other 
regular daily activities as a result of your physical health? 
 
Yes No 
13. Cut down the amount of time you spent on work or other activities 1 2 
14. Accomplished less than you would like 1 2 
15. Were limited in the kind of work or other activities 1 2 
16. Had difficulty performing the work or other activities (for example, it took extra effort) 1 2 
During the past 4 weeks, have you had any of the following problems with your work or other 




17. Cut down the amount of time you spent on work or other activities 1 2 
18. Accomplished less than you would like 1 2 
19. Didn't do work or other activities as carefully as usual 1 2 
20. During the past 4 weeks, to what extent has your physical health or emotional problems 
interfered with your normal social activities with family, friends, neighbors, or groups?  
Not at all  1          Slightly  2       Moderately   3 
Quite a bit  4 Extremely  5 
21. How much bodily pain have you had during the past 4 weeks? 
None   1  Very mild   2 Mild   3 
Moderate   4 Severe   5 Very severe  6 
22. During the past 4 weeks, how much did pain interfere with your normal work (including 
both work outside the home and housework)?  
Not at all  1 A little bit   2 Moderately   3 
Quite a bit  4 Extremely  5 
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These questions are about how you feel and how things have been with you during the past 4 























23. Did you feel full of pep? 1 2 3 4 5 6 
24. Have you been a very nervous person? 1 2 3 4 5 6 
25. Have you felt so down in the dumps 
that nothing could cheer you up? 
1 2 3 4 5 6 
26. Have you felt calm and peaceful? 1 2 3 4 5 6 
27. Did you have a lot of energy? 1 2 3 4 5 6 
28. Have you felt downhearted and blue? 1 2 3 4 5 6 
29. Did you feel worn out? 1 2 3 4 5 6 
30. Have you been a happy person? 1 2 3 4 5 6 
31. Did you feel tired? 1 2 3 4 5 6 
32. During the past 4 weeks, how much of the time has your physical health or emotional 
problems interfered with your social activities (like visiting with friends, relatives, etc.)? 
All of the time   1 Most of the time  2 Some of the time  3 
A little of the time  4 None of the time  5 










33. I seem to get sick a little easier than other people 1 2 3 4 5 
34. I am as healthy as anybody I know 1 2 3 4 5 
35. I expect my health to get worse 1 2 3 4 5 














Open a tight or new jar 1 2 3 4 5 
Write 1 2 3 4 5 
Turn a key 1 2 3 4 5 
Prepare a meal 1 2 3 4 5 
Push open a heavy door 1 2 3 4 5 
Place and object on a shelf above your head 1 2 3 4 5 
Do heavy household chores (wash walls, wash 
floors) 
1 2 3 4 5 
Garden or do yard work 1 2 3 4 5 
Make a bed 1 2 3 4 5 
Carry a shopping bag or briefcase 1 2 3 4 5 
Carry a heavy object (over 10lbs) 1 2 3 4 5 
Change a lightbulb overhead 1 2 3 4 5 
Wash or blow dry your hair 1 2 3 4 5 
Wash your back 1 2 3 4 5 
Put on a pullover sweater 1 2 3 4 5 
Use a knife to cut food 1 2 3 4 5 
Recreational activities which require little effort 
(card playing, knitting etc) 
1 2 3 4 5 
Recreational activities in which you take some 
force or impact through your arm, shoulder or 
hand (e.g., golf, hammering, tennis, etc.). 
1 2 3 4 5 
Recreational activities in which you move your 
arm freely (e.g., playing Frisbee, badminton). 
1 2 3 4 5 
Manage transportation needs (getting from one 
place to another). 
1 2 3 4 5 
Sexual activities 1 2 3 4 5 
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 Not at all Slightly Moderately Quite a bit Extremely  
During the past week, to what extent has your arm, 
shoulder or hand problem interfered with your 
normal social activities with family, friends, 
neighbours or groups? 
1 2 3 4 5 






Very limited Unable 
During the past week, were you limited in your work 
or other regular daily activities as a result of your 
arm, shoulder or hand problem? 
1 2 3 4 5 
Please rate the severity of the following symptoms in the 
last week. None Mild  Moderate  Severe  Extreme 
Arm, shoulder or hand pain 1 2 3 4 5 
Arm, shoulder or hand pain when you perform 
any specific activity 
1 2 3 4 5 
Tingling (pins and needles) in your arm, 
shoulder or hand 
1 2 3 4 5 
Weakness in your arm, shoulder or hand 1 2 3 4 5 
Stiffness in your arm, shoulder or hand 1 2 3 4 5 






I can’t sleep 
During the past week, how much difficulty have you 
had sleeping because of the pain in your arm, 
shoulder or hand? 
1 2 3 4 5 
 Strongly 
Disagree 
Disagree Neither agree 
or disagree  
Agree Strongly 
agree 
I feel less capable, less confident or less useful because 
of my arm, shoulder or hand problem. 
1 2 3 4 5 
Indicate work/job ability  (if you do not work skip 








Using your usual technique for your work? 1 2 3 4 5 
Doing your usual work because of arm, shoulder 
or hand pain? 
1 2 3 4 5 
Doing your work as well as you would like? 1 2 3 4 5 
Spending your usual amount of time doing your 
work? 
1 2 3 4 5 
Indicate sport/instrument (if you do not play sports or an 









Using your usual technique for playing your 
instrument or sport? 
1 2 3 4 5 
Playing your musical instrument or sport 
because of arm, shoulder or hand pain? 
1 2 3 4 5 
Playing your musical instrument or sport as 
well as you would like? 
1 2 3 4 5 
Spending your usual amount of time practising 
or playing your instrument or sport? 
1 2 3 4 5 
 
